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Abstract 
 
N-type voltage-gated calcium (CaV2.2) channels are expressed predominantly 
in the central and peripheral nervous systems and play a crucial role in 
neurotransmitter release.  Expression of these channels at the plasma 
membrane and in the membrane of presynaptic terminals is key for their 
function, however, how they are trafficked from the subcellular organelles is still 
poorly understood.  In this study, trafficking of mutually-exclusive alternative 
splice variants of CaV2.2, containing either exon 37a or 37b at the proximal C-
terminus and its mechanisms were examined.  CaV2.2 with exon 37a 
(selectively expressed in nociceptors) reveals a significantly greater intracellular 
trafficking to the axons and plasma membrane of DRG neurons than CaV2.2 
with exon 37b.  Further examination of the amino acid sequence in exon 37 
uncovers that the canonical binding motifs for adaptor protein 1 (AP-1), YxxΦ 
and [DE]xxxL[LI], present only in exon 37a are accountable for mediating the 
enhanced channel trafficking from the trans-Golgi network to the plasma 
membrane.  Finally, the dopamine-2 receptor (D2R) and its agonist-induced 
activation, reveal differential effects on trafficking of these CaV2.2 isoforms.  
D2R slowed the endocytosis of CaV2.2 containing exon 37b but not exon 37a, 
and activation by the D2R-selective agonist quinpirole reversed the effect of the 
D2R.  Disrupting the interaction between adaptor proteins and YxxΦ or 
[DE]xxxL[LI] in CaV2.2 perturbed these effects, suggesting that the interaction of 
adaptor proteins with CaV2.2 channels may also be key underlying mechanisms 
for differential trafficking of CaV2.2 splice variants, mediated by D2R.  This study 
thus reveals key mechanisms involved in the trafficking of N-type calcium 
channels.  
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Chapter 1 Introduction 
1.1 Background 
1.1.1 Neurons 
Neurons are excitable cells, and in human more than 86 billion neurons 
comprise the central and peripheral nervous systems (Herculano-Houzel, 
2009).  The neuronal plasma membrane contains transporters and channels 
that establish the resting potential of approximately -70 mV.  Neurons 
differentiate to adapt highly polarised morphologies for their specialised 
functions: signalling and transmitting information.  Typically, a neuron in the 
central nervous system has an axon, a cell body (soma) and dendrites (Figure 
1.1).  These compartments differ from each other in the composition of their 
proteins to mediate their designated functions.  These special morphologies are 
established in response to the extracellular signals as well as the intracellular 
mechanisms (reviewed in Arimura and Kaibuchi, 2007).  
 
1.1.2 Plasma membrane and membrane potential 
In mammalian cells, the intracellular compartment is separated from the 
extracellular environment by the plasma membrane (Alberts et al., 2002).  The 
plasma membrane consists of a phospholipid bilayer, which forms an 
impermeable barrier to ions while allowing diffusion of nonpolar molecules such 
as O2, CO2 and water.  The only route for ions to cross the lipid bilayer is via 
transporter proteins or ion channels, which allow the controlled movement of 
ions across the plasma membrane, thus establishing different ionic solute 
compositions inside from outside the cell. The difference in electrochemical 
gradient across the plasma membrane creates the membrane potential.  This 
property is crucial for the physiological function of the cells, especially for  
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Figure 1.1 Schematic diagram of neurons. 
Diagram of a presynaptic neuron shows a cell body containing a 
nucleus, and projections from the cell body such as dendrites and 
an axon which is surrounded by electrically insulating myelin 
sheath.   At presynaptic terminals, the presynaptic neuron makes 
a connection with a postsynaptic neuron via synapses for signal 
transmission.  (http://science.kennesaw.edu/) 
 
excitable cells such as neurons for transmitting signals in the form of potential 
changes.   
1.1.3 Ion channels 
Ion channels exist as the selective pores in the plasma membrane for 
inorganic ions such as Na+, K+, Ca2+ and Cl- (Hille, 2001).  Ion channels are 
different from transporters such that their fast conductance (105 times faster 
than transporters) does not require energy input, and they mediate passive 
transport of specific ions down the electrochemical gradient.  Ion channels 
interchange between open (active) and closed (inactive or desensitised) states, 
a process known as gating, in response to a change in their environment.  
There are mainly two types of ion channels: voltage-gated and ligand-gated.  
Voltage-gated ion channels are activated and deactivated by membrane 
potential changes, while ligand-gated ion channels are activated by binding of 
small molecules or peptides.   
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1.1.4 Action potential 
An action potential is a large rise and fall in membrane potential from 
the resting membrane potential.  It occurs in excitable cells such as neurons, 
muscle cells and endocrine cells, and is crucial for the communication between 
multiple cells.  Action potentials in neurons were first measured by Hodgkin and 
Huxley in 1952.  In their study, they determined the time and voltage-
dependence of inward Na+ current and outward K+ current in the squid giant 
axon, and deduced that these changes in conductance cause the action 
potential (Hodgkin and Huxley, 1952).  Indeed, later it was discovered that 
activation of voltage-gated sodium (NaV) channels is fully accountable for the 
influx of Na+ (Narahashi et al., 1964), as a result of small depolarization that was 
propagated by the neighbouring region and activates the channels when it 
reaches the threshold, which leads to a large depolarization (Figure 1.2).  Action 
potentials are typically initiated by NaV channel activation and are self-
propagating. Action potentials are automatically triggered once this threshold is 
surpassed, thus they are said to be “all-or-none”.   
 
1.1.5 Neurotransmitter release 
Neurotransmitters are endogenous chemicals that transmit signals from 
a neuron to another neuron or its targets such as muscle and endocrine cells.  
Junctions between multiple neurons are called synapses, in which an electrical 
signal in a neuron is converted into a chemical signal by release of 
neurotransmitters, which then activate the neighbouring neuron(s) by diffusing 
across the synapse.  Neurotransmitter release from presynaptic terminals are 
tightly regulated by multiple events, however, the most crucial event is the Ca2+ 
influx into the synapses via calcium ion channels (Katz and Miledi, 1965).  
When the action potential reaches the presynaptic terminal, the depolarisation 
activates voltage-gated calcium ion channels (VGCCs) and Ca2+ in the 
presynaptic terminal triggers the exocytosis of vesicles containing 
neurotransmitter to be released into the synaptic cleft (Reynolds et al., 1986).  
The region of presynaptic terminals dense with vesicles and release machinery 
is known as the active zone (reviewed in Südhof, 2012).   
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Figure 1.2 Action potential.  
At resting state, the plasma membrane of neurons is at around   
-70 mV (known as resting potential). Electrical stimulation of a 
neuron raises the membrane potential, and when the stimulus is 
large enough for the membrane potential to rise above the 
threshold potential (~ -55 mV), a burst of depolarisation occurs 
where the membrane potential rises to ~ +40 mV by opening of 
NaV channels. At this potential, potassium channels are 
activated and cause repolarisation of the membrane potential.  
After a small overshoot (hyperpolarisation), the membrane 
potential returns to the resting potential, ready for the next action 
potential.    
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Neurotransmitter release from the vesicles at the active zone is tightly 
regulated by numerous proteins which compose the presynaptic release 
machinery (reviewed in Südhof, 2013).  First, synaptobrevin (also known as 
VAMP) on the synaptic vesicle forms a complex with the SNARE (soluble NSF 
attachment receptor) proteins, syntaxin-1 and SNAP-25 on the plasma 
membrane in the active zone (Söllner et al., 1993).  Munc18 also interacts with 
syntaxin-1 to form a part of a SNARE protein complex to complete the initial 
stage of the vesicle priming (Hata et al., 1993; Dulubova, 1999).  The zippering 
of the four-helical SNARE complexes forces the vesicle membrane and the 
plasma membrane to a close proximity for fusion (Hanson et al., 1997).  
Complexin then binds to the SNARE protein complex (McMahon et al., 1995), 
which engages the Ca2+-binding transmembrane protein synaptotagmin on the 
synaptic vesicle (Perin et al., 1990; Brose et al., 1992) to the SNARE complex 
by acting as a cofactor of synaptotagmin, and completes the priming.  
Synaptotagmin is thought to act as a Ca2+ sensor in the SNARE protein 
complex, and its interaction with Ca2+ is necessary for triggering fast vesicle 
exocytosis (Geppert et al., 1994; Fernández-Chacón et al., 2001; Sørensen et 
al., 2003; Pang et al., 2006).  For a fast vesicle fusion in response to the action 
potential, the VGCC needs to be in a close proximity to the vesicle fusion site to 
allow Ca2+ influx.  Another cytosolic protein complex, which consists of Rab3-
interacting molecule (RIM), RIM-Binding Protein (RIM-BP) and Munc-13, binds 
to Rab3 on the vesicle and mediates the docking and priming of the synaptic 
vesicle, and recruits VGCC to the primed vesicle in the active site (Kaeser et al., 
2011).  VGCCs are generally positioned within 100 nm away from the docked 
vesicle to ensure the fast coupling of the action potential to Ca2+-triggered 
neurotransmitter release (Eggermann et al., 2012).   
 
 
1.2 Voltage-gated calcium ion channels (VGCCs) 
VGCCs are expressed in all excitable cells such as neurons, skeletal 
muscle cells, heart cells and endocrine cells and play an important role in the 
physiological function of these cells.  VGCCs consist of 3 subfamilies, 
comprised of 10 members in total (Figure 1.3); the CaV1 and CaV2 families are 
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activated by high voltage, whereas the CaV3 family is activated by low voltage.  
All members contain a pore forming α1 subunit, which allow influx of Ca2+ upon 
activation.  The majority of these interact with auxiliary subunits α2δ, β and γ, 
which modulate the activity of the α1 subunit.  Tissue distribution, specific 
blockers and association with auxiliary subunits of each VGCC are summarised 
in Table 1.1.  
 
 
 
Cav1.1 (α1S)
Cav1.2 (α1C)
Cav1.3 (α1D)
Cav1.4 (α1F)
Cav2.1 (α1A)
Cav2.2 (α1B)
Cav2.3 (α1E)
Cav3.1 (α1G)
Cav3.2 (α1H)
Cav3.3 (α1I)
HVA
LVA
Cav1
Cav2
Cav3
L-type
T-type
P/Q type
N-type
R-type
+β, α2δ
 
Figure 1.3 Subtypes of VGCCs. 
VGCC family consists of 10 members (previous nomenclatures in 
brackets). CaV1 and CaV2 are high-voltage activated (HVA) 
channels and associated with auxiliary subunits β and α2δ. CaV3 
are low-voltage activated (LVA) and their function is not dependent 
on the auxiliary subunits.   
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Table 1.1 Characteristics of VGCCs. 
Type VGCC Tissues Specific 
blockers 
Functions 
L 
CaV1.1 Skeletal muscle DHPs Excitation-contraction 
coupling 
Calcium homeostasis 
Gene regulation 
CaV1.2 Cardiac muscle 
Endocrine cells 
Neurons 
DHPs Excitation-contraction 
coupling 
Calcium homeostasis 
Gene regulation 
CaV1.3 Endocrine cells 
Neurons 
DHPs Hormone secretion 
Gene regulation 
CaV1.4 Retina DHPs Tonic neurotransmitter 
release 
P/Q CaV2.1 Nerve terminals  
Dendrites 
ω-Agatoxin 
IVA 
Neurotransmitter 
release 
Dendritic Ca2+ 
transients 
N CaV2.2 Nerve terminals 
dendrites 
ω-Conotoxin 
GVIA 
Neurotransmitter 
release 
Dendritic Ca2+ 
transients 
R CaV2.3 Cell bodies 
Nerve terminals 
dendrites 
SNX-482* Neurotransmitter 
release 
T 
 
CaV3.1 Cardiac muscle 
Skeletal muscle 
Neurons 
TTA-A2 
TTA-P2 block 
all CaV3 
Pacemaking and 
repetitive firing of action 
potential 
 
CaV3.2 Cardiac muscle  
Neurons 
None ** 
 
CaV3.3 Neurons None 
*only in some cell types.  ** Ni has some selectivity. Adapted from Catterall 
(2000). 
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1.2.1 CaV2.2 (N-type) 
The N-type VGCC (CaV2.2) encoded by the CACNA1b gene is widely 
expressed in the central and peripheral nervous system, and plays an important 
role in neurotransmission.  CaV2.2 was first distinguished from other calcium 
channels, such as L-type and T-type channels, present in isolated chick dorsal 
root ganglions (DRGs) by observation of its different voltage-dependence and 
rate of inactivation (Nowycky et al., 1985).  CaV2.2 is also pharmacologically 
distinguishable. CaV2.2 is persistently blocked by ω-conotoxin GVIA, but is 
insensitive to the L-type calcium channel blockers, 1,4-dyhydropyridines 
(McCleskey et al., 1987).  The function of CaV2.2 channels is particularly 
important at presynaptic terminals where they are recruited to the active zone 
where they are activated upon the arrival of action potentials, triggering influx of 
Ca2+ through the pore-forming α1 subunit and causing neurotransmitter release 
(Reynolds et al., 1986; Hirning et al., 1988; Maximov and Bezprozvanny, 2002; 
Han et al., 2011).  The recruitment of the channels to the vicinity of the docked 
synaptic vesicle in the active site is mediated by the binding of RIM and RIM-BP 
to the C-terminus (Hibino et al., 2002; Kaeser et al., 2011).  CaV2.2 is thought to 
be important in neurotransmission particularly in the development of 
neuropathic pain, as treatments with selective CaV2.2 antagonists and CaV2.2 
α1 subunit knockout mice show markedly reduced response to painful stimuli 
(Bowersox et al., 1996; Chaplan et al., 1994; Hatakeyama et al., 2001; Kim et 
al., 2001; Saegusa et al., 2001).     
 
1.2.2 Structure of CaV2.2 
CaV2.2 was first purified using 125I ω-conotoxin GVIA from rat brain, 
which co-purified with auxiliary subunits β and α2δ (McEnery et al., 1991), at a 
molecular weight of 230 kDa (α1), 60-70 kDa (β) and 175 kDa (α2δ). 
Traditionally, these auxiliary subunits are thought to play a key role in 
modulating the biophysical properties and trafficking of CaV2.2. CaV2.2 consists 
of 4 repeated domains (I-IV) (Figure 1.4).  Each domain contains 6 
transmembrane α helices (S1-S6) (Dubel et al., 1992).  S4 is a voltage-sensing 
transmembrane segment. The intracellular linkers between these domains, as 
well as the N-terminal and C-terminal domains interact with a number of 
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cytosolic proteins including CaV auxiliary β subunits, and these interactions are 
thought to play important role in modulating channel properties and cell surface 
expression (Catterall, 2000; Dolphin, 2012).   
 
 
 
 
 
 
1.2.2.1 α2δ subunits 
There are 4 genes encoding α2δ proteins, CACNA2D1 - 4, which 
encode for α2δ-1, -2, -3 and -4.  α2δ-1, α2δ-2 and α2δ-3 are expressed widely in 
the central and peripheral nervous system.  In particular, α2δ-1 is found in many 
neuronal cell types, including DRGs (Dolphin, 2012).  α2δ subunits are 
glycosylphosphatidylinositol (GPI)-anchored extracellular proteins (Davies et al., 
2010) and are thought to interact weakly with the extracellular loops of α1 
subunits (Gurnett et al., 1997), and increase the Ca2+ current density and 
modulate voltage dependency (Cantí et al., 2003).  α2δ increases Ca2+ current 
I II III IV
C
N
δ
α2
β
 
Figure 1.4 Structure of CaV2.2 and auxiliary subunits β and 
α2δ. 
The pore forming α1 subunit (blue) consists of domain I-IV, each 
containing 6 transmembrane α helices (S1-S6). Auxiliary subunits 
β (green) binds to the intracellular I-II loop, while α2δ (orange) is a 
GPI-anchored protein which associates with the extracellular 
region of α1. 
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density at least in part by increasing the trafficking of VGCCs to the cell surface 
(Cassidy et al., 2014).  The trafficking mechanism of α2δ is still unknown, but 
the metal ion-dependent adhesion site (MIDAS) motif found within a Von 
Willebrand factor A (VWA) domain may be crucial (Cantí et al., 2005).  The 
proteolytic cleavage and formation of the disulphide bond between α2 and δ are 
also important for α1 subunit functions (Figure 1.5) (Jay et al., 1991; Davies et 
al., 2010; Calderón-Rivera et al., 2012).  In addition, antiepileptic and 
neuropathic pain treatment drug gabapentin which binds to α2δ reduces the cell 
surface expression of CaV2.2 when applied chronically, leading to reduction in 
CaV2.2 current (Field et al., 2006; Hendrich et al., 2008; Cassidy et al., 2014). 
 
 
 
 
 
Figure 1.5 Formation of α2δ subunits.  
α2δ is encoded as a single gene to be expressed as a pro-form 
protein. The VWA domain is indicated in red.  Its C-terminus end 
of the protein is GPI-anchored, and glycosylation (denoted as V) 
takes place on both α2 and δ proteins. The GPI-anchor consists of 
ethanolamine (orange), three mannose rings (blue), glucosamine 
(pink), and inositol (yellow).  Disulphide bridge is thought to form 
between α2 and δ before the pro-form is proteolytically cleaved by 
an unknown protease (Davies et al., 2010).  
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1.2.2.2 β subunits 
There are four β subunit genes encoding β1, β2, β3, and β4. A splice 
variant form of β1, β1b is also identified in neuronal cells (reviewed in Buraei 
and Yang, 2010; Dolphin, 2003a, 2012).  Crystal structures have been solved 
for β2, β3, and β4 by three groups, showing two highly conserved domains: a 
guanylate kinase (GK) domain and src homology 3 (SH3) domain (Chen et al., 
2004; Opatowsky et al., 2004; Van Petegem et al., 2004).  From these studies it 
was found that the α interaction domain (AID) motif in the I-II loop of α1 subunit 
interacts with the GK domain, not the β interaction domain (BID) motif where it 
was originally predicted to bind (Figure 1.6).  The increased Ca2+ current 
density due to co-expression of β subunits with CaV channels has been 
demonstrated in a number of electrophysiological and immunocytochemistry 
studies in heterologous expression systems.  It was originally thought that β 
subunits mask an endoplasmic reticulum (ER) retention signal and increase the 
trafficking of the α1 subunit to the cell membrane (Bichet et al., 2000; Cornet et 
al., 2002), however, no such motifs have been identified in the I-II loop of α1 
subunit.  Instead, it is likely that β subunits increase the cell surface expression 
of the α1 subunit by protecting it from proteasomal degradation (Altier et al., 
2011; Waithe et al., 2011).  
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1.2.2.3  γ subunits 
γ subunits were originally identified by co-purification with then skeletal 
muscle isoform of VGCCs from dihydropyridine labelling (Takahashi et al., 
1987).  Association of γ subunits with VGCCs in the brain is still unclear, since 
the purification and immunoprecipitation of N-type and P/Q-type channels from 
the brain membrane preparation did not reveal γ subunits, despite the fact that 
several forms of γ subunit-like proteins, including stargazin are expressed in the 
brain (Catterall, 2011).  These γ subunit-like proteins are also known as 
transmembrane α-amino-3-hydroxy-5-metheyl-4-isoxazolepropionic acid 
(AMPA) regulatory proteins (TARPs), which interact with AMPA receptors and 
stabilise their lateral diffusion at the post-synaptic cell surface (Bats et al., 
2007).   
 
Figure 1.6 Crystal structure of a CaV β subunit. 
Cytosolic protein CaV β consists of SH3 domain (yellow) and GK 
domain (green), connected by a HOOK region (purple).  AID motif 
in the I-II loop of CaV α subunit (red) is modelled in this structure, 
showing its interaction with GK domain.  BID motif of β3 (dark blue) 
modelled in the crystal structure shows a very little interaction with 
AID (Buraei and Yang, 2010).   
- 30 - 
 
1.2.3 G-protein-mediated regulation of VGCCs 
Activities of VGCCs are regulated by the action of G protein-coupled 
receptors (GPCRs) that are activated by extracellular signals such as 
neurotransmitters and hormones that act as agonists (for reviews see Dolphin, 
2003b; Tedford and Zamponi, 2006).  GPCR activation causes activation of 
heterotrimeric G protein (Gαβγ), which dissociates into Gα and Gβγ that act as 
signalling molecules, and can either enhance or inhibit the activity of VGCCs.  
G-protein mediated inhibition of VGCCs was first described in chick DRG 
neurons, in which the action potential was reduced in response to the γ-
aminobutyric acid (GABA), 5-hydroxytryptamine (5-HT) and noradrenaline.  It 
was revealed that inhibition of VGCCs leads to the reduction in the action 
potential (Dunlap and Fischbach, 1981).  
 The subtypes of GPCRs that are involved in inhibition of VGCCs are 
typically the Gi/Go subtypes that couple to and activate pertussis toxin-sensitive 
Gi/Go G proteins.  Examples of these receptors are α2 adrenergic, GABAB, δ 
and μ-opioid, adenosine A1 receptors (Dolphin and Scott, 1987; Scott and 
Dolphin, 1987).  The tonic inhibition by the activation of these GPCRs can be 
removed by a depolarising prepulse immediately prior to the channel activation 
pulse (Ikeda, 1991).   
Gβγ directly modulates the biophysical properties of VGCCs, 
predominantly N- and P/Q-type VGCCs, whereas the Gα species do not.  This 
mode of direct G-protein modulation was first reported from transfection of 
neurons or cell lines with Gβγ, which led to inhibition of the calcium current that 
could be transiently reversed by a depolarising pulse, similarly to the activation 
of GPCRs by neurotransmitters, whereas transfection with different Gα species 
had no effect (Herlitze et al., 1996; Ikeda, 1996).  The exact mechanism of how 
Gβγ modulates CaV2.1 and CaV2.2 channels is still unclear, however, binding of 
Gβγ to the N-terminus, I-II loops and C-terminus of CaV2.2 is considered to play 
a crucial role (De Waard et al., 1994; Zamponi et al., 1997; Page et al., 1998; 
Cantı ́ et al., 1999; Li et al., 2004).  G-protein mediated inhibition of CaV2.2 is 
due to the slowed rate of activation and the shift of activation voltage to a more 
depolarised potential.  In addition, the gating of CaV2.2 is accelerated by 
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prolonged depolarisation to a more positive potential, which indicates that the 
movement of S4 voltage-sensor is impaired (Jones et al., 1997).    
Different Gα subunits can also modulate VGCCs indirectly via activation 
of intracellular signalling cascades.  Activated Gαs activates adenylyl cyclase 
which increases cyclic AMP (cAMP) level, and activates cyclic AMP-dependent 
protein kinase, protein kinase A, whereas protein kinase C is mainly activated 
indirectly by Gq-coupled receptors. Phosphorylation by these kinases enhances 
activity of VGCCs, particularly for L-type VGCCs (for review see Catterall, 
2000).   
 
 
1.3 Alternative splicing 
During pre-mRNA splicing, introns are removed and appropriate exons 
are joined by spliceosomes.  Alternative splicing occurs in > 80 % of genes, and 
enables formation of multiple isoform proteins from a single gene, thereby 
generating complex proteomes (Matlin et al., 2005).  Different splice sites can 
be joined together (Figure 1.7).  This process is regulated by cis (sequences in 
pre-mRNA) and trans (protein or RNA) components of splicing.   
 
1.3.1 Alternative splicing in VGCCs 
There are a number of studies on various alternative splicing in VGCCs, 
reporting its effects on biophysical properties, tissue distributions, and 
expression at different developmental stages.  The VGCC splice variants 
discussed here are summarised in Table 1.2.  
 
1.3.1.1 P/Q-type 
A number of alternative splicing variants of CaV2.1 are reported to occur 
in the C-terminus.  Exon 37 of CaV2.1 contains exon 37a and 37b, which are 
alternatively spliced in a mutual exclusive manner (Krovetz et al., 2000).  In rat 
hippocampus, CaV2.1e37b is expressed throughout the developmental stages,  
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whereas CaV2.1e37a is not expressed in embryonic rat hippocampus (Vigues et 
al., 2002).  Exon 37 of Cav2.1 overlaps with a EF hand-like region where 
calmodulin binds, and the channels containing e37 give rise to a larger current 
that show calcium-dependent facilitation, and the PCR of the human cDNA 
library shows that CaV2.1e37a is upregulated during development (Chaudhuri et 
al., 2004).  Furthermore, immunocytochemistry with specific antibodies against 
e37a and 37b show enhanced localisation of CaV2.1e37b channels in dendrites 
of Purkinje neurons (Chaudhuri et al., 2005).  In addition, this splice isoform 
 
Figure 1.7 Different modes of alternative splicing.  
A schematic diagram showing different modes of alternative 
splicing of exons. (A) Exon inclusion / exclusion, in which the 
alternative exon (black) is included or excluded. (B) Mutually 
exclusive exons (black and shaded), in which the final mRNA 
sequence can contain one of the exons, but not the other 
simultaneously. (C) The alternate 5’ splice donor can include or 
exclude the 3’ end of the sequence (black) of the first exon. (D) 
The alternate 3’ splice acceptor can include or exclude the 5’ end 
of the sequence (black) of the second exon. (Kaneko, 2003)   
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CaV2.1e37b shows a ~30% increase in its expression in the cerebellum of 
ducky (du2J/du2J) mice, which contain mutations in α2δ-2, compared to the wild-
type without changing the total expression level of CaV2.1 (Donato et al., 2006).   
Another CaV2.1 splice variant which is missing exon 44 shows inactivation 
which is 3 times slower than CaV2.1 with exon 44 (Krovetz et al. 2000).  An 
insertion in exon 46 in the distal C-terminus of CaV2.1 creates a stop codon, 
resulting in a CaV2.1 splice variant with a C-terminus that is 151-amino acids 
shorter (BI-1) than the longer form (BI-2).  BI-2 has a more hyperpolarised 
activation voltage in the presence of β3 and β4, as well as a significantly larger 
whole-cell current with β4.  On the other hand, the biophysical properties of BI-1 
are not significantly affected by these β subunits (Mori et al., 1991; Sandoz et 
al., 2001).  In patients with spinocerebellar ataxia 6 (SCA6), inclusion of exon 
47 leads to expression of an expanded CAG repeat sequence, which generates 
CaV2.1 channels with an extended poly-glutamine repeat that correlates with 
the severity of SCA6 (Zhuchenko et al., 1997).     
Another site of CaV2.1 splice variation occurs in S3-S4 loop in Domain 
IV, as an insertion of two amino acids (NP) exhibits 10 times less selective-
antagonist agatoxin IVA inhibition compared to CaV2.1 without the NP insertion 
(Bourinet et al. 1999).  There are a number of other short isoforms identified by 
western blot and in-situ hybridization, which could arise from an exon inclusion 
or exclusion during splicing events which causes a frame shift and termination 
of a coding sequence, but it is unclear whether these truncated channels arise 
as a result of alternative splicing (Sakurai et al., 1995; Scott et al., 1998), and  
require further confirmation by pre-mRNA analysis such as reverse 
transcriptase PCR (RT-PCR). 
 
1.3.1.2 N-type 
Tissue specific expression of CaV2.2 splice variants has been reported, 
for example the rat brain isoform contains an alternative exon 24a, which leads 
to an insertion of four amino acids (SMGF) in the S3-S4 loop in Domain III, 
whereas the sympathetic neuronal isoform contains an alternative exon 31a, 
which causes an insertion of two amino acids (ET) in the S3-S4 loop in Domain 
IV, and shifts the activation voltage to a more hyperpolarized potential and 
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slows the opening of the channel (Lin et al., 1997, 1999; Lipscombe et al., 
2002).  Alternative splicing at exon 18 of CaV2.2 leads to an insertion of 21 
amino acids and causes a shift in the steady-state inactivation to a more 
depolarised state (Pan and Lipscombe, 2000; Lipscombe et al., 2002).  
Furthermore, CaV2.2 splice variants that omit exon 18 to 21 (Δ1) and exon 18 to 
19 (Δ2) in the II-III loop are identified in human brain (Kaneko et al., 2002).  
These splice variants do not interact with syntaxin 1A, and interestingly, Δ1 
shows 10-30 times less affinity towards the selective antagonist ω-conotoxin 
GVIA.   
Exon 37 in the C-terminus of CaV2.2 is also alternatively spliced in a 
mutually exclusive manner, similarly to CaV2.1, which will be discussed in detail 
below.  In addition, at the distal end of CaV2.2 C-terminus a splice variant from 
the rabbit brain that is 187-amino acid shorter, due to the loss of the 3’ acceptor 
splice site at exon 46 has been reported (Williams et al., 1992).  The long splice 
variant appears to be trafficked to the axons and presynaptic terminals of 
mature cultured hippocampal neurons and excluded from the somatodendritic 
compartments, whereas the short splice variant is expressed throughout the 
neurons (Maximov and Bezprozvanny, 2002).     
 
1.3.1.3 L-type 
Alternative splicing in L-type VGCCs has been extensively studied, 
especially in the context of diseases (for reviews, see Liao et al., 2009; 
Lipscombe et al., 2013). CaV1.2 in Timothy syndrome patients contains a gain-
of-function mutation (often G406R) in an alternative spliced mutually exclusive 
exon 8a within the S6 transmembrane of Domain I, which exhibits a more 
severe phenotype than when the same mutation is in exon 8 (Splawski et al., 
2004).  Mutually-exclusive alternative splicing occurs in exon 8 of CaV1.3 as 
well, and a loss-of-function mutation in exon 8b is found in patients with 
hereditary hearing loss and bradycardia (Baig et al., 2011).  Somatic gain of 
function mutations, including in exon 8a have been identified in adrenal zona 
glomerulosa cells, leading to hyperaldosteronism (Azizan et al., 2013).   
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Table 1.2  Summary of VGCC alternative splice variants. 
VGCC Exon Consequences of splicing References 
CaV1.2 8 Severe phenotype with exon 8a when 
gain-of-function mutation (often G406R) is 
found in Timothy syndrome patients 
Splawski et al., 
2004   
CaV1.3 8 Loss-of-function mutation in exon 8b in 
patients with hereditary hearing loss and 
bradycardia 
Baig et al., 
2011 
8 Somatic gain of function mutations in exon 
8a in adrenal zona glomerulosa cells lead 
to hyperaldosteronism 
Azizan et al., 
2013 
CaV2.1 37a/37b  Channels containing exon 37 give rise 
to a larger current that show calcium-
dependent facilitation 
 Exon 37b is expressed throughout the 
developmental stages 
 Exon 37a is upregulated during 
development to adult 
 Enhanced localisation of exon 37b 
containing channels in dendrites of 
Purkinje neurons 
 Exon 37b shows a ~30% increase in its 
expression in the cerebellum of ducky 
(du2J/du2J) mice 
Vigues et al., 
2002,  
Chaudhuri et 
al., 2004, 
Chaudhuri et 
al., 2005, 
Donato et al., 
2006   
44 3 times slower inactivation in channels 
missing exon 44  
Krovetz et al., 
2000 
46 Insertion in exon 46 creates a stop codon, 
resulting in a shorter form (BI-1) and a 
longer form (BI-2). BI-2 has a more 
hyperpolarised activation voltage with β3 
and β4, and a significantly larger whole-
cell current with β4, compared to BI-1  
Mori et al., 
1991; Sandoz 
et al., 2001  
47 Inclusion of exon 47 leads to an expanded 
CAG (ploy-glutamine) repeat expression 
which correlates with the severity of SCA6 
Zhuchenko et 
al., 1997  
CaV2.2 18 Exon18a leads to 21-amino acids 
insertion, causes a shift in the steady-state 
inactivation to a more depolarised state 
Pan and 
Lipscombe, 
2000; 
Lipscombe et 
al., 2002 
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CaV2.2 24 Exon 24a leads to an insertion of four 
amino acids (SMGF) in the S3-S4 loop in 
Domain III, shifts the activation voltage to 
a more hyperpolarized potential and slows 
the opening of the channel 
Lin et al., 
1997, 1999; 
Lipscombe et 
al., 2002 
31 Exon 31a leads to an insertion of two 
amino acids (ET) in the S3-S4 loop in 
Domain IV, shifts the activation voltage to 
a more hyperpolarized potential and slows 
the opening of the channel 
Lin et al., 
1997, 1999; 
Lipscombe et 
al., 2002 
omitted 
exon 18-21 
(Δ1),18-19 
(Δ2) 
Identified in human brain, do not interact 
with syntaxin 1A.  Δ1 shows 10-30 times 
less affinity towards the selective 
antagonist ω-conotoxin GVIA 
Kaneko et al., 
2002     
37a/37b  Exon 37b is expressed in all neuronal 
cells 
 Exon 37a expression is found in 
nociceptive DRG neurons, coexpressed 
with TRPV1 and NaV1.8, and down-
regulated in DRGs of neuropathic pain 
models 
 Exon 37a conducts larger Ca2+ current, 
opens for longer and shows greater 
gating charges than 37b 
 Exon 37a is important in thermal 
hyperalgesia, both isoforms contribute 
to mechanical allodynia  
 Exon 37a is voltage-independently 
inhibited by GABA and μ-opioid 
receptor activation, and important for 
morphine analgesia 
Bell et al., 
2004, 
Castiglioni et 
al., 2006, Altier 
et al., 2007, 
Raingo et al., 
2007, Andrade 
et al., 2010, 
Jiang et al., 
2013 
46 The loss of the 3’ acceptor splice site at 
exon 46 leads to a short form which is187-
amino acid shorter.  The long form is 
trafficked to the axons and presynaptic 
terminals and excluded from the 
somatodendritic compartments. The short 
form is expressed throughout the neurons 
Williams et al., 
1992, 
Maximov and 
Bezprozvanny, 
2002 
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1.3.2 Expression of CaV2.2e37a/b 
Cav2.2e37a/b splice variants arise from the alternative splicing of two 
mutually-exclusive exons 37a (e37a) and 37b (e37b) in the CACNA1B gene. 
Both exon 37 variants code for 32 amino acids, and 14 of those are different 
between e37a and e37b (Figure 1.8).  CaV2.2 containing e37b is expressed 
abundantly in the central and peripheral nerves, whereas CaV2.2 containing 
e37a is only detected in DRGs, and at very low levels in brain (Bell et al., 2004; 
Castiglioni et al., 2006).  The RNA level of CaV2.2e37a determined by RNase 
protection assay is approximately 6 % of the total CaV2.2 RNA in DRGs, on the 
other hand it is less than 2 % in brain.  Whether or not these RNA levels reflect 
the protein expression of the isoforms has not been determined, due to the lack 
of specific antibodies against these splice variants.   
Despite the low level of CaV2.2e37a RNA, it is thought to have a 
significant role in modulating nociception.  Bell et al. (2004) determined the level 
of CaV2.2 from individual DRG neurons by single-cell RT-PCR using e37a- and 
e37b- specific primers after testing for capsaicin responsiveness.  Interestingly, 
CaV2.2e37a is preferentially expressed in small-diameter DRG neurons that are 
responsive to capsaicin.  In addition, all of the DRG neurons expressing e37a 
also express the tetrodotoxin (TTX)-resistant sodium ion channel NaV1.8 (Bell et 
al., 2004).  Taken together, from these single cell RT-PCR experiments, 
approximately 75 % of DRG neurons expressing CaV2.2e37a are nociceptive 
small-diameter neurons (Bell et al., 2004).  These small diameter neurons are 
likely to be unmyelinated C-fibre neurons, which project into laminae I and II of 
the dorsal horn of the spinal cord (Snider and McMahon, 1998; Basbaum et al., 
2009).  It is estimated that at least 20% of total DRG neurons express 
CaV2.2e37a (Castiglioni et al., 2006), whereas CaV2.2e37b was expressed 
ubiquitously in all types of DRG neurons.   
In another study where the RNA levels of e37a and e37b were 
determined in rat DRGs after spinal nerve ligation as an animal model of 
neuropathic pain, surprisingly transcription of e37a was significantly down-
regulated from 7 % to 3 % while the mRNA level of e37b remained the same 
(Altier et al., 2007).   
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In summary, these studies indicate that CaV2.2e37a is highly expressed 
in the small nociceptive DRGs and serves an important role in nociception, and 
may be down-regulated following sensory nerve injury, as a part of endogenous 
anti-nociceptive mechanism.  
 
 
 
a 
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Figure 1.8 Mutually exclusive alternative splicing in CaV2.2 
exon 37  
(a) Exon 37 (yellow) is located in the proximal C-terminus of 
CaV2.2, close to the S6 of Domain IV and the plasma membrane.  
(b) Schematic diagram of mutually-exclusive exons 37a and 37b, 
and their amino acid alignment. The conserved residues are 
highlighted.  
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1.3.3 CaV2.2e37a channels conduct more Ca2+ current than e37b 
The capsaicin-responsive DRGs expressing both CaV2.2e37a and e37b 
have shown a significantly larger N-type Ca2+ current than those expressing 
only CaV2.2e37b (Bell et al., 2004).  A number of studies have also 
demonstrated that the e37a isoform has greater current density than e37b when 
it is co-expressed with β and α2δ subunits in heterologous expression systems 
such as tsA-201 cell line and Xenopus oocytes (Bell et al., 2004; Castiglioni et 
al., 2006; Raingo et al., 2007).  The factors that contribute to an increase in 
current density could be a combination of more than one property of the 
channel.  Castiglioni et al. studied this in detail, and concluded that; 1) e37a 
opens for longer duration due to the slower deactivation and inactivation of the 
channel, 2) the gating charge of e37a was greater than that of e37b when they 
were expressed in tsA-201 cells, and 3) The open probabilities of these 
isoforms are the same (Castiglioni et al., 2006).  This greater gating charge 
suggests that functional CaV2.2 channels containing e37a may be expressed at 
a higher density than e37b.  
 
1.3.4 CaV2.2e37a/b undergo different modes of inhibition upon GPCR 
activation 
GPCRs such as GABAB, μ-opioid and endocannabinoid receptors are 
activated by binding to the endogenous neurotransmitters and agonists for 
signal transduction in both central and peripheral neurons.  G protein-mediated 
inhibition of CaV2.2 has been extensively studied, and there are mainly two 
types of inhibition.  The first type is the voltage-dependent inhibition where Gβγ 
(downstream of Gi- and Go- class of G proteins) binds directly to CaV2.2 to 
stabilise the closed state of the channel, which is often ineffective during intense 
neuronal firing as the inhibition is removed by depolarisation (Herlitze et al., 
1996; Ikeda, 1996). The second type is the voltage-independent inactivation 
mediated by second messengers, including phosholipase C (PLC) activation, 
which is often downstream of Gq/11- class G-proteins, to cause slow inhibition 
that is not relieved by depolarisation in sympathetic neurons (Bernheim et al., 
1991; Delmas et al., 2005).  In DRGs, voltage-independent inhibition of CaV2.2 
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has been suggested to occur through phosphorylation of tyrosine residues as a 
result of crosstalk between G protein and tyrosine kinase pathways, although 
the mechanism underlying this is unknown (Wijetunge et al., 2002).  
Raingo et al. (2007) revealed that CaV2.2e37a undergoes voltage-
independent inhibition as well as voltage-dependent inhibition upon Gi/Go 
activation, while the majority of CaV2.2e37b inhibition was voltage-dependent in 
tsA-201 cells (Raingo et al., 2007).  They found that the voltage-independent 
inhibition of e37a does not involve Gβγ, but requires phosphorylation of Y1747 
by tyrosine kinase.  This amino acid is widely conserved in different species, 
which indicates the evolutionary importance of its role in CaV2.2 function.  This 
finding was further investigated in transgenic mice which were generated to 
express only CaV2.2e37a by replacing exon 37b with 37a (aa*), and to express 
only CaV2.2e37b by replacing exon 37a with 37b (b*b) in the CACNA1B gene 
(Andrade et al., 2010).  Surprisingly, the DRG current density from the aa* mice 
was smaller than the b*b or wild-type (WT) mice, due to the specific down-
regulation of CaV2.2 protein expression in the brain and DRGs of the aa* mice, 
compared to the b*b and WT mice.  Nevertheless, the small diameter DRG 
neurons of aa* mice exhibited voltage-independent inhibition upon μ-opioid 
receptor activation, relative to that in b*b mice.  This finding is in agreement with 
the initial studies in tsA-201 cells, and shows the importance of voltage-
independent inhibition through CaV2.2e37a in modulating the nociception.   
 
1.3.5 Roles of CaV2.2e37a/b in neuropathic pain 
To address the question of whether Cav2.2e37a and e37b are equally 
effective in mediating transmission of nociceptive signals, Altier et al. (2007) 
used RNA interference approaches to knockdown these isoforms in cultured 
DRG neurons and in rat neuropathic pain models (Altier et al., 2007).  Small 
interfering RNAs (siRNAs) against CaV2.2e37a and e37b reduce the Substance 
P release from cultured DRG neurons, which implies that these channels are 
effective in modulating the nociception.  Silencing CaV2.2e37a by intrathecal 
injection of the siRNA in the naïve rats reduces both the basal mechanical and 
thermal nociception, while silencing CaV2.2e37b does not.  CaV2.2e37a siRNA 
also prevents formalin-induced thermal and mechanical hyperalgesia, and 
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reverses the thermal hyperalgesia in the neuropathic pain model with a chronic 
constriction injury in the sciatic nerve.  On the other hand, CaV2.2e37b siRNA 
appears to be only effective in reducing the nociceptive score in the mechanical 
hyperalgesia model.  Therefore, CaV2.2e37a is the predominant channel 
isoform in thermal hyperalgesia, whereas both isoforms contribute to the tactile 
allodynia.   
Transgenic mice that express only CaV2.2e37a (aa*) or e37b (b*b) by 
exon substitution show no effect on the basal nociception (Andrade et al., 
2010), unlike the previous report in the intrathecal CaV2.2e37a siRNA-treated 
rats (Altier et al., 2007).  Upon intrathecal morphine injection, the paw 
withdrawal latency is increased for the aa* and WT mice against thermal 
noxious stimuli, whereas the b*b mice show a reduced latency score, indicating 
that CaV2.2e37a plays a predominant role in morphine-mediated analgesic 
effect at spinal level (Andrade et al., 2010).  Subsequently, comparing maximal 
possible effect of intrathecal morphine on the b*b and WT mice in thermal 
hyperalgesia confirmed the important role of e37a in morphine analgesia (Jiang 
et al., 2013).  Although both e37a and e37b contributed to the development of 
the thermal and mechanical hypersensitivity in this study, it is clear that e37a 
plays a key role in the analgesic action of intrathecal morphine.         
 
 
1.4 Protein sorting to and from plasma membrane 
The plasma membrane is a fluid structure, and the functional integral 
components of the membrane such as transmembrane proteins are able to 
move within the membrane laterally, but also in and out of the membrane, to 
maintain the homeostatic regulations of the components, as well as to increase 
or decrease the components at the cell surface in response to cell signalling 
(Maxfield and McGraw, 2004).  CaV2.2 is no exception and its overall cell 
surface level is regulated by a number of cellular events (Figure 1.9).  CaV2.2 is 
translated in association with the ER, and is then translocated across the Golgi 
stack.  At the trans-Golgi network (TGN), CaV2.2 is thought to be packaged into 
an exocytic vesicle, and inserted into the plasma membrane where it is 
functional.  At the cell surface, CaV2.2 channels are internalised into 
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endosomes, which can either be recycled back to the plasma membrane 
(recycling endosomes), or degraded in the lysosomes.  
 
 
 
 
ER
TGN
Recycling 
Endosomes
Cav2.2
Cell 
membrane
Lysosomes
 
Figure 1.9 Pathways of intracellular protein sorting.  
CaV2.2 is transcribed in the nucleus and translated in association 
with the endoplasmic reticulum (ER) and translocated across the 
stack of Golgi. At the trans-Golgi network (TGN) it is sorted and 
packaged into vesicles to be trafficked to the plasma membrane. 
The cell surface CaV2.2 is endocytosed into recycling endosomes 
and then to endosomal recycling compartment, where it is 
repackaged into vesicles to return to the plasma membrane, or 
degraded via late endosomes and lysosomes.  
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1.4.1 Trans-Golgi Network (TGN) to plasma membrane 
Newly synthesised proteins are translocated into the TGN from ER via 
the Golgi stack, where they are sorted into carrier vesicles for their destinations.  
The majority of the cargo containing vesicles from the TGN are clathrin-coated.  
Coatomer Protein Complex I (COPI)-coated buds are also found on the TGN, 
but at a much lower frequency, as it is thought that their main function is to 
mediate vesicle trafficking from the ER to Golgi (reviewed in Klumperman, 
2011).  Cytosolic cargo adaptors play a key role in cargo sorting by directly or 
indirectly interacting via sorting signal in the cytosolic domains of 
transmembrane proteins at the TGN (reviewed in Guo et al., 2014). 
 
1.4.1.1 Adaptor protein complexes (APs) 
The AP family is the most studied cargo adaptor proteins (APs) for 
clathrin-mediated protein sorting (Table 1.3) (Boehm and Bonifacino, 2001; 
Owen et al., 2004; Robinson, 2004; Hirst et al., 2011).  There are 5 members 
(AP-1 to 5) in this family of hetero-tetrameric proteins, and so far AP-1, AP-3 
and AP-4 have been implicated in cargo sorting at TGN.  Recruitment of AP-1 
and AP-3 to the cargo in the membrane of the TGN is regulated by the ADP-
ribosylation factor (Arf) family of small GTP proteins, in particular Arf1 and Arf3.  
The protein cargo binds to μ and σ subunits of APs via its signalling motifs, 
YxxΦ and [DE]xxxL[LI] respectively, with a exception of AP-5 for which the 
mechanism of cargo interaction is still unknown (Bonifacino and Traub, 2003).  
AP-1, 2 and 3 mediates interaction with clathrin via the ear-domain of the β 
subunits. 
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Table 1.3 Adaptor binding protein family. 
 Subunits Cargo motif 
Clathrin 
dependent 
Location 
AP-1 
 
YxxΦ 
[DE]xxxL[LI] 
Yes Trans-Golgi network 
Endosomes 
AP-2 
 
YxxΦ 
[DE]xxxL[LI] 
NPXY 
Yes Plasma membrane 
AP-3 
 
YxxΦ 
[DE]xxxL[LI] 
Yes Endosomes 
Trans-Golgi network 
Lysosomes 
AP-4 
 
YxxΦ 
 
No Trans-Golgi network 
AP-5 
 
Unknown No Late endosomes 
Lysosomes 
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1.4.1.2 Golgi-localised γ-ear containing Arf-binding proteins (GGAs)    
GGAs are another class of clathrin adaptors, which interact with a cargo 
through the DxxLL motif and mediate trafficking between TGN and endosomes 
(Guo et al., 2014).  GGAs are thought to be targeted to the membrane of the 
TGN via ADP ribosylation factor-1 (Arf1) and phosphatidylinositol 4-phosphate 
(PtdIns4P).  Some reports suggest that GGAs and AP-1 are involved in a 
cooperative protein sorting at TGN, while other evidence indicates that these 
proteins can function independently of each other (Hirst et al., 2009, 2012).  
 
1.4.1.3 Epsin-related proteins (epsinR) 
EpsinR is a class of monomeric clathrin adaptors that regulates cargo 
trafficking between TGN and endosomes (Guo et al., 2014).  EpsinR contains 
binding sites for AP-1 and GGAs, which indicates that these protein may either 
function together or regulate each other in mediating trafficking between TGN 
and endosomes (Owen et al., 2004).   
 
1.4.1.4 Exomer 
Exomer is a heteromeric cargo adaptor protein that mediates trafficking 
directly from TGN and the cell surface (Guo et al., 2014).  Exomer binds directly 
to a novel sorting signal (IXTPK) on a cargo, a fusion protein Fus1p, and 
mediate its trafficking from the TGN to the plasma membrane (Barfield et al., 
2009).  The cell surface membrane recruitment of exomer is mediated by Arf1-
GTP, but requires other proteins to deform lipid membranes for vesicle budding 
(Wang et al., 2006).   
 
1.4.2 Plasma membrane to endosomes 
1.4.2.1 Clathrin-dependent pathways 
Clathrin in the cytoplasm is recruited to the plasma membrane to 
mediate endocytosis in the classical clathrin-dependent pathway (Kirchhausen, 
2000).  The soluble clathrin molecule in a shape of a three-legged triskelion 
forms a lattice at the plasma membrane which invaginates and pinches off to 
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form a coated vesicle.  The adaptor protein 2 complex (AP-2) binds both to the 
cargo protein and clathrin to mediate this process (Kirchhausen, 1999).   
Binding of AP-2 to the cargo in the plasma membrane is regulated by 
phosphatidylinositol-4,5-bisphosphate (PtdIns4,5P2) in the membrane and AP-
binding motifs in the cytosolic domain of the cargo protein.  The proportion of 
total endocytosis mediated by the clathrin-dependent pathway is unknown; 
however, some studies report as much as 95 % of endocytosis is mediated by 
clathrin-dependent pathway in certain cell types such as a HeLa cell line 
(Bitsikas et al., 2014). 
 
1.4.2.2 Clathrin-independent pathways 
Clathrin-independent endocytosis is sensitive to cholesterol-depletion, 
and may be further subdivided into dynamin-GTPase-dependent and dynamin-
GTPase-independent for pinching off vesicles (Figure 1.10) (for reviews, see Le 
Roy and Wrana, 2005; Mayor and Pagano, 2007).  Caveolae are small (50-100 
nm diameter) invaginations, and their scission at the plasma membrane is 
mediated by dynamin-GTPase.  Cargo selection for clathrin-independent 
endocytosis is not as well-defined as the clathrin-dependent pathway; however, 
mechanisms such as ubiquitination and interaction with integral transmembrane 
proteins flotillin-1 and flotillin-2 are implicated in clathrin-independent pathways 
(Glebov et al., 2006).  
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1.4.2.3 Activity-dependent bulk endocytosis (ADBE) 
Endocytosis of synaptic vesicles after exocytosis is essential for 
neuronal activity.  Activity-dependent bulk endocytosis (ADBE) is an effective 
way to retrieve a large area of plasma membrane by forming a large 
invagination into an endosome-like structure known as a bulk endosome, from 
which synaptic vesicles bud off to join the recycling synaptic vesicle pool 
(Richards et al., 2000).  This budding of synaptic vesicles from the bulk 
endosome is clathrin-dependent, which is mediated by AP-1 and AP-3 (Cheung 
and Cousin, 2012).   
 
 
 
Figure 1.10 Different modes of endocytosis. 
Small scale (50-100nm) endocytosis events are divided into 
clathrin-dependent endocytosis, caveolin-dependent endocytosis, 
and clathrin- and caveolin-independent pathways (Mayor and 
Pagano, 2007). CLIC, clathrin- and dynamin-independent carrier. 
GEEC, glycosyl phosphatidylinositol-anchored protein enriched 
early endosomal compartment. 
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1.4.2.4 Ultrafast Endocytosis 
Watanabe et al. (2013) demonstrated another mode of synaptic vesicle 
membrane recycling called ultrafast endocytosis (Watanabe et al., 2013), 
occurring between 50-100 ms after the neuronal terminal stimulation, which is 
much faster than previous models of synaptic vesicle recycling, kiss-and-run 
(Fesce et al., 1994) and clathrin-mediated endocytosis (Miller and Heuser, 
1984).  This fast endocytosis in active nerve terminals occurs independently of 
clathrin and generates recycling endosomes, followed by a clathrin-dependent 
process in which the new synaptic vesicles bud off from the endosomes 
(Watanabe et al., 2014).  The ultrafast endocytosis was observed at 34 °C, 
which is close to the physiological temperature, whereas it collapsed when the 
experiment was conducted at room temperature (22 °C), at which many 
experiments demonstrating the clathrin-mediated endocytosis in synaptic 
vesicle recycling commonly take place.  This type of endocytosis may provide a 
fast clearance of the fusion site, and allows for other vesicles to fuse in rapid 
succession (Watanabe, 2015).  
 
 
1.4.3 Recycling endosome pathways 
After endocytosis, most of the proteins and lipids return to the plasma 
membrane with a relatively fast rate (τ1/2~2 min) (Maxfield and McGraw, 2004).  
The endocytosed vesicles are pooled into the endocytic recycling compartment, 
where proteins are repackaged into vesicles (clathrin-dependent and clathrin-
independent) and return to the plasma membrane.  This is regulated by sorting 
motifs on the cargo proteins and regulatory molecules such as Rab proteins, 
particularly Rab 4, 5 and 11, which are a family of more than 60 small GTPase 
regulatory proteins, and play important roles in vesicle sorting (Stenmark, 
2009).  
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1.5 VGCC trafficking mechanisms and regulations 
1.5.1 Auxiliary subunits  
The role of α2δ and β auxiliary subunits in trafficking of VGCCs is well-
established.  β subunits are likely to promote the channel cell surface 
expression by preventing the interaction between E3 ubiquitin ligase and the I-II 
loop of the channels that leads to proteasomal degradation, which has been 
demonstrated for CaV1.2 (Altier et al., 2011) and CaV2.2 (Waithe et al., 2011).  
On the other hand, although the vital role of α2δ in CaV2.2 trafficking is shown in 
both expression system and in vivo models (Bauer et al., 2009; Tran-Van-Minh 
and Dolphin, 2010; Cassidy et al., 2014), the precise mechanism(s) of how α2δ 
mediates CaV2.2 trafficking is poorly understood.  Gabapentinoids such as 
gabapentin and pregabalin bind to α2δ and reduce trafficking of CaV2.2 to the 
cell surface and leads to a reduction in Ca2+ influx through CaV2.2 upon chronic 
application (Hendrich et al., 2008; Cassidy et al., 2014).  Furthermore, 
gabapentin has been shown to reduce the Rab11-dependent recycling of 
CaV2.2 (Tran-Van-Minh and Dolphin, 2010).   
 
1.5.2 Cytosolic proteins  
VGCCs interact with numerous cytosolic proteins that regulate 
intracellular localisation of the channels.  CaV2.2 requires protein kinase C 
activation for interaction with actin and membrane insertion of the channels 
(Zhang et al., 2008).  Collapsin response mediator protein, CRMP-2 binds to 
dynein to link transport vesicles to microtubules and is important for long 
distance axonal transport (Arimura et al., 2009; Rahajeng et al., 2010).  CRMP-
2 co-localises with CaV2.2 in the growth cones of immature sensory neurons 
and in presynaptic terminals of hippocampal neurons, by directly binding to the 
I-II loop and distal C-terminus of CaV2.2, and thus enhances Ca2+ current 
(Brittain et al., 2009; Chi et al., 2009).  However, whether CRMP-2 increases 
CaV2.2 trafficking to the cell surface or retains CaV2.2 at the cell surface is not 
clear.  The light chain (LC2) of microtubule-associated protein (MAP1A) 
interacts with the distal C-terminus of CaV2.2 and enhances retention of the 
channel at the presynaptic terminal membrane (Leenders et al., 2008).  On the 
other hand, CaV2.2/LC1-MAP1B complex is bound by ubiquitin conjugase 
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UBE2L3, which may regulate proteasomal degradation of CaV2.2 and reduces 
the cell surface expression of the channels (Gandini et al., 2014).  Moreover, α-
actinin directly binds to the C-terminus to increase surface expression of L-type 
(CaV1.2) channels by stabilising the channels at the cell surface, but its function 
in other type of VGCCs have not been explored.  The regulation of CaV1.2 
trafficking via α-actinin is channel activity-based, since it requires calmodulin to 
bind to Ca2+ and the activated calmodulin competes with α-actinin for its shared 
binding site, which leads to CaV1.2 internalisation (Hall et al., 2013).  At 
presynaptic terminals, CaV2.2 channels are recruited to the active zone, and 
allow neurotransmitter release upon activation.  Presynaptic protein interactions 
at the C-terminus of the channels are also important for their recruitment to the 
presynaptic terminals.  RIM and RIM-BP have been shown to directly interact 
with CaV1.3 and CaV2 channels at the distal C-terminus (Hibino et al., 2002; 
Kaeser et al., 2011).     
 
1.5.3 GPCRs 
Another way in which GPCRs can modulate the function of VGCCs is 
through regulation of channel trafficking.  GPCRs such as dopamine-1 (D1R) 
and -2 (D2R) receptor interact directly with CaV2.2 and increase the channel cell 
surface expression (Kisilevsky and Zamponi, 2008; Kisilevsky et al., 2008).  
Upon receptor activation, D1R and D2R internalise together with CaV2.2, and 
reduce the cell surface presence of the channels.  Another example is opioid-
receptor like receptor-1 (ORL1) which also co-localises with CaV2.2 in 
expression systems; furthermore ORL1 activation by nociceptin leads to CaV2.2 
internalisation in DRG neurons (Altier et al., 2006).  Mechanisms regarding how 
CaV2.2 is endocytosed have not been reported, but AP-2 binds to the synprint 
site in the II-III loop of CaV2.2, which is originally described as an interaction site 
for syntaxin, synaptotagmin (Syt) and SNAP25 (Watanabe et al., 2010).  AP-2 
and Syt compete for the synprint site in a Ca2+-dependent manner, therefore 
clathrin-mediated endocytosis may be important for CaV2.2 function. 
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1.6 Hypothesis 
Mutually exclusive alternative splice variants, CaV2.2e37a and e37b are 
differentially expressed in small nociceptive DRG neurons where their function 
is also differentially modulated by GPCR activation.  However, whether these 
two splice isoforms are trafficked equally to the cell surface where their function 
is vital in mediating Ca2+ influx upon activation by action potentials is still 
unknown.   
I hypothesised that CaV2.2 channels containing e37a may be more 
readily trafficked to the cell membrane compared to CaV2.2e37b, and remain at 
the cell surface which leads to greater cell surface expression.  This greater cell 
surface presence of CaV2.2e37a could be the source of the larger whole-cell 
Ca2+ current and gating charges which have been reported previously 
(Castiglioni et al., 2006).  If this is the case, the underlying mechanism(s) for 
CaV2.2 trafficking may be due to the difference in a relatively small number of 
amino acids in the C-terminus between the two isoforms.  As indicated in the 
discussion of Raingo et al. (2007), one of the possible key amino residue could 
be Y1773, which is a part of the AP-binding motif YxxΦ.  Although there are 
other potential AP-binding motifs identified in the CaV2.2 sequence (Figure 
1.11), the interaction between VGCCs and AP has not been reported so far. 
In addition, the differential GPCR control of CaV2.2e37 splice variants 
could also be a result of differences in the intracellular trafficking between 
CaV2.2e37 splice variants.  Studying the effects on Cav2.2 isoform trafficking 
mediated by the action of GPCRs may elucidate further mechanisms of GPCR-
mediated regulation of CaV2.2.       
- 52 - 
I II III IV
C
N 59 - 62 811 - 814 1154 - 1157
1771 - 1774
1797 - 1800
1880 - 18832256 - 2260
Cav2.2e37b
I II III IV
C
N 59 - 62 811 - 814 1154 - 1157
1771 - 1774
1773 - 1778
1797 - 1800
1880 - 18832256 - 2260
Cav2.2e37a
Yxxφ , AP-1μ1 / AP-2 μ2 interaction motif
[DE]xxxL[LI] , AP-1σ1 / AP-2σ2 interaction motif
 
 
Figure 1.11 Adaptor protein interaction sites in CaV2.2e37a/b. 
Schematic diagrams of CaV2.2e37 isoforms and the locations of 
YxxΦ (green) and [DE]xxxL[LI] (yellow) motifs.  The start- and the 
end-amino acid residue numbers of the motifs are indicated. 
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1.7 Aim 
The aim of this study is to investigate the mechanism of CaV2.2 splice 
variant trafficking by developing and critically assessing the molecular tools, in 
the expression systems and neuronal cells (Chapter 3).  One important point of 
this study is to examine whether CaV2.2e37 splice variants are differentially 
trafficked to the cell surface (Chapter 4).  If the trafficking of the CaV2.2e37 
isoforms is found to be different, then the underlying mechanism(s) mediating 
this trafficking will be investigated.  Furthermore, the amino acid sequence that 
is vital for the CaV2.2 trafficking will also be determined.   
In addition, how the activation of GPCRs such as D2R may regulate the 
trafficking of CaV2.2 splice variants will also be investigated (Chapter 5).  
Further understanding of interactions between GPCRs and Cav2.2, and the 
modulation by CaV2.2 alternative splicing could be important for elucidating the 
physiological and pathological observations related to GPCR activities, as well 
as for discovering novel pharmacological targets in treating neurodegenerative 
diseases.     
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Chapter 2 Materials and Methods 
2.1 cDNA constructs  
Table 2.1 and Table 2.2 list the information on all the cDNA constructs 
used in the experiments. 
 
Table 2.1 Description of CaV2.2 e37a and e37b cDNA constructs 
Name Tag Vector 
Species / 
GenBank 
association 
number 
Source 
mEos2-
CaV2.2 37b 
mEos2 at N-
terminus 
pMT2, 
pRK5 
Rabbit / 
D14157 
Created by 
W.Pratt, 
subcloned into 
pMT2 by 
N.Macabuag 
HA-CaV2.2 
37b 
2xHA between 
A566 and V567 
pMT2, 
pcDNA3.0 
Rabbit / 
D14157 
(Cassidy et al., 
2014) 
BBS-CaV2.2 
37b 
2xBBS between 
A566 and V567  
pMT2, 
pcDNA3.0 
Rabbit / 
D14157 
(Cassidy et al., 
2014) 
GFP-CaV2.2 
37b 
GFP at N-
terminus 
pMT2, 
pcDNA3.0 
Rabbit / 
D14157 
(Raghib et al., 
2001) 
GFP-HA-
CaV2.2 37b 
GFP at N-
terminus, 2xHA 
between A566 
and V567 
pMT2, 
pcDNA3.0 
Rabbit / 
D14157 
Created by 
N.Macabuag 
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mEos2-
CaV2.2 37a 
mEos2 at N-
terminus 
pMT2, 
pRK5 
Rabbit  Created by 
W.Pratt, 
subcloned into 
pMT2 by 
N.Macabuag 
HA-CaV2.2 
37a 
2xHA between 
A566 and V567 
pMT2, 
pcDNA3.0 
Rabbit  Created by 
W.Pratt, 
subcloned into 
pcDNA3 by 
N.Macabuag 
BBS-CaV2.2 
37a 
2xBBS between 
A566 and V567 
pMT2, 
pcDNA3.0 
Rabbit Created by 
N.Macabuag 
GFP-HA-
CaV2.2 37a 
GFP at N-
terminus, 2xHA 
between A566 
and V567 
pMT2, 
pcDNA3.0 
Rabbit Created by 
W.Pratt, 
subcloned into 
pcDNA3 by 
N.Macabuag 
 
Table 2.2 Description of all other cDNA 
Name cDNA Vector 
Species/ 
GenBank 
association 
number 
Source 
α2δ-1 α2δ-1 pMT2, 
pcDNA3.0 
Rat / M86621  
β1b β1b pMT2, 
pRK5 
Rat / X61394 From Dr T.P. 
Snutch 
β3 β3 pMT2 Rat  
CD8 CD8    
mCherry mCherry pcDNA3.0   
mut3 GFP GFP    
D2R Dopamine 2 
receptor (long splice 
form) 
pMT2 Rat  
FLAG-D2R Dopamine 2 
receptor (long splice 
pMT2 Rat Created by 
N.Macabuag 
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form) with  a signal 
sequence and 
3xFLAG tag at the N 
terminus 
AP-2μ2 WT AP-2μ2 subunit (wild 
type) 
pcDNA3.1 Rat From Dr M.S. 
Robinson 
(Motley et al., 
2006) 
AP-2μ2 
T156A  
Dominant-negative 
mutant of AP-2μ2 
subunit with a 
mutation in the 
phosphorylation site 
pcDNA3.1 Rat From Dr M.S. 
Robinson 
(Motley et al., 
2006) 
AP-2μ2 
F174A 
/D176S 
Dominant-negative 
mutant of AP-2μ2 
subunit with 
mutations in the 
YXXΦ interaction 
site 
pcDNA3.1 Rat From Dr M.S. 
Robinson 
(Motley et al., 
2006) 
AP-1 1a 
shRNA 
shRNA against AP-
1γ with mCerulean 
mSUPER Mouse, 
Human, Rat 
From Prof. M.A. 
Cousin (Cheung 
and Cousin, 
2012) 
AP-1 1b 
shRNA 
shRNA against AP-
1γ with mCerulean  
mSUPER Rat From Prof. M.A. 
Cousin (Cheung 
and Cousin, 
2012) 
AP-1σ1 WT AP-1σ1a subunit 
(wild type) 
pcDNA3.1 Human From Dr J.S. 
Bonifacino (Jain 
et al., 2015) 
AP-1σ1 
V98S 
Dominant-negative 
mutant of AP-1σ1a 
subunit with 
mutations in the 
[D/E]xxxL[L/I] 
pcDNA3.1 Human From Dr J.S. 
Bonifacino (Jain 
et al., 2015) 
vGlut1-
pHlourin 
(vGpH) 
vGlut1 with the 
super-ecliptic 
pHlourin tag 
pcDNA3.0  From Prof. T.A. 
Ryan (Hoppa et 
al., 2012) 
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2.2 Antibodies 
Table 2.3 and Table 2.4 list the information on antibodies that were 
used in the experiments. 
 
Table 2.3: A list of primary antibodies used in experiments. 
Name Epitope Species Dilution used 
Manufacture / 
source 
CaV2.2 CaV2.2 II-III loop Rabbit 1:500 
(immunocytoche
mistry), 1:1000 
(western blot) 
In-house (Raghib 
et al., 2001) 
HA HA (3F10), 
YPYDVPDYA 
Rat 1:500 Roche 
Myc c-myc (9E10), 
EQKLISEEDL 
Mouse 
(mono-
clonal) 
1:100 Santa Cruz 
FLAG FLAG, 
DYKDDDDK 
Rabbit 1:500 Sigma 
α2δ-1  Mouse 
(mono-
clonal) 
1:1000 Sigma 
attached 
Dynamin WT Dynamin-1 pcDNA3.1 Human From Dr 
O.Staub 
(Ruffieux-Daidié 
et al., 2008) 
Dynamin 
K44R 
Dominant-negative 
mutant of dynamin-1 
pcDNA3.1 Human From Dr 
O.Staub 
(Ruffieux-Daidié 
et al., 2008) 
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Akt   Rabbit 1:1000 Cell Signaling 
Technology 
GAPDH  Mouse 1:25000 Ambion 
 
Table 2.4: A list of secondary antibodies used in experiments. 
Name Epitope Species Dilution  
Manufacture / 
source 
Alexa Fluor® 488 anti-
rabbit 
Rabbit IgG Goat 1:500  Life Technologies 
FITC anti-rat Rat IgG Goat 1:500 Sigma 
Alexa Fluor® 594 anti-
rabbit 
Rabbit IgG Goat 1:500  Life Technologies 
Alexa Fluor® 594 anti-
rat 
Rat IgG Goat 1:500  Life Technologies 
Alexa Fluor® 594 anti-
mouse 
Mouse IgG Goat 1:500  Life Technologies 
Alexa Fluor® 647 anti-
mouse 
Mouse IgG Goat 1:500  Life Technologies 
Alexa Fluor® 647 anti-
rabbit 
Rabbit IgG Goat 1:500  Life Technologies 
Horseradish peroxide 
(HRP) anti-mouse 
Mouse IgG Goat 1:3000 Life Technologies 
Horseradish peroxide 
(HRP) anti-rabbit 
Rabbit IgG Goat 1:3000 Life Technologies 
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2.3 Molecular biology 
2.3.1 Polymerase-chain reaction (PCR) 
In order to introduce point mutations or to insert tags in expression 
vectors, the following DNA oligonucleotide primers were designed (Table 2.5).  
Oligonucleotides were purchased from Eurofins Genomics (Ebersberg, 
Germany) in lyophilised form, which were re-constituted in nuclease-free water 
to 50 pmol/μl.  PCR was performed using a Veriti® thermal cycler (Applied 
Biosystems) in the following PCR reaction mix and cycle protocol. 
 
Table 2.5: A list of oligonucleotide primers used in 
experiments. 
Primers Sequence (5’ to 3’) 
pMT2-R GGTCGAACCATGATGGCAGC 
α1B-Kpn21-F CACAATAACTTCCGGACGTTTCTGCAG  
LA-F GGATATGTACAGTGCGTTGCGTTGTATTGC 
LA-R GCAATACAACGCAACGCACTGTACATATCC 
LLAA-F GGATATGTACAGTGCGGCGCGTTGTATTGC 
LLAA-R GCAATACAACGCGCCGCACTGTACATATCC 
YA-F AGGATATGGCCAGTTTGTTGCGTTG 
YA-R CAACGCAACAAACTGGCCATATCCT 
YALLAA-F AGGATATGGCCAGTGCGGCGCGTTGTATTGC 
YALLAA-R GCAATACAACGCGCCGCACTGGCCATATCCT 
AP-1a_ 
Scrambled-A 
GATCCCCGAGACCTTAAGATCCTATTTTCAAGAGAAATA
GGATCTTAAGGTCTCTTTTTA 
AP-1a_ 
Scrambled-B 
AGCTTAAAAAGAGACCTTAAGATCCTATTTCTCTTGAAAA
TAGGATCTTAAGGTCTCGGG 
ss_3FLAG_D2
_R 
TTCAGTGGATCCTTGTCGTCATCGTCTTTGTAGTCGATGT
CATGATCTTTATAATCACCGTCATGGTCTTTGTAGTCACC
GGTTTCAGCTACG 
ss_3FLAG_D2
_F2 
CAGCTGGTACCGCCACCATGGGCATTCTTCCCAGCCCT
GGG 
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Table 2.6: PCR reaction mix. 
 Volume (μl) 
Forward primer (50 pmol/μl) 1 
Reverse primer (50 pmol/μl) 1 
cDNA (1 μg/ml) 2 
Pfu DNA polymerase (Promega) 1 
10x buffer (Promega) 10 
PCR nucleotide mix (Promega) 2 
DMSO (Sigma) 5 
Nuclease-free water 78 
Total 100 
 
Table 2.7: PCR thermal cycle protocol. 
98 °C 2 min x 1 
98 °C 1 min 
 
x 30 
50 °C 40 s 
73 °C 
1 min for every 500 
base pair PCR products  
73 °C 10 min x 1 
16 °C   
 
2.3.1.1 Generating HA-CaV2.2e37a-pMT2 mutants 
In order to generate HA-tagged CaV2.2e37a mutants in pMT2, the 
following combination of primers with HA-CaV2.2e37a-pMT2 cDNA were used in 
the PCR (Table 2.8).  These combinations were used to perform the first PCR 
using HA-CaV2.2e37a-pMT2 as a cDNA template in the protocol described in 
Table 2.6 and Table 2.7.  The schematic diagram of the overall PCR strategy to 
introduce site-directed mutagenesis is described in Figure 2.1. 
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Table 2.8: Primer combinations for the first PCR. 
 Primer combination 1 Primer combination 2 
Mutation Forward Reverse Forward Reverse 
Y1775A (Y/A) LA-F  pMT2-R 
α1B-
Kpn21-F 
LA-R 
L1777A (L/A) LLAA-F pMT2-R 
α1B-
Kpn21-F 
LLAA-R 
L1777A/L1778A (LL/AA) YA-F pMT2-R 
α1B-
Kpn21-F 
YA-R 
Y1775A/L1777A/L1778A 
(YSLL/ASAA) 
YALLAA-F pMT2-R 
α1B-
Kpn21-F 
YALLAA-R 
 
Molecular weights of the PCR products were confirmed on a 1 % 
agarose gel in TAE buffer containing 0.01 % ethidium bromide (EtBr) by running 
8 μl of the product together with the molecular weight marker Hyperladder™ 
1kb (Bioline).  The rest of the PCR products were then separated on a 1 % 
agarose gel in Tris-Acetate-EDTA (TAE) buffer, which was post-stained with 
GelStar™ (Lonza) and visualised on ultra-violet (UV) light using the blue light 
box.  The PCR fragment was extracted from the gel using QIAquick Gel 
Extraction kit (QIAGEN) following the manufacturer’s protocol, and DNA was 
eluted in 50 μl nuclease-free water from the column.  For the second PCR 
reaction to amplify from the two PCR products (1 and 2) from the two primer 
combinations (1 and 2) per mutant as described above, the following PCR 
reaction mix was used. 
The unincorporated nucleotides and primers were removed using 
QIAquick PCR purification kit (QIAGEN) following the manufacture’s protocol, 
and the PCR product was eluted in 50 μl nuclease-free water from the column.  
The PCR fragment was then digested with restriction enzymes BspEI and SpeI.  
The host plasmid HA-CaV2.2e37a-pMT2 was also digested with SpeI and SalI, 
and SalI and BspEI separately to perform a 3-part ligation (Figure 2.2). 
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Kpn21 (BspEI) SpeI
HA-Cav2.2e37a_pMT2 ….…. x
X
X
Primer combination 1
Primer combination 2
X
X
PCR 1
PCR 2
X
Kpn21 (BspEI) SpeI
 
Figure 2.1 Schematic diagram of site-directed mutagenesis 
protocol.  
This protocol was used to generate a fragment (1kb) containing a 
desired mutation, which is inserted into the original CaV2.2 
expression vector using two restriction sites (Kpn21 and SpeI).  
The first PCR (PCR 1) involves two sets of separate PCRs: with 
primer combination 1 (green) and 2 (yellow).  The template cDNA 
(dark blue) showing the original amino acid as X, whereas the 
forward primer from combination 1 and the reverse primer from 
combination 2 contain a mutated amino acid as X.  The second 
PCR (PCR2) contains the products from PCR1 where the two 
large primers extend to generate the final DNA fragment 
containing the mutation and two restriction sites, Kpn21 (also 
known as BspEI) and SpeI to be inserted into a HA-CaV2.2e37a-
pMT2 plasmid.  
 
 
 
- 63 - 
HAgHA Cav2.2e37a pMT2
12284 bp
BspEI - 2509 - T'CCGG_A
SalI - 2874 - G'TCGA_C
BspEI - 6103 - T'CCGG_A
SpeI - 8202 - A'CTAG_T
a1
B
H
A
g
H
A
e37
 
Figure 2.2 Ligation strategy for generating HA-CaV2.2e37a-
pMT2 mutants. 
The host plasmid HA-CaV2.2e37a-pMT2 was digested in order to 
insert the PCR fragment with appropriate mutations generated by 
PCR as described above.  SpeI-SalI and SalI-BspEI fragments 
were generated by restriction digest of the host plasmid.  3-part 
ligation was then performed with these two fragments and the 
digested PCR fragment. 
 
 
Table 2.9: PCR reaction mix for the second PCR reaction for 
generating CaV2.2e37a mutants 
 Volume (μl) 
PCR product 1 5 
PCR product 2 5 
α1B-Kpn21-F 1 
pMT2-R 1 
Pfu DNA polymerase (Promega) 1 
10x buffer (Promega) 10 
PCR nucleotide mix (Promega) 2 
DMSO (Sigma) 5 
Nuclease-free water 70 
Total 100 
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2.3.1.2 Generating scrambled AP-1 shRNA 
In order to generate a scrambled AP-1 shRNA expression cDNA vector 
as a control for AP-1 1a and 1b shRNA_mCerulean_pSUPER (Cheung and 
Cousin, 2012), DNA oligonucleotides AP-1a_Scrambled-A and AP-
1a_Scrambled-B (Table 2.5) were designed using an online software on 
GenScript (https://www.genscript.com/ssl-bin/app/scramble) from AP-1 1a 
sequence described in Cheung and Cousin (2012).  The oligonucleotides were 
adjusted to 5 pmol/μl in nuclease-free water. To anneal these oligonucleotides, 
1 μl each of the two oligonucleotides were added to 13 μl of ligation buffer (1 
mM EDTA pH 8.0, 10 mM Tris, 0.1 mM NaCl) in a PCR tube, and annealed at 
95 °C for 5 min.  This was inserted into the mCerulean_pSUPER vector which 
contains BglII and HindIII ends.  The following reaction mix was set up for the 
ligation: 15 μl of the annealed oligonucleaotides in ligation buffer, 2 μl 
mCerulean_pSUPER vector (BglII, HindIII), 1 μl T4 ligase (Promega), 2 μl 10x 
T4 ligase buffer (Promega). 
 
2.3.1.3 Generating FLAG-tagged dopamine 2 receptor (D2R) 
3xFLAG and an ER signal sequence were added to D2R in pMT2 
vector at the N-terminus of the receptor, in order to detect the cell surface 
expression by anti-FLAG antibody (Figure 2.3).  Primers against the signal 
sequence in the in-house pHLsec construct (based on Aricescu et al., 2006), 
termed ss_3FLAG_D2_F2 and ss_3FLAG_D2_R were designed (Table 2.5), 
which contain KpnI and BamHI restriction sites. The PCR protocol was 
performed as below.  To confirm, the PCR products (~ 200 bp) were run on 2.5 
% TBE gel with 0.01% EtBr.  The unincorporated nucleotides and primers were 
removed using QIAquick PCR purification kit (QIAGEN) following the 
manufacture’s protocol, and the PCR product was eluted in 50 μl nuclease-free 
water from the column prior to the restriction digests.   
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Table 2.10 PCR reaction mix for the second PCR reaction for 
generating ss_3xFLAG-tagges D2R 
 Volume (μl) 
ss_3FLAG_D2_F2 1 
ss_3FLAG_D2_R 1 
CLC2-pHLsec (1 μg/ml) 2 
Pfu DNA polymerase (Promega) 1 
10x buffer (Promega) 10 
PCR nucleotide mix (Promega) 2 
DMSO (Sigma) 5 
Nuclease-free water 78 
Total 100 
 
 
 
pMT2 D2R
KpnI BamHI
pMT2
KpnI
D2R
BamHI
3xFLAGER signal sequenceKozak
D2R_pMT2
ss_3FLAG_D2R_pMT2
….
….
….
….
 
Figure 2.3 3xFLAG-tagged D2R with ER signal sequence. 
ER signal sequence (yellow) containing Kozak sequence (blue) 
and 3xFLAG tag (green) were inserted into 5’ end of D2R in pMT2. 
The start codon of D2R and an additional BamHI in the signal 
sequence were removed in the primer design.      
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2.3.2 Restriction digests 
To subclone a construct into another vector, or to confirm the positive 
clones after ligation, a restriction digest with appropriate restriction enzymes 
was performed under the following condition; 
 
Table 2.11: A protocol for restriction digests.  
 Vector PCR product Miniprep elute 
cDNA 3 μg 50 μl elute 2.5 μl  
Restriction enzyme 2 μl 2 μl 0.2 μl 
Buffer (x10) 4 μl 6 μl 1 μl 
H2O To 40 μl total  To 60 μl total To 10 μl total 
    
Reaction condition 2 h at 37 °C 2 h at 37 °C 1 h at 37 °C 
 
In order to avoid self-ligation of the vector after the restriction digest, 
dephosphorylation of the 5’ end was performed using calf-intestinal alkaline 
phosphatase (CIP) in some cases.  Once the vector was digested, the reaction 
mix was cleaned up to remove enzymes and exchange buffer using QIAquick 
PCR purification kit (QIAGEN) following the manufacture’s protocol. The 
digested cDNA was eluted from the column with nuclease-free water. The 
cDNA was incubated with 4 μl Buffer 1 (New England Biolab) and 2 μl CIP for 1 
h at 37 ̊ C.  The reaction mix was cleaned again prior to the ligation. 
 
2.3.2.1 Generating GFP-tagged HAgHA-CaV2.2 
N-terminus cDNA sequence of GFP-CaV2.2-pMT2 cDNA construct 
including GFP was digested with BglII and NotI, and inserted into the N-
terminus of HAgHA-CaV2.2-pMT2 (Figure 2.4).  Positive clones containing the 
insert were screened and the sequence was confirmed by sequencing. 
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GFP HAgHA Cav2.2 pMT2
12986 bp
BglII - 979 - A'GATC_T
NotI - 1844 - GC'GGCC_GCGFP
a1
B
exon37b
H
A
g
H
A
HAgHA Cav2.2 pMT2
12284 bp
BglII - 979 - A'GATC_T
NotI - 1142 - GC'GGCC_GC
a1
B
H
A
g
H
A
e37
 
Figure 2.4 Plasmid maps and restriction sites to create GFP-
HA-CaV2.2. 
HA-CaV2.2e37b (left) and GFP-HA-CaV2.2e37b (right) in pMT2 are 
shown with BglII and NotI sites. GFP (green) at N-terminus of HA-
CaV2.2 from GFP-CaV2.2-pMT2 was inserted into HA-CaV2.2-
pMT2 at these restriction sites. HA (yellow), e37b (blue).  
  
 
2.3.3 Gel electrophoresis 
In order to determine the size of the cDNA fragments from PCR or 
restriction digest, the samples were typically run on 1 % TAE agarose gel (Life 
Technology).  When the fragments of interest are smaller than 200 bp, 2.5-3 % 
TAE or Tris-Borate-EDTA (TBE) agarose gel was used to resolve the bands 
with lower molecular weight.  To visualise the DNA, the agarose gel contained 
0.01 % EtBr.  The fragments were separated for 1-2 h at 90V along with 
appropriate molecular weight markers.  If the cDNA fragments were to be used 
in subsequent cloning, the agarose gel without EtBr was post-stained with 
GelStar™ in the same buffer as the gel for 30 min on a shaking platform.  The 
bands with correct molecular weights were cut out of the gel on a filtered UV 
box.  The fragments of interest were extracted from the gel using QIAquick Gel 
Extraction kit (QIAGEN) following the manufacturer’s protocol, and DNA was 
eluted from the column in 30-50 μl nuclease-free water.   
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2.3.4 Ligation  
To ligate DNA fragments with compatible ends, the ligation reaction was 
performed under the following condition: 
Table 2.12: Protocol for ligation. 
Vector 6.5 μl 
Insert(s) 2 μl (2-part ligation) or 1 μl each (3-part ligation) 
T4 ligase 0.5 μl 
10x T4 ligase buffer 1 μl 
  
Reaction condition 3 h at room temperature or overnight at 4 °C 
 
2.3.5 Transformation 
To transform E.coli cells with the ligation mix or diluted plasmid (1 
ng/μl), 5 μl of cDNA was added to a vial of OneShot® Chemically Competent 
E.coli (Life Technology), mixed by gentle tapping, and was incubated on ice for 
30 min.  The cells were heat-shocked at 42 °C for 30 s and incubated on ice for 
2 min.  250 μl of S.O.C. medium (Life Technologies) was added to the cells and 
incubated in the shaking incubator at 225 rpm for 1 h at 37 °C.  The cells (200 
μl on one plate and 20 μl on the other) were spread on Luria-Bertani (LB, 10 g 
bacto-tryptone, 5 g bacto-yeast extract, 10 g NaCl, pH 7.0) agar plates 
containing 15 g/l agar and 50 μg/ml ampicillin in LB medium.  The culture plates 
were incubated at 37 °C overnight. 
 
2.3.6 Clone selection 
In order to select an appropriate clone, isolated colonies of transformed 
E.coli cells were picked from the culture plate, and were cultured in 5ml LB 
medium containing 50 μg/ml ampicillin for 8 -16 h at 37 °C shaking incubator at 
225 rpm.  Plasmids from these clones was isolated using Miniprep kit (QIAGEN) 
following manufacture’s protocol.  Briefly, 2 ml of cell suspension was 
centrifuged at 7000 g in a tabletop centrifuge for 3 min. The cell pellets were 
lysed and cDNA was collected in the columns.  The cDNA was eluted in 50 μl 
nuclease-free water.  Test digests were performed to select the clones, which 
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contained the correct insert by determining the size of cDNA fragments after the 
restriction digest.   In some cases, a part of the miniprep construct was 
sequenced to confirm that the clones contained correct fragments.  
 
2.3.7 Plasmid cDNA purification 
300 μl of cell culture of the positive clone from the clone selection was 
added to 200 ml LB medium containing 50 μg/ml ampicillin, and cultured for 16 
h at 37 °C in a shaking incubator at 225 rpm.  cDNA from these clones was 
isolated using QIAGEN Plasmid Maxi or Endofree Plasmid Maxi kit following 
manufacturer’s protocol.  The cDNA concentration was determined by DU-800 
spectrophotometer (Beckman Coulter) at 260 nm and 280 nm wavelength and 
adjusted to 1 μg/μl.   
 
2.3.8 Sequencing  
All cDNA sequences were confirmed by sequencing.  Briefly, the PCR 
was run with appropriate sequencing primers under the conditions stated in 
Table 2.13 and Table 2.14. 
The PCR products were precipitated by adding 10 μl nuclease-free 
water, 2 μl 3 M sodium acetate (pH 5.2), 50 μl ethanol, which were incubated on 
ice for 10 min.  The samples were centrifuged at 13000 rpm for 15 min at room 
temperature.  The pellet was washed with 70 % ethanol, centrifuged at 13000 
rpm for 5 min, and air-dried.  The samples were resuspended in 10 μl Hi-Dye 
formamide (Life Technology) and analysed on 3100 Avant Genetic Analyser 
(Applied Biosystems) with a NanoPOP-6 polymer (Nimagen).  
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Table 2.13: Protocol for sequencing PCR. 
Sequencing primer (2 pmol/μl) 2 μl 
cDNA (1 μg/μl) 0.5 μl 
BigDye® Terminator v1.1 (Life 
Technology) 
4 μl 
DMSO  0.5 μl 
Nuclease-free water 3 μl 
 
Table 2.14: PCR thermal cycle protocol for sequencing. 
98 °C 3 min x 1 
98 °C 30 s 
 
x 25 
50 °C 15 s 
60 °C 4 min  
16 °C   
 
 
2.4 Cell culture and transfection 
2.4.1 tsA-201 cell culture 
tsA-201 cells (human embryonic kidney 293 cell line, stably expressing 
SV40 T-antigen) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
with high glucose and L-glutamine, supplemented with 1 unit/ml penicillin, 1 
μg/ml streptomycin, 10 % foetal bovine serum (FBS), and 1 % GlutaMAX (Life 
Technologes).  The cells were cultured to 80 % confluence in a 5 % CO2 
incubator at 37 °C, and passaged every 3 to 4 days.  
 
2.4.2 N2a cell culture 
The mouse neuroblastoma cell line Neuro-2a (N2a) was cultured in 50 
% DMEM (with high glucose and L-glutamine) and 50 % OPTI-MEM (with L-
glutamine), supplemented with 1 unit/ml penicillin, 1 μg/ml streptomycin, 5 % 
FBS, and 1 % GlutaMAX (Life Technologies).  The N2a cells were cultured to 
80 % confluence in a 5 % CO2 incubator at 37 °C, and passaged every 3 to 4 
days. 
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2.4.2.1 tsA-201 and N2a cell transfection 
To transiently express recombinant proteins, tsA-201 cells were 
transfected using either PolyJet™ (SignaGen Laboratories) or Fugene® 6 
(Promega) in 1:3 ratio with cDNA mix. tsA-201 cells were plated to 30-60% 
confluent >3 h prior to a transfection procedure.  Typically for a 35 mm cell 
culture dish, 2 μg cDNA was mixed with 50 μl serum-free DMEM, and 6 μl 
PolyJet was mixed with 50 μl serum-free DMEM in separate tubes by pipetting.  
These were then mixed by gentle pipetting, and incubated for 15 min at room 
temperature before they were added dropwise to the cells. Similarly for a 
Fugene-transfection in a 35 mm cell culture dish, 6 μl Fugene was mixed with 
94 μl serum-free DMEM, and left to incubate for 5 min at room temperature.  2 
μg cDNA mix (typically CaV2.2: β1b: α2δ-1= 3:2:2, in pMT2 vector for tsA-201, 
in pcDNA3 or pRK5 for N2a) was then gently mixed with the mixture and 
incubated for further 30 min before they were added dropwise to the cells. 
 
2.4.3 DRG neuronal cell culture 
DRGs were extracted in Hank’s Balanced Salt Solution (HBSS) without 
Ca2+ and Mg2+, from the spinal column of a male rat in postnatal Day 10 (P10), 
which were killed under the Schedule 1 procedure. DRGs were then dissociated 
in 1 ml of a dissociation solution (5 mg/ml Dispase (Life Technologies), 2 mg/ml 
Collagenase (231 U/mg) and 0.1 mg/ml (or 0.1 U/μl) DNase (Life Technologies) 
in HBSS without Ca2+ and Mg2+) in a 15 ml falcon tube in a shaking water bath 
at 37 °C for 30 min.  The enzymes were inactivated by addition of 10% FBS.  
The cells were triturated by pipetting and centrifuged at 1000 rpm for 3 min to 
remove the solution.  The cells were re-suspended in the culture medium 
(DMEM/F12, 10 % FBS, 100 ng/ml nerve growth factor (NGF), 1 unit/ml 
penicillin, 1 μg/ml streptomycin), which were then plated onto coverslips that 
were pre-coated with 17.9 μg/ml poly-L-lysine, and cultured at 37 °C in a 5 % 
CO2 incubator.  The culture medium was changed 2 h after plating. 
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2.4.3.1 DRG transfection 
After the DRGs were dissociated, triturated and centrifuged, the cell 
pellet was re-suspended in 1 ml HBSS, and split into two Eppendorf tubes (500 
μl each) to be further centrifuged at 1000 rpm for 3 min.  The cell pellet was re-
suspended in 80 μl Nucleofector™ (Lonza) transfection reagent, containing 2 
μg of cDNA mix (typically, CaV2.2-pcDNA3: β1b-pRK5: α2δ-1-pcDNA3: 
mCherry-pcDNA3= 3:1.5:2:0.5).  Following the electroporation protocol in the 
Nucleofector cuvette, 500 μl of RPMI supplemented with 10 % FBS and 50 
ng/ml NGF was added to the cells in the cuvette, which were then transferred 
into a 1.5 ml Eppendorf tube and incubated in a 5 % CO2 incubator at 37 °C for 
8 min. The cells were plated onto coverslips (250 μl each) that were pre-coated 
with poly-L-lysine (Sigma), and cultured at 37 °C in a 5 % CO2 incubator. The 
culture medium was changed at 2 h after plating. 
 
2.4.4 DRG-dorsal horn (DH) co-culture 
DRGs and DH were extracted in ice-cold L15 dissection medium, from 
a male rat at postnatal day 0 (P0), which was killed under the Schedule 1 
procedure.  The DH was dissociated in 100 μl 2.5% trypsin in S-MEM at 37 °C 
for 20-25 min in a dish.  The dissociated DH was transferred into a 15 ml tube 
and was washed twice with warm culture medium (50 % NeuroBasal A (Life 
Technologies), 2 % B27-supplement (Life Technologies), 100 ng/ml NGF, 1 
unit/ml penicillin, 1 μg/ml streptomycin, 1 % Glutamax, 50 % astrocytes-
conditioned medium*), and triturated gently using a fire polished glass pipette.  
DH neurons were plated onto coverslips coated with poly-L-lysine and laminin 
(Sigma).  DRGs were dissociated in 1 ml of 5 mg/ml Dispase at 37 °C for 25-30 
min in a dish.  The dissociated DRGs were transferred to a 1.5ml Eppendorf 
tube and triturated with pipettes.  The supernatant was removed by centrifuging 
at 1000 rpm for 3 min.  The pellet was washed with 1 ml of warm HBSS and 
centrifuged again.  For DRG transfection, the supernatant was discarded and 
the cells were resuspended in 80 μl Nucleofector™ (Lonza) transfection 
reagent, and they were transferred to a fresh tube containing 2 μg of cDNA mix 
(HA-CaV2.2-pcDNA3: β1b-pRK5: α2δ-1-pcDNA3: vGpH-pcDNA3= 3:1:1.5:1.5).  
Following the electroporation protocol in the Nucleofector cuvette, 500 μl of 
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RPMI supplemented with 10 % FBS and 50 ng/ml NGF was added to the cells 
in the cuvette, which were then transferred into a 1.5 ml Eppendorf tube and 
incubated in a 5 % CO2 incubator at 37 °C for 8 min. The cells were plated on 
top of the DH neurons.  The wells were flooded with warm medium 1 h after the 
transfected DRG neurons were plated.  The growth medium was replaced after 
16h, and half of the medium every 3-4 days.  Cells were cultured for 7 days 
before the experiment.  
(*Astrocytes-conditioned medium was prepared from growth medium of 
the astrocytes culture from dissociated cerebral cortex of P0 rat.  The growth 
medium contained DMEM with 10 % horse serum, 2.5 % FBS, 1 unit/ml 
penicillin, 1 μg/ml streptomycin.)  
 
2.4.5 Hippocampal neuronal cell culture 
Hippocampal neurons were isolated from the hippocampus of P0 rats, 
which were killed under the Schedule 1 procedure.  The cerebrum was cut into 
two, and the hippocampi were extracted from each hemisphere in ice cold 
HBSS with 10 mM HEPES.  The hippocampi were then cut into small segments 
and digested gently in Papain solution (7 U/ml Papain, 0.2 mg/ml L-Cysteine, 
0.2 mg/ml Bovine Serum Albumin (BSA), 5 mg/ml glucose, 10 mM HEPES in 
HBSS with 200 μl DNase) in a shaking water both for 40 min at 37 °C.  The 
cells were washed twice with the growth medium (NeuroBasal, 2 % B27-
supplement, 1 unit/ml penicillin, 1 μg/ml streptomycin, 1 % Glutamax, 0.1% β-
marcaptoethanol), and triturated gently.  The cells were plated onto the 
coverslips that are coated with poly-L-lysine and laminin at 750 cell/μl, 100 μl 
per coverslip.  The entire growth medium was changed after 2 h of plating, and 
half of the medium was then changed every 3-4 days.  
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2.5 Western Blot 
2.5.1 Whole-cell proteins 
Cells were transfected with CaV2.2 with α2δ-1, β1b subunits and GFP 
either in T25 or T75 flasks, using PolyJet.  Control cells were transfected with 
GFP only. After 40 h expression, the cell transfection was confirmed by visually 
examining GFP expression under a fluorescent microscope.  
The cells were washed twice with PBS, and harvested in 5 ml PBS 
containing Complete Protease Inhibitor Cocktail (PI, Roche) using a cell 
scraper. The cell suspension was centrifuged at 1000 x g for 5 min at 4 °C.  The 
cell pellet was re-suspended with either Lysis Buffer (50 mM Tris pH 7.4, 50 mM 
NaCl, PI), or in PBS.  To prevent the protein aggregation of CaV2.2, 25 mM N-
ethylmaleimide (NEM) was added to the samples to prevent the formation of 
CaV2.2 α subunit aggregates in some experiments as stated.  The suspension 
was sonicated for 7 s and 1 % IGEPAL® CA-630 (a detergent from Sigma) was 
added, which was then left on ice for 45 min to complete the lysis. The lysate 
was centrifuged at 14000 x g for 20 min.  The supernatant was transferred to a 
fresh Eppendorf tube and the protein concentration was determined by Bradford 
assay (Bio-Rad).  Samples were denatured by heating at 55 °C for 15 min with 
reducing Laemmli Sample Buffer (2 % SDS, 2 % glycerol, 0.02 % bromophenol 
blue, 50 mM Tris HCl pH 6.8, 20 mM dithiothreitol (DTT)).  Proteins were 
separated on a 3-8 % Tris-Acetate gel (Life Technologies), and transferred onto 
a polyvinylidene fluoride (PVDF) membrane.  The membrane was blocked in 
Tris-buffered saline (TBS) solution (10mM Tris pH7.4, 500mM NaCl, 0.5 % 
IGEPAL CA-630) with 3 % BSA, and was then incubated with the primary 
antibody (1:1000) in antibody diluent (10% goat serum, 3 % BSA, 0.02 % 
IGEPAL in TBS) overnight at 4 ̊C.  The secondary antibody conjugated with 
horseradish peroxide (HRP) (1:3000) in antibody diluent was incubated with the 
membrane for 1h at room temperature.  The proteins were detected using ECL 
Plus Western Blotting Detection Reagents (GE Healthcare) according to the 
manufacturer’s protocol and scanned using the fluorescent detection mode on 
Typhoon 9410 (GE Healthcare).   
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2.5.2 Biotinylation of plasma membrane proteins 
Cells were transfected with CaV2.2, α2δ-1, β1b and GFP either in T25 or 
T75 flasks using PolyJet.  Control cells were transfected with GFP only.  After 
64 h expression, the transfection efficiency was confirmed to be the same in all 
conditions by visually examining GFP expression under a fluorescent 
microscope.  The culture medium was replenished 1 h before the experiment to 
increase the cell adhesion during biotinylation.  The cells were washed twice in 
PBS, and incubated with 5 ml of 1mg/ml EZ-Link™ Sulfo-NHS-SS-Biotin 
(Thermo Fisher) at 4 °C for 30 min.  The biotinylated cells were washed once 
with PBS, and washed twice with 200 mM glycine (pH 8.0) in PBS to quench 
the biotin. The cells were washed twice with PBS and harvested in 5 ml PBS 
containing PI using a cell scraper. The cells were centrifuged and lysed in PBS 
containing 1 % IGEPAL as above.  50 μl of Pierce streptavidin agarose beads 
(Life technologies) were pre-equilibrated by centrifuging at 500 x g for 2 min, 
removing the supernatant and adding 800 μl PBS with 1 % IGEPAL.  These 
steps were repeated twice, and 800 μg of lysate was incubated with the beads 
at 4 °C overnight on a tube rotator.  The beads were then washed three times 
with PBS with 1 % IGEPAL by centrifuging and removing supernatant.  The 
biotinylated proteins were liberated by incubating with 100 mM DTT and 2x SDS 
sample buffer for 1 h at 37 °C.  The supernatant was run on a gel to separate 
the proteins as described above.  
 
 
2.6 Visualisation of calcium ion channels  
2.6.1 Immunocytochemistry 
Cells were plated onto either coverslips or glass-bottomed dishes 
(MatTek Corporation) which were coated with poly-L-lysine prior to transfection, 
and cultured in a 5 % CO2 incubator at 37 °C.  After 40-72 h expression, cells 
were fixed with 4 % paraformaldehyde (PFA) in PBS, pH7.4 at room 
temperature for 10 min.  For labelling the HA epitope on the cell surface in non-
permeabilised conditions, the cells were incubated with primary antibody with 
2.5% BSA and 10% goat serum in PBS at room temperature for 1 h for N2a 
cells, or overnight at 4 °C for DRG neurons.  The secondary antibody was 
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added with 2.5% BSA and 10% goat serum in PBS, and incubated for 1 h at 
room temperature.  In experiments in which the D2R was activated, 100nM 
quinpirole (Quin, Sigma) was added to N2a cells in Krebs-Ringer solution with 
HEPES (KRH) (in mM; 125 NaCl, 5 KCl, 1.1 MgCl2, 1.2 KH2PO4, 2 CaCl2, 6 
Glucose, 25 HEPES, 1 NaHCO3) at 37 °C for 30 min.  500 ng/ml pertussis toxin 
(PTX, Life Technologies) was added to the cells in the culture media overnight.  
To label intracellular proteins, the cells were permeabilised with 0.2 % Triton X-
100 in PBS for 10 min.  The primary and secondary antibodies in 2.5 % BSA 
and 10 % goat serum were added to the cells as above.  Cell nuclei were 
stained with 0.5 µM 4’,6’-diamidino-2-phenylindole (DAPI) in PBS for 10 min.  
The coverslips were mounted onto glass slides using VECTASHIELD® 
mounting medium (Vector Laboratories).  
 
2.6.2 Endocytosis assay 
Transfected cells were plated onto glass-bottomed dishes (MatTek 
Corporation), coated with poly-L-lysine, and cultured in a 5 % CO2 incubator at 
37 °C.  After 40 h expression, N2a cells in glass-bottomed dishes were washed 
twice with KRH.  The cells were incubated with 10 µg/ml α-bungarotoxin Alexa 
Fluor® 488 conjugate (BTX-488) (Life Technologies) in 100 μl KRH for 30 min 
at 17 °C.  The unbound BTX-488 was removed by washing with KRH, and the 
labelled cells were returned to 37 °C for the kinetic assay.  Endocytosis was 
terminated by fixing the cells with cold 4 % PFA in PBS.  For endocytosis 
experiments in which the D2R was activated, 100 nM Quin was added to the 
cells in KRH buffer after the BTX-488 labelling stage.  The cells were then 
permeabilised and intracellular CaV2.2 and nuclei were labelled as described 
above.  The 13 mm coverslips were mounted onto dishes using 
VECTASHIELD® mounting medium. 
 
2.6.3 Forward trafficking assay 
Transfected cells were plated onto glass-bottomed dishes (MatTek 
Corporation), coated with poly-L-lysine, and cultured in a 5 % CO2 incubator at 
37 °C.  After 40 h expression, N2a cells in glass-bottomed dishes were washed 
twice with KRH.  The cells were incubated with 10 μg/ml unlabelled α-
- 77 - 
bungarotoxin (BTX) (Life technologies) for 30 min at 17 °C.  The unbound BTX 
was washed off with KRH, and the cells were then incubated with 10 µg/ml 
BTX-488 in KRH at 37 °C.  To terminate the reaction, cells were washed twice 
with cold KRH and then fixed with 4 % PFA in PBS at specified times for the 
kinetic assay.  200 ng/ml (0.713 μM) Brefeldin A (BFA, Sigma) in 0.4 % DMSO 
was added to the cells in FBS-free N2a cell culture medium for 4 h before and 
during the experiment in KRH buffer.  The cells were then permeabilised and 
intracellular CaV2.2 and nuclei were labelled as described above.  The 13 mm 
coverslips were mounted onto dishes using VECTASHIELD® mounting 
medium. 
 
2.6.4 Confocal microscopy 
All images were acquired using either an LSM 510 or LSM 780 Meta 
scanning confocal microscope (Zeiss), equipped with a Plan-Apochromat 
63x/1.4 or 40x/1.3 DICII oil immersion objective lens, in 8- or 16-bit mode.  The 
laser powers, gains and acquisition settings were kept constant for images that 
were used subsequently for quantification.  The region of interest was 
determined by identifying cells with expression of a transfection marker or 
intracellular staining of the protein of interest (e.g. GFP, CaV2.2 II-III loop 
staining), without selecting for the cell surface immunostaining to avoid bias.  In 
addition, on the LSM 780 confocal microscope, the region of interest was 
selected as described here, and the tile scan of 3 x 3 (9 tiles including the 
selected tile) was performed to further remove the bias in selecting cells with 
high expression.  For cell surface expression analysis, images were taken with 
0.7 μm optical section.  For neurite expression analysis, images were taken with 
0.9 μm optical sections in Z-stack, and presented as maximum projection.  
Confocal images were imported and analysed in ImageJ (National Institutes of 
Health).  The membrane fluorescence was quantified using the freehand brush 
tool with a selection width of 0.66 μm, and tracing the membrane region 
manually.  Neurite fluorescence was quantified using the freehand brush tool 
with a selection with of 2 μm and manually tracing the entire neurites using 
mCherry expression as a marker.  Lengths of neurites expressing GFP-CaV2.2 
were quantified using the freehand brush tool with a selection with of 2 μm and 
manually tracing the neurites expressing GFP as a marker.  The measured area 
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in μm2 was divided by the width of the selection (2 μm) to derive the length.  
Intracellular and whole-cell fluorescence was quantified using freehand 
selection, omitting the signal intensity from the nuclei.  The background 
fluorescence intensity in each channel was also taken from the same image, 
and subtracted from the signal intensity.  In the cell surface expression and 
trafficking experiments, all cells chosen for analysis contained CaV2.2 II-III loop 
immunostaining, confirming the CaV2.2 α subunit expression.  The whole-cell 
CaV2.2 expression levels were not significantly different in all experiments.  For 
the endocytosis assay, the normalized membrane fluorescent intensities were 
fitted to the single exponential decay equation (Equation 1), where x is time, y is 
intensity, y0 is the initial intensity, A is amplitude, and τ is the time constant.  
                (Equation 1) 
For the forward trafficking assay, the membrane fluorescent intensities 
were fitted to the single exponential association equation (Equation 2), where x 
is time, y is intensity, y0 is the initial intensity, A is amplitude, and τ is the time 
constant. 
         (Equation 2) 
All experiments were repeated n=3 to n=5, and approximately 30 to 50 
cells (N2a) were analysed for each experiment. All data were presented as 
pooled in the resulting graphs, except for the trafficking rates and time 
constants, which are averages of separate experiments.   
 
 
2.7 Electrophysiology 
tsA-201 cells were transfected with cDNA mix containing CaV2.2, α2δ-1, 
β1b, and CD8 or GFP at a ratio of 3 : 2 : 2 : 0.4 using a Fugene transfection 
protocol.  After 40 h expression, cells were replated in cell culture medium at 1 
in 3 or 5 dilution depending on their confluency.  Transfected cells were 
identified by co-expression of either GFP or CD8.  CD8 expression was 
detected with CD8 Dynabeads (Life Technologies).  Whole-cell currents were 
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recorded in voltage-clamp mode in following solutions; intracellular (electrode) 
solution (mM): 140 Cs-aspartate*, 5 EGTA, 2 MgCl2, 0.1 CaCl2, 2 K2ATP, 20 
HEPES, pH 7.2, 310 mOsm (* 0.5 M stock is made with 6.65 g L-aspartic acid 
in 50 ml H2O and 3 M CsOH was added to adjust the pH to 7.2, then H2O was 
added to make up to 100 ml).  Extracellular solution (mM): 1 BaCl2, 3 KCl, 1 
NaHCO3, 1 MgCl2, 10 HEPES, 4 D-glucose, 160 tetraethylammonium bromide, 
pH 7.4, 320 mOsm.  The borosilicate glass electrode resistance was between 
1.5 and 4 MΩ.  Cell capacitance and series resistance were compensated to 
70-80 %.  Whole-cell currents were recorded on Axopatch-200B amplifier using 
pClamp 9 or 10 (Molecular Devices).  The cells were held at -90 mV, and 50 ms 
pulses were applied in +5 mV steps between -30 mV and +70 mV.  For D2R 
activation, Quin was applied by local application through a perfusion system.  
To correct for the leak current, P/8 leak subtraction protocol was applied.  
Recordings were made at 20 kHz sampling frequency and filtered at 5 kHz (low-
pass 4-pole Bessel filter) in the amplifier.  The digital low-pass 8-pole Bessel 
filter with 1 kHz 3dB cut-off was applied in Clampfit 10.9 (Molecular Devices) 
before the current amplitudes were determined.  Average peak currents were 
taken between 8–13 ms after the test potentials were applied, and normalized 
to the cell capacitance to obtain current density.  Current-voltage (IV) 
relationships were fitted to a modified Boltzmann equation (Equation 3) to give 
V50 activation (V50,act), conductance (Gmax), and reversal potential (Vrev) using 
Origin 7. 
            (Equation 3) 
 
2.8 Co-localisation analysis 
Co-localisation of two different fluorophores was analysed using ImageJ 
plugin, Just Another Co-localisation Plugin (JACoP) (Bolte and Cordelières, 
2006).  Pearson’s correlation coefficient (rP), overlapping coefficient (r), and 
Manders’ co-localisation coefficients (M1 and M2) (Manders et al., 1993) were 
assessed for each set of images.  Pearson’s coefficient provides the correlation 
between the distributions of two signals, while overlapping coefficient 
represents fraction of co-localising objects, if there are an equal number of 
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components in each channel.  Mander’s coefficients are independent of the 
number of objects, and better express the fraction of co-localising objects, 
however, they are ineffective for comparing images with a very high background 
noise.   
 
 
2.9 Sample numbers 
The number of samples (n) in most of the experiments in this study is 
the total number of individual cells analysed, which are pooled from separate 
experiments (with a minimum of three repeats), and from this the mean and the 
standard error of mean (SEM) were calculated.  The only exception is for the 
experiments determining the rates of CaV2.2 trafficking, in which the rate of 
CaV2.2 trafficking was determined from each experiment by analysing 20 to 50 
cells per data point, and then the mean and SEM were determined from the 
repeated experiments.   
 
 
2.10 Statistical analysis 
Statistical analysis was performed using Student’s t test or one-way 
ANOVA with Bonferroni post-hoc test as appropriate in GraphPad Prism.  All 
the data were expressed as mean ± SEM.  
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Chapter 3 Molecular tools to study 
trafficking of CaV2.2 splice variants 
3.1 Introduction 
Cellular localisation of a single VGCC can be visualised by tagging the 
channel with a fluorescent protein or a tag that can be specifically identified.  
Such molecular tools for locating calcium channels have been generated and 
have been used in various studies previously, however not all of these resulted 
in functional VGCCs.  It is essential to ensure that the tagged VGCCs are also 
functional for the modelling of the channel localisation to be physiologically 
relevant since the channel activity may modulate its cellular localisation, which 
has been shown in other channels such as AMPA and N-methyl-D-aspartate 
(NMDA) receptors (Ju et al., 2004; Lau and Zukin, 2007).   
Here, new molecular tools and methods to study CaV2.2 trafficking are 
developed.  In addition, expression and trafficking of the exofacial-tagged 
CaV2.2 that have been previously developed (Cassidy et al., 2014) have been 
assessed for CaV2.2e37 splice variants to compare the difference in their cell 
surface expression and intracellular trafficking.    
 
 
3.2 mEos-tagged CaV2.2 
Photoactivatable fluorescent proteins are variants of fluorescent 
proteins, which can be activated by a specific wavelength to significantly 
change the excitation and emission wavelengths.  Monomeric Eos2 (mEos2) is 
one of the recently developed photoactivatable proteins, which is functional at 
physiological temperature (i.e. at 37 °C), and its fluorescence is relatively stable 
(McKinney et al., 2009), therefore it is a good candidate as a tag to monitor the 
trafficking of CaV2.2 splice variants.  The advantage of mEos-tagged CaV2.2 is 
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two-fold; 1) expression of the channel can be detected in live-cells without the 
need of immunocytochemistry, 2) green-to-red photoconverting mEos can be 
used to track the movement of the tagged-channels and monitored 
quantitatively as a ratio of red to green.  mEos-tagged CaV2.2 splice variants 
were generated by attaching mEos sequence to the N-terminus of CaV2.2.   
 
3.2.1 Biophysical properties of mEos-CaV2.2 splice variants 
3.2.1.1 Whole-cell current of mEos-CaV2.2 splice variants 
To determine whether mEos-CaV2.2 splice variants are functional, and 
mEos tag does not interfere with the biophysical properties of CaV2.2, the Ba2+ 
whole-cell current was recorded from these isoforms, which were expressed 
with α2δ-1 and β1b in tsA-201.  All of the electrophysiological recordings were 
performed in tsA-201, since the neuronal cell line N2a was not robust enough 
as an expression system for whole-cell patch clamp recordings (Appendix 1).  
The current density peak of mEos-Cav2.2e37a was greater than mEos-
CaV2.2e37b (Figure 3.1a).  The current density of the untagged CaV2.2e37b 
was not significantly different from the mEos-tagged CaV2.2e37b, suggesting 
that mEos at the N-terminus does not affect the biophysical properties of the 
channels.  Activation voltage (V50, act) was obtained from the fit of the modified 
Boltzmann equation, and showed that activation of CaV2.2e37a was 
significantly more hyperpolarised compared to CaV2.2e37b (Figure 3.1b).  
These properties of CaV2.2e37a and e37b currents are in agreement with the 
previous reports in expression systems (Bell et al., 2004; Castiglioni et al., 
2006; Raingo et al., 2007) and in transgenic mice (Andrade et al., 2010). 
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Figure 3.1 Whole-cell current of mEos-CaV2.2e37 splice 
variants. 
(a) Whole-cell current densities of mEos-CaV2.2e37 isoforms and 
CaV2.2e37b control, expressed with β1b and α2δ-1 in tsA-201. 
Peak current densities were; mEos-CaV2.2e37a, -124.6 ± 19.5 
pA/pF at 0mV (n=15), mEos-CaV2.2e37b, -71.0 ± 8.6 pA/pF at 
+5mV (n=17), CaV2.2e37b, -69.4 ± 25.2 pA/pF at 0mV (n=6). (b) 
Activation voltage (V50,act) of mEos-CaV2.2e37a was significantly 
more hyperpolarised than e37b. ***P<0.001 (Student’s unpaired t-
test). 
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3.2.1.2 Steady-state inactivation of mEos-CaV2.2 splice variants 
To compare the inactivation of CaV2.2 splice variants, steady-state 
inactivation protocol (Figure 3.2a) was utilised.  The normalised current showed 
that CaV2.2e37a was inactivated at a more hyperpolarised potential, compared 
to CaV2.2e37b (Figure 3.2b).  Inactivation voltage (V50, inact) determined from the 
sigmoidal curve fit reveals that the V50, inact of CaV2.2e37a was modestly but 
significantly more negative than CaV2.2e37b (Figure 3.2c).  
 
3.2.1.3 Effect of β subunits on mEos-CaV2.2 splice variants 
β1b (brain isoform of β1) and β3 (neuronal) are the isoforms of β 
subunits that are likely to be expressed where CaV2.2 channels are important.  
To determine whether different β isoforms affect the biophysical properties of 
the tagged CaV2.2 splice variants, CaV2.2e37b was expressed with either β1b 
or β3 in the presence of α2δ-1, and the whole-cell current was recorded.  The 
current-voltage (IV) relationships of CaV2.2e37b with β1b and β3 were largely 
identical.  In addition, CaV2.2e37a with β3 also showed a greater whole-cell 
current density (Figure 3.3a).  V50, act of CaV2.2e37a was significantly shifted to 
a more hyperpolarised potential than CaV2.2e37b in the presence of β3, 
similarly to the findings with β1b (Figure 3.3b).  Therefore, I conclude that the 
biophysical properties of CaV2.2e37 isoforms with β1b and β3 are very similar 
to each other. 
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Figure 3.2 Steady-state inactivation of mEos-CaV2.2e37 
isoforms. 
(a) Schematic diagram of the steady-state inactivation protocol 
(top), and exemplary whole-cell current traces of mEos-
CaV2.2e37b (blue) and e37a (red), expressed with β1b and α2δ-1 
in tsA-201. (b) The average relative current from steady-state 
inactivation of CaV2.2e37 isoforms. (c) Half-maximal inactivation 
voltage (V50,inact) obtained from (b). V50,inact of mEos-CaV2.2e37a 
was significantly more hyperpolarised than e37b.  *P<0.05 
(Student’s unpaired t-test). 
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Figure 3.3 Effect of β1b and β3 on mEos-CaV2.2e37 splice 
variants. 
(a) Whole-cell current densities of mEos-CaV2.2e37 isoforms with 
β3 and mEos-CaV2.2e37b with β1b as a control, expressed with 
α2δ-1 in tsA-201. Peak current densities were; mEos-
CaV2.2e37a+β3, -225.2 ± 32.7 pA/pF at 5mV (n=14); mEos-
CaV2.2e37b+β3, -132.9 ± 18.3 pA/pF at 10mV (n=12); mEos-
CaV2.2e37b+β1b, -141.1 ± 17.1 pA/pF at 10mV (n=5). (b) 
Activation voltage (V50,act) of mEos-CaV2.2e37a was significantly 
more hyperpolarised than e37b with β1b or β3. **P<0.01, 
***P<0.001 (one-way ANOVA). 
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3.2.2 Cellular localisation of mEos-tagged CaV2.2 
To determine the protein expression patterns in N2a cells, mEos-tagged 
CaV2.2e37b was transiently expressed with α2δ-1 and β1b (Figure 3.4).  Firstly, 
the fluorescence intensity from mEos-CaV2.2e37b on average appeared lower 
in comparison to GFP-tagged CaV2.2e37b.  Secondly, some cells expressed 
mEos-CaV2.2 possibly at the plasma membrane, which was exhibited as a ring-
like expression pattern, separate from the intracellularly accumulated channels.  
However, cell surface localisation of the tagged-channels is difficult to 
determine reliably without a plasma membrane marker, which is essential for 
comparing the cell surface expression of CaV2.2 splice variants. 
 
3.2.3 Photoconversion of mEos-CaV2.2 
mEos2 undergoes green-to-red photoconversion when it is exposed to 405 nm 
wavelengths (McKinney et al., 2009).  A small region of N2a cell expressing 
mEos-CaV2.2e37b in a glass-bottom dish was photoactivated under a confocal 
microscope with a localised laser at 405 nm, and the fluorescence signal of both 
green and red channels were recorded continuously for 100 frames (Figure 
3.5).  Prior to the photoactivation, there was no fluorescence in the red channel.  
Immediately after the photoactivation, the red fluorescence appeared in the 
region of excitation, but it was not localised as weaker red fluorescence was 
also observed around the region (Figure 3.5, right column).  In addition, the 
green fluorescence was also increased after photoactivation over the entire cell 
(Figure 3.5, left column).  This observation was unexpected and has not been 
reported in any literature, but this increase in the green fluorescence was 
observed in all the cells analysed.  It is possible that the laser exposure is 
causing a change in intracellular pH, which alters the fluorescence level 
temporarily, however, lowering the laser power and exposure length was 
ineffective in photoactivation.  Nonetheless, monitoring the channel movement 
to and from the plasma membrane could not be achieved with this method, as 
the photoconversion could not be localised to a sufficiently small region such as 
plasma membrane, and there were significant signal decay over a long period 
of time due to photobleaching. 
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Figure 3.4 mEos- and GFP-tagged CaV2.2e37b in N2a cells.  
Exemplary confocal images of N2a cells expressing mEos- (top) 
and GFP-(bottom) tagged Cav2.2e37b with β1b and α2δ-1, 
demonstrating the heterogeneous expression of these constructs..  
Plasma membrane-like expression is observed from both 
constructs, albeit weak in some cells. Most of cells exhibited 
aggregated expression of the tagged-channels around the nuclei.  
In general, fluorescence intensity of GFP-CaV2.2e37b appeared 
stronger than mEos-CaV2.2e37b. Scale bar, 20 μm 
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Figure 3.5 Photoconversion of mEos-CaV2.2. 
N2a expressing mEos-CaV2.2e37b with β1b and α2δ-1 was 
imaged on a confocal microscope with a temperature-control 
chamber at 37 °C.  The white box indicates the region of excitation 
at 405 nm for green-to-red photoconversion of mEos2. Green 
channel (left, excitation 488 nm, emission 490-562 nm), red 
channel (right, excitation 543 nm, emission 562-650  nm), scale 
bar, 20 μm. 
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3.3 Cell surface biotinylation 
A high affinity interaction between biotin and avidin is a useful tool in 
immunocytochemistry and western blot, as the side chain of biotin forms a 
covalent link with a lysine residue in a protein of interest, which remains 
conjugated.  This is particularly useful and has been used frequently for 
examining transmembrane proteins.  Biotin can be used to selectively label 
transmembrane proteins by applying biotin to intact cells extracellularly, without 
detecting the intracellular proteins.   
To examine the cell surface expression of CaV2.2 splice variants in tsA-201, the 
cell surface proteins including CaV2.2 were labelled extracellularly with biotin 
before the cells were lysed.  Biotin-conjugated CaV2.2 was precipitated with 
streptavidin-coated beads, and detected with a specific antibody against 
CaV2.2.  CaV2.2 splice variants were successfully expressed and detected in 
the cell lysis, however, the biotin-coupled CaV2.2 was hardly detected, despite 
that α2δ-1 co-expressed with CaV2.2 was successfully detected in both fractions 
(Figure 3.6). The protein-load for streptavidin-precipitation was therefore 
doubled, and as a result biotinylated CaV2.2 splice variants were detected 
(Figure 3.7).  The band intensities for both biotinylated CaV2.2 and α2δ-1 from 
cells expressing CaV2.2e37a were consistently lower than those expressing 
CaV2.2e37b, even though the whole-cell expression of these subunits were 
similar.  The difference in cell surface expression of α2δ-1 in the cells 
expressing CaV2.2e37a and 37b was unexpected, but it is unlikely that cell 
surface expression of α2δ-1 is modulated in this expression system, which 
makes the interpretation of the difference in biotinylated CaV2.2 splice variants 
difficult.  In addition, untagged CaV2.2e37b was not detected in the biotinylated 
fraction in this experiment (Figure 3.7).  Overall, this experiment is not robust 
enough to reliably compare the cell surface expression of CaV2.2 splice variants 
and examine the factors that affect CaV2.2 cell surface expression.   
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Figure 3.6 Cell surface biotinylation of CaV2.2 splice variants.  
Biotin-labelled CaV2.2 (top) precipitated with streptavidin (left) and 
whole-cell lysate (right). α2δ-1 (middle) was detected as a positive 
control, showing the glycosylated and non-glycosylated form as 
separate bands. Soluble protein Akt (bottom) was shown as a 
negative control for biotinylation, and as a protein loading control 
in lysate blot. 800 μg lysate was loaded on the streptavidin-coated 
beads for precipitation. 20 μg lysate per lane was loaded as a 
protein expression control.   
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Figure 3.7 Cell surface biotinylation of CaV2.2 splice variants.  
Biotin-labelled CaV2.2 (top) precipitated with streptavidin (left) and 
whole-cell lysate (right). α2δ-1 (middle) was detected as a positive 
control, and soluble protein Akt (bottom) was shown as a negative 
control. 1600 μg lysate was loaded on the streptavidin-coated 
beads for precipitation. 15 μg lysate per lane was loaded as a 
protein expression control.   
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3.4 BBS-tagged CaV2.2 
Labelling with bungarotoxin (BTX) by inserting a short sequence of the 
bungarotoxin binding site (BBS) into an extracellular region of transmembrane 
proteins has proven useful for monitoring intracellular trafficking of a number of 
receptors and channels in live cells (Sekine-Aizawa and Huganir, 2004; Wilkins 
et al., 2008; Bogdanov et al., 2006; Tran-Van-Minh and Dolphin, 2010; Cassidy 
et al., 2014).  Taking advantage of the recently developed BBS-tagged 
CaV2.2e37b (Cassidy et al., 2014), two BBS sequences in tandem were 
inserted into the extracellular loop of CaV2.2e37a to generate BBS-tagged 
CaV2.2e37a.   
To test the channel function of BBS-CaV2.2e37a and e37b, the whole-
cell current densities were determined by transient expression in tsA-201 with 
α2δ-1 and β1b.  In order to examine the trafficking of CaV2.2e37 isoforms to and 
from the plasma membrane with BTX-labelling, the effect of BTX-binding itself 
on CaV2.2 surface expression was also determined by comparing the whole-cell 
current densities with and without BTX.  
Both BBS-CaV2.2e37a and e37b channels were fully functional as 
previously described (Figure 3.8).  The presence of BTX did not affect the 
whole-cell current densities of the CaV2.2e37 isoforms, indicating that BTX itself 
does not modulate the overall cell surface expression of CaV2.2.   
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Figure 3.8 Whole-cell current densities of BBS-CaV2.2e37 
splice variants in the presence and absence of BTX. 
The whole-cell current densities of BBS-CaV2.2e37 splice variants 
expressed with β1b and α2δ-1 in tsA-201 were determined in the 
presence and absence of 10 μg/ml BTX in the extracellular 
solution.  (a) Whole-cell current densities of BBS-CaV2.2e37a. No 
BTX (red closed circle), n=14. With BTX (red open circle), n=15.  
(b) Whole-cell current densities of BBS-CaV2.2e37b.  No BTX 
(blue closed circle), n=11.  With BTX (blue open circle), n=8.  
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3.4.1 Live cell imaging of BBS-CaV2.2 
To compare the intracellular trafficking kinetics of CaV2.2e37 isoforms, it 
was necessary to understand the time course at which CaV2.2 internalises from 
the cell surface.  Turnover durations of VGCCs are poorly understood so far, 
mainly due to the lack of molecular tools to monitor their trafficking.  
Fluorescently labelled BTX, BTX-488 was incubated with N2a cells 
expressing BBS-CaV2.2e37 isoforms for 30 min at 17 °C and washed off prior to 
the start of the imaging in glass-bottom dishes, and fluorescence intensity at the 
plasma membrane was monitored by taking time-lapse images on a confocal 
microscope over the 60-min time course in the temperature-controlled chamber 
at 37 °C and 20 °C to determine the temperature effect on the cell surface 
CaV2.2 (Figure 3.9).  At 37 °C which is the physiological temperature, a majority 
of the BTX-labelled cell surface CaV2.2 was internalised by 15 min after the 
start of the recording and some intracellular puncta were observed, however, 
these puncta were not observed as an accumulation, suggesting either that the 
BTX-488 dissociates from the channels after endocytosis, or the internalised 
channels are degraded.  By the 30 min-time point, there were hardly any 
labelled channels left at the plasma membrane (Figure 3.9).  On the other hand, 
at 20 °C there was still a considerable amount of labelled CaV2.2 in the plasma 
membrane at 30 min after the start of the experiments, as the internalising 
events were drastically reduced at this temperature compared to 37 °C (Figure 
3.9).   
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Figure 3.9 Time-lapse images of cell surface BBS-CaV2.2 in 
N2a cells at 37 °C and 20 °C.  
Live N2a cells expressing BBS-CaV2.2e37b were labelled with 
BTX-488 for 30 min at 17 °C and washed off prior to the start of 
the imaging, and the time-lapse images were taken on a confocal 
microscope every 5 min at a fixed gain over 60 min.  The effect of 
incubation temperature on cell surface CaV2.2 were demonstrated 
at 37 °C (top) and 20 °C (bottom).   
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3.4.2 Endocytosis and forward trafficking assays of BBS-CaV2.2 
In order to maximise the sampling number per condition in one 
experiment, N2a cells with BTX-labelled CaV2.2 were fixed at various times 
after the start of the experiment.  The cells were also post-stained with CaV2.2 
antibodies as an expression marker to aid the selection of the cells expressing 
CaV2.2, rather than selecting cells that have cell surface staining to avoid bias.  
 
3.4.2.1 BBS-CaV2.2 endocytosis assay optimisation 
To monitor and compare endocytosis of CaV2.2 splice variants, the 
following protocol was established, which is explained in a schematic diagram 
(Figure 3.10).  During the labelling step, BBS-CaV2.2 was incubated with 10 
μg/ml BTX-488 at 17 °C for 30 min to label all of the channels at the cell surface 
by minimising the internalisation which occurs at faster rate at higher 
temperature.  All the washes were performed on the bench at room 
temperature.  The endocytosis experiment was performed at 37 °C, and cells 
were fixed with PFA on ice immediately at various time points to minimise 
further channel internalisation during fixation.  As shown in the initial experiment 
at 37 °C, the CaV2.2 internalisation occurs relatively fast during the first 15 min, 
therefore the cells were sampled at 0, 5, 10, 20 and 40 min after the start of the 
experiment (Figure 3.11).  The BTX-labelled cell surface BBS-CaV2.2 was 
internalised and increasing numbers of intracellular puncta were observed 
during the experiment.  By 20 min after the start of the experiment, most of the 
cell surface CaV2.2 was internalised.  In this protocol, the cells were exposed to 
multiple washes and more prone to detachment from the dishes.  Therefore, a 
higher seeding density (1:25-30 cell dilution) was required prior to the 
transfection, compared to that for the standard immunocytochemistry 
experiment (1:40-60 cell dilution), for a successful experiment.  Quantification of 
cell surface BBS-CaV2.2e37 isoforms and their endocytosis rates will be 
discussed in Chapter 4. 
A limitation of this experiment is that 1) internalised BTX-labelled 
CaV2.2 can be recycled and re-appear on the cell surface, which cannot be 
distinguished, 2) there may be a dissociation of BTX from the cell surface 
CaV2.2, independent of channel endocytosis.  Association and dissociation 
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kinetics of BTX at 37 °C have not been reported, although at 20 °C it poses a 
minor factor in the disappearance of the BTX label (Salvaterra and Mahler, 
1976; Cassidy et al., 2014).  In addition, when the experiment was carried out at 
4 or 20 °C, the majority of the cell surface CaV2.2 remained at the plasma 
membrane (Figure 3.12).  Diffusion of small molecules such as BTX is less 
temperature-dependent compared to biological processes such as endocytosis. 
Therefore, the rate of endocytosis by this method should be relatively 
representative of the physiological event.  
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Figure 3.10 BBS-CaV2.2 endocytosis assay protocol. 
During the labelling step, N2a cells expressing BBS-CaV2.2 with 
β1b and α2δ-1 was incubated with 10 μg/ml BTX-488 at 17 °C for 
30 min to label all of the channels at the cell surface.  Unbound 
BTX-488 was washed off at room temperature.  The endocytosis 
experiment was performed at 37 °C, and cells were fixed with PFA 
on ice immediately at various time points to minimise further 
channel internalisation during fixation. 
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Figure 3.11 Endocytosis of BBS-CaV2.2 splice variants.  
Exemplary confocal images of N2a cells expressing BBS-
CaV2.2e37a (top) and e37b (bottom) with β1b and α2δ-1 from an 
endocytosis experiment.  The cells were fixed with 4 % PFA at 0, 
5, 10, 20 and 40 min after the start of the experiment at 37 °C.  
Reduction of BTX-488 at the cell surface at later time points 
indicates the CaV2.2 endocytosis.  Scale bar, 20 μm. 
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Figure 3.12 BBS-CaV2.2 endocytosis is blocked at 4 °C.  
Exemplary confocal images of N2a cells expressing BBS-
CaV2.2e37b in endocytosis experiments at 4 °C (top) and 37 °C 
(bottom) at 40 min. BBS-CaV2.2 remains at cell surface at 4 °C, 
which indicates that the channel endocytosis is blocked at this 
temperature, and very little dissociation of BTX from the cell 
surface CaV2.2 during this time period.  DAPI (blue), BTX-488 
(green), CaV2.2 (red). Scale bar, 20 μm. 
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3.4.2.2 Forward trafficking (exocytosis) assay optimisation 
A forward trafficking experiment to monitor the CaV2.2 appearance at 
the cell surface was established in a similar manner to the endocytosis protocol, 
which was described above (Figure 3.13 and Figure 3.14).  The same 
concentration of unlabelled BTX as the BTX-488 (10 μg/ml) was applied to 
saturate the entire cell surface CaV2.2.  This concentration was sufficient as 
there was no CaV2.2 labelling by BTX-488 when the experiment was carried out 
at 4 °C to block any movement of the channels in the plasma membrane (Figure 
3.15).  Quantification of cell surface BBS-CaV2.2e37 isoforms and their forward 
trafficking rates will be discussed in Chapter 4. 
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Figure 3.13 BBS-CaV2.2 forward trafficking protocol.  
During the blocking step, N2a cells expressing BBS-CaV2.2 with 
β1b and α2δ-1 was incubated with 10 μg/ml unconjugated BTX at 
17 °C for 30 min to label all of the channels at the cell surface.  
Unbound BTX was washed off at room temperature, and 10 μg/ml 
BTX-488 was added to the cells to label newly inserted channels 
at the cell surface during the forward trafficking experiment, 
performed at 37 °C.  The cells were fixed with 4 % PFA on ice 
immediately at various time points to minimise further channel 
internalisation during fixation.  
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Figure 3.14 Forward trafficking of BBS-CaV2.2 splice variants. 
Exemplary confocal images of N2a cells expressing BBS-
CaV2.2e37a (top) and e37b (bottom) with β1b and α2δ-1 from a 
forward trafficking experiment.  The cells were fixed with 4 % PFA 
at 0, 5, 10, 20, 40 and 60 min after the start of the experiment at 
37 °C.  Increase in BTX-488 at the cell surface at later time points 
indicates an increase in newly inserted CaV2.2 in the plasma 
membrane from the forward trafficking.  Scale bar, 20 μm. 
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Figure 3.15 No BBS-CaV2.2 forward trafficking at 4 °C. 
Exemplary confocal images of N2a cells expressing BBS-
CaV2.2e37b in forward trafficking experiments at 4 °C (top) and 37 
°C (bottom) at 60 min. No surface staining of BBS-CaV2.2 is 
observed at 4 °C, indicating the forward trafficking does not occur 
at this temperature.  DAPI (blue), BTX-488 (green), CaV2.2 (red).  
Scale bar, 20 μm. 
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3.4.3 Monitoring BBS-CaV2.2 trafficking in neurons 
In order to examine the trafficking of CaV2.2 splice variants in neurons 
using BBS-tagged CaV2.2 constructs, rat hippocampal neurons were chosen as 
the most robust expression system, as they provide more tissue per animal, 
thus more neurons in each experiment to test multiple conditions such as 
transfection and immunostaining protocols than DRG neurons.  Before 
expressing BBS-Cav2.2 in the hippocampal neurons, the background signal 
from BTX-488 binding was assessed, as these neurons express a large number 
of endogenous nicotinic acetylcholine receptors (Salvaterra and Mahler, 1976), 
and the acetylcholine binding site of these receptors are also bound by BTX 
with a sub-nM affinity (Tzartos and Changeux, 1983).  A competitive antagonist 
of the nicotinic acetylcholine receptor, tubocurarine was used to block the BTX 
binding (Wenningmann and Dilger, 2001).  100 μM tubocurarine was sufficient 
in reducing the background signal from BTX-488 in cultured hippocampal 
neurons (Figure 3.16).   
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Figure 3.16 Endogenous binding of BTX in rat hippocampal 
neurons. 
Exemplary confocal images of cultured hippocampal neurons 
labelled with BTX-488 in the presence or absence of tubocurarine.  
BTX-488 (green) binds to endogenous nicotinic acetylcholine 
receptors in cultured hippocampal neurons to give a high 
background signal (top). 100 μM tubocurarine, a competitive 
antagonist, reduced the background signal from BTX-488 
(bottom).  βIII-tubulin (red) was used as a neuronal marker.  DAPI 
(blue), scale bar, 20 μm. 
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3.5 HA-tagged CaV2.2 
To compare the subcellular localisation of CaV2.2 isoforms containing 
e37a or e37b, both channels were exofacially-tagged with haemagglutinin (HA) 
as described previously to generate HA-tagged CaV2.2e37 splice variants 
(Cassidy et al., 2014).  The advantage of HA-tagged CaV2.2 is that detection by 
secondary and possibly tertiary antibodies can amplify the signal.  Furthermore, 
HA-antibody labelling gives more options for confocal microscopy analysis as it 
allows the use of more than one channel, compared to other tags discussed in 
this chapter, which is useful in dual labelling with multiple proteins.  
 
3.5.1 Biophysical properties of HA-tagged CaV2.2 splice variants 
3.5.1.1 Whole-cell current density of CaV2.2e37 isoforms 
First, to demonstrate that the exofacial tag does not affect the function 
of the CaV2.2 splice variant channels, whole-cell Ba2+ currents were recorded 
from tsA-201 cells that are transiently expressing HA-tagged CaV2.2e37a and 
CaV2.2e37b, together with the auxiliary subunits α2δ-1 and β1b.  The average 
whole-cell current density of CaV2.2e37a was significantly larger than that of 
CaV2.2e37b at test potentials between -25 mV and 15 mV (Figure 3.17), which 
was in agreement with the previous reports (Bell et al., 2004; Castiglioni et al., 
2006; Raingo et al., 2007).   
 
3.5.2 Conductance and activation voltage 
The whole-cell conductance (Gmax) and the half-maximal activation 
voltage (V50,act) were determined from fitting the IV curves to the modified 
Boltzmann equation.  The average Gmax for CaV2.2e37a currents was 
approximately 1.5-fold greater than Cav2.2e37b currents (Figure 3.18a).  
Furthermore, Cav2.2e37a channels were activated at a more hyperpolarized 
potential than those containing e37b (Figure 3.18b).  These properties of 
CaV2.2e37a and e37b currents are in agreement with the previous reports in 
expression systems (Bell et al., 2004; Castiglioni et al., 2006; Raingo et al., 
2007) and in transgenic mice (Andrade et al., 2010). 
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Figure 3.17 Whole-cell current density of HA-tagged 
CaV2.2e37 splice variants. 
(a) Exemplary traces of HA-CaV2.2e37b (left, blue) and e37a 
(right, red) whole-cell current in tsA201, expressed with β1b and 
α2δ-1. (b) Average whole-cell current density of HA-tagged 
CaV2.2e37a and e37b. The average peak current density was: 
CaV2.2e37a (red), -245.0 ± 29.1 pA/pF at +5mV (n=22); 
CaV2.2e37b (blue), -156.0 ± 17.7 pA/pF at +10mV (n=24).   
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Figure 3.18 Conductance (Gmax) and activation voltage (V50, act) 
of HA-CaV2.2e37a and e37b. 
The values of Gmax and V50,act were determined from fitting each IV 
curve to the modified Boltzmann equation (see method).  (a) The 
average Gmax of CaV2.2e37a (red, n=22) was significantly larger 
than CaV2.2e37b (blue, n=24).  (b) V50,act of CaV2.2e37a (red, 
n=22) was significantly more hyperpolarised compared with 
CaV2.2e37b (blue, n=24).  *P<0.05, ***P<0.001, Student’s 
unpaired t-test. 
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3.5.3 G protein-mediated inhibition of CaV2.2e37 isoforms 
In order to determine whether the exofacial tagged CaV2.2e37 isoforms also 
exhibited differential voltage-dependence upon GPCR activation, in a similar 
manner to that previously reported (Raingo et al., 2007; Andrade et al., 2010), 
D2R was co-expressed with CaV2.2 isoforms in the presence of α2δ-1 and β1b.  
Using a double pulse protocol (Figure 3.19a), CaV2.2e37a and CaV2.2e37b 
currents (P1) were inhibited by the D2R selective agonist, quipirole (Quin, 
Tsuruta et al., 1981).  When a large depolarising pulse was applied just prior to 
the second test pulse (P2) in the presence of Quin, CaV2.2e37a exhibited 
significantly smaller relative currents (P2/P1), compared to CaV2.2e37b (Figure 
3.19b).  This voltage-independent inhibition of CaV2.2e37a by D2R activation 
largely agrees with previous findings with GABAB and μ-opioid receptor 
activation in expression systems and in transgenic mice (Raingo et al., 2007; 
Andrade et al., 2010), albeit the difference in voltage dependence between the 
two splice variants from this study is smaller than these reports.  This could be 
due to the different GPCRs used and/or difference in the β subunits (β3 
subunits used in these reports instead of β1b in this study).  These results 
demonstrate that the CaV2.2e37 isoforms containing exofacial tags function as 
predicted by previous studies.   
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Figure 3.19 D2 receptor-mediated inhibition of CaV2.2e37 
isoforms.   
The whole-cell currents of HA-CaV2.2e37 isoforms expressed with 
D2R, β1b and α2δ-1 in tsA-201 cells with or without D2R agonist, 
quinpirole (Quin).  (a) Whole-cell current was recorded before and 
after 300nM Quin, applied in a perfusion system.  The voltage 
clamp protocol is shown on the top.  The exemplary current traces 
of CaV2.2e37b (black for control, blue for 300nM Quin) and 
CaV2.2e37a (grey for control, red for 300nM Quin) are also shown. 
(b) The relative current in the presence of 300nM Quin as P2/P1.  
CaV2.2e37b (blue, n=22), CaV2.2e37a (red, n=19).  *P<0.05 
(Student’s unpaired t-test). 
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3.6 GFP-tagged HA-CaV2.2 (GFP-HA-CaV2.2) 
Green fluorescent protein (GFP) was added to the N-terminus of the 
CaV2.2 splice variants containing the exofacial HA tag (Figure 3.20).  The 
advantage of these constructs is that expression of the channel at the plasma 
membrane can be detected by immunostaining for the cell surface HA epitope 
in non-permeabilising conditions after fixation, and the total channel localization 
determined by GFP simultaneously. 
 
 
 
a 
 
b 
 
 
Figure 3.20 GFP-HA-CaV2.2e37 splice variants. 
(a) A schematic diagram showing GFP-HA-tagged CaV2.2, which 
contains GFP at the N-terminus and HAgHA in the extracellular 
loop. (b) Exemplary confocal images of N2a cells expressing GFP-
HA-CaV2.2e37a and e37b with α2δ-1 and β1b.  Non-permeabilised 
cells are showing CaV2.2 on the cell surface, which is visualised 
by extracellular HA labelling (red).  All the intracellular GFP 
(green) co-localises with HA, as shown in the permeabilised cells.  
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3.6.1 Western blot 
Whole-cell protein expression levels of both GFP-HA-tagged CaV2.2e37 
isoforms were at a similar level from the western blot, in which these isoforms 
were co-expressed with α2δ-1 and β1b (Figure 3.21).  The molecular weights of 
these isoforms were as expected for full-length channels, and were slightly 
larger than HA-CaV2.2 due to the GFP at the N-terminus.  
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Figure 3.21 Western blot of GFP-HA-CaV2.2e37 splice 
variants. 
(Top panel) GFP-HA-Cav2.2e37a and both clones of GFP-HA-
CaV2.2e37b were expressed in full-length in the tsA201. Similar 
whole cell protein expression levels were obtained from all clones.  
GFP-HA-CaV2.2 isoforms show a higher molecular weight relative 
to HA-CaV2.2 due to the GFP in the N-terminus.  (Bottom panel) 
Glyceraldehyde 3-phosphate dehydrogenease (GAPDH) was 
shown as a protein loading control. 
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3.6.2 Whole-cell current 
The average whole-cell current density of GFP-HA-CaV2.2e37a was 
significantly larger than CaV2.2e37b between -20 and 0 mV (Figure 3.22a).  The 
V50,act of this CaV2.2e37a was also shifted to a significantly more hyperpolarised 
potential compared to CaV2.2e37b, similarly to the other tagged-channels.  
These properties were in agreement with those of HA-tagged CaV2.2 (3.5.1), 
therefore, GFP at the N-terminus does not affect these biophysical propertised 
of CaV2.2e37 splice variants.  
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Figure 3.22 Whole-cell current of GFP-HA-CaV2.2e37 splice 
variants. 
(a) Average whole-cell current densities of GFP-HA-CaV2.2e37 
isoforms expressed with β1b and α2δ-1 in tsA-201.  The average 
peak current density was: CaV2.2e37a (red), -256.5 ± 46.6 pA/pF 
at +0mV (n=12); CaV2.2e37b (blue), -175.9 ± 24.2 pA/pF at 
+10mV (n=8).  (b) The average activation potential of GFP-HA-
CaV2.2e37a (red) was significantly more hyperpolarised than e37b 
(blue).  ***P<0.001, Student’s unpaired t-test.     
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3.7 CaV2.2 splice variant trafficking in DRG 
Taking advantage of the GFP-HA-tagged CaV2.2 constructs, expression 
of CaV2.2 splice variants in different compartment of DRG neurons was 
visualised.  GFP on the N-terminus of CaV2.2 was observed in DRG soma, as 
well as the neuronal projections (Figure 3.23).  Staining with HA antibody post 
fixation completely co-localised with GFP in the neurites and on the plasma 
membrane of the soma.  However, in the case of the neurites, the extracellular 
HA-labelling may be unreliable as an indicator for the neurite plasma membrane 
expression, since the fixation with PFA can cause permeabilisation of the 
neurites (from the observation by other members of the laboratory), therefore 
the cell surface CaV2.2 is indistinguishable from the intracellular CaV2.2.  To 
resolve this, the cell surface CaV2.2 was live-labelled to avoid the neurites being 
permeabilised.  HA antibody was applied to the DRG in serum-free medium for 
1 h at 37 °C, before fixation, and the secondary antibody was applied post-
fixation, similarly to the standard immunocytochemistry procedure.  The 
limitations of this method is that the cell surface-bound antibodies can be 
internalised at 37 °C during labelling and requires higher concentration of 
primary antibodies.  The live-labelling was performed at 1:250 dilution of HA 
antibody which is double the standard immunostaining concentration, however, 
very small amount of cell surface labelling was observed (Figure 3.23), and this 
method was not sufficiently robust in comparing CaV2.2 isoforms.  This could be 
due to the fast turnover of cell surface HA-CaV2.2 at 37 °C, and the HA antibody 
is internalised.  A greater expression level of GFP-HA-CaV2.2 may be required 
to resolve the detection of cell surface CaV2.2 in the neurites. 
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Figure 3.23 GFP-HA-CaV2.2e37b expressed in DRG neurons. 
(a) DRG neurons were fixed in 4 % PFA and surface CaV2.2 was 
immunostained with HA antibody without permeabilisation.  Cell 
bodies of DRG neurons show cell surface staining of CaV2.2, but 
most of the neurites were permeabilised by PFA.  (b) DRG 
neurons were live-labelled with HA antibody at 37 °C before 
fixation with 4 % PFA.  Very little immunostaining was observed 
with this method.  GFP (green), HA (red).  Scale bar, 20 μm.   
 
 
 
 
 
 
 
 
 
3.8 Expression of tagged-CaV2.2 in DRG-DH co-cultures 
VGlut1-pHluorin (vGpH) is expressed at the presynaptic terminals of 
glutamatergic neurons, and co-localises with a presynaptic protein, synapsin 
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(Todd et al., 2003; Hoppa et al., 2012; Ferron et al., 2014).  DRG and DH 
neurons in co-culture form functional synapses (Hendrich et al., 2012), therefore 
the localisation of HA-tagged CaV2.2 in the presynaptic terminals was 
examined.  Puncta of vGpH and HA-staining were observed in the DRG 
neurites (Figure 3.24).  HA-CaV2.2 generally co-localised with vGpH along the 
axons, which indicated that the tagged CaV2.2 channels were trafficked to the 
presynaptic terminals.  However, visualisation of HA-CaV2.2 in the DRG-DH co-
culture was more challenging than it was anticipated, as not many neurons 
exhibited this pattern of expression.  HA-staining was often lacking, probably 
due to the thick culture that results from this dense co-culture that does not 
allow sufficient antibody penetration, even with a long permeabilisation with 
PFA.  This unreliable HA staining could be a source of error when comparing 
the expression of HA-CaV2.2e37 splice variants and other factors that may 
influence the synaptic expression of CaV2.2.  Therefore, an appropriate positive 
control is required for immunostaining at these synaptic terminals.   
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Figure 3.24 Presynaptic expression of HA-CaV2.2 in DRG-DH 
co-culture.  
Confocal images of the axon of DRG neurons in DRG-DH co-
culture.  DRG neurons are expressing HA-CaV2.2e37b (red) and 
vGpH (green). Immunostaining against HA and βIII-tubulin (grey) 
was performed without permeabilisation.  In this neuron the axon 
was not permeabilised, as there is no βIII-tubulin staining.  After 
the HA and βIII-tubulin immunostaining protocol, the neurons were 
permeabilised to reveal the vGpH, which fluoresces in the neutral 
pH.  CaV2.2 shows punctate immunostaining that co-localise with 
vGpH along the axon.  Scale bar, 5μm.    
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3.9 Summary and Discussion 
In this study, the protein expression and properties of tagged-CaV2.2 
channels such as mEos-CaV2.2 and GFP-HA-CaV2.2 were investigated as 
novel molecular tools for examining the channel cell surface expression and 
trafficking.  All of the tagged CaV2.2 splice variants containing exon 37a or 37b 
generated here were expressed sufficiently in the recombinant cells, with 
electrophysiological properties as expected from the previous studies of these 
splice variants in the expression systems (Bell et al., 2004; Castiglioni et al., 
2006; Raingo et al., 2007) and in the transgenic mice (Andrade et al., 2010).  
The activation voltage of CaV2.2e37a is significantly hyperpolarised compared 
to CaV2.2e37b, and more importantly, the peak current density of the tagged 
CaV2.2e37a is consistently larger than that of CaV2.2e37b, suggesting that 
CaV2.2 channels containing exon 37a are trafficked to the cell surface more 
readily.  Different β subunits did not alter these properties in this study.  
Trafficking of these CaV2.2 splice variants will be further investigated in the next 
chapter.    
mEos-CaV2.2 constructs could not be visualised reliably at the plasma 
membrane in N2a cells, although some of the cells exhibited membrane-like 
localisation of fluorescently tagged channels.  This could be addressed by 
plasma membrane labelling agents such as fluorescent wheat germ agglutinin, 
which is a lectin that binds to N-acetyl-D-glucosamine and sialic acid residues 
found on the surface of the plasma membranes.  Although this was used in an 
attempt to stain the plasma membrane of N2a cells and assess the signal co-
localisation with mEos-CaV2.2, it resulted in considerable non-specific 
intracellular labelling (result not shown), therefore successful visualisation of 
CaV2.2 in the plasma membrane could not be obtained.  The use of the 
photoconvertible property of the mEos-tag for monitoring intracellular 
movements of CaV2.2 channels presents a potential for investigating CaV2.2 
trafficking, however, the excitation of mEos from green to red was not 
sufficiently localised in my hands to be reliable in subsequent studies to monitor 
the subtle movement of CaV2.2 to and from the plasma membrane.  The 
improved mEos such as mEos3 (Zhang et al., 2012) and mEos4 (Paez-Segala 
et al., 2015) which are reported to be brighter than mEos2 used in this study 
might be useful as a tag for CaV2.2 in the future studies. Furthermore, it was 
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concluded that biotinylation of the cell surface CaV2.2 to compare the cell 
surface expression of the two splice variants was also not robust enough to be 
used in examination of various factors affecting CaV2.2 trafficking.   
HA-tagged CaV2.2 constructs are robust and versatile molecular tools to 
assess the level of cell surface CaV2.2 splice variants.  They were expressed 
successfully at the presynaptic terminals of DRG neurons in rat DRG-DH co-
culture.  However, in order to compare the expression CaV2.2 splice variants, I 
faced a multitude of challenges.  Firstly, reliable and robust quantification 
methods such as the fluorescent intensity, size of each synapse and number of 
the synapses with HA-staining present, need to be established to compare 
different conditions influencing CaV2.2 trafficking to the synapses.  Secondly, 
the synaptic HA fluorescence intensity is dependent on the total protein 
expression as well as the efficiency of immunostaining, as these cultures can be 
thick with multiple layers of cells, and antibody penetration could be insufficient.  
To overcome these issues, appropriate positive controls should be used to 
reliably compare the synaptic expression of CaV2.2 splice variants in the DRG-
DH co-cultures.     
Addition of GFP to the N-terminus of HA-tagged CaV2.2 proves to be a 
useful tool to study the trafficking of CaV2.2 channels.  This construct allows 
visualisation of cell surface expression by immunostaining for HA extracellularly, 
as well as intracellular localisation of the channels by GFP simultaneously.  
Overexpression of GFP-HA-CaV2.2 resulted in saturation of the channels in all 
organelles in N2a cells and DRG cell bodies, and it was difficult to distinguish if 
one of the splice variants was localised more highly than the other in a 
particular subcellular compartment in this study.  Nonetheless, this construct 
was expressed well in the DRG neurites, therefore it is a useful molecular tool 
to assess the cell surface expression in the cell body, as well as the trafficking 
to the neurites simultaneously in the same DRG neuron.  
This study showed that the N-terminus GFP does not alter the peak 
current density of HA-CaV2.2, which is in agreement with the previous report of 
current densitied of the untagged CaV2.2 and CaV2.2 tagged with GFP at the N-
terminus (Raghib et al., 2001), however, the effect of the N-terminus GFP in 
V50,act and G-protein modulation of CaV2.2 have not been reported so far.  
Furthermore, the role of CaV2.2 N-terminus has been reported in G-protein 
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modulation (Page et al., 1998).  For these reasons, GFP-HA-CaV2.2 is a good 
tool to study the channel trafficking, however, HA-CaV2.2 should be used for 
investigating its interaction with GPCRs.   
BBS-tagged CaV2.2 constructs were then used to establish protocols to 
examine the endocytosis and forward trafficking in N2a cells in this study.  Live-
cell labelling with BTX-488 gives more physiologically relevant information on 
the intracellular trafficking of CaV2.2, therefore it is a powerful molecular tool in 
studying the movement of the channels to and from the plasma membrane.   
Monitoring transmembrane protein trafficking in live cells is effective on 
a confocal microscope with a pre-programmed image acquisition with fixed time 
intervals.  This method is only effective if it does not require a large sampling 
number per condition due to a small expression variability (e.g. stable cell line).  
However, transient expression of BBS-CaV2.2 in N2a cells resulted in a large 
variability in the expression level of cell surface CaV2.2.  This is due to the fact 
that in transient expression system, the number of copies of the CaV2.2 plasmid 
can vary among the cells, and leads to a large variation in the expression level 
of CaV2.2.  Furthermore, CaV2.2 requires co-expression of auxiliary subunits 
α2δ and β for its protein expression and cell surface localisation, however, these 
subunits had to be transfected in separate plasmids.  Moreover, expression of 
auxiliary subunits is not monitored in individual cells under the assumption that 
when a cell expresses CaV2.2, α2δ and β subunits are also expressed as these 
are much smaller in terms of their molecular weights, relative to CaV2.2.  Finally, 
the repetitive laser exposure for image acquisition during the course of 
experiment could potentially cause bleaching of the fluorophore, and may lead 
to a source of error.  For these reasons, the best approach to monitor CaV2.2 
trafficking in live cells would be to conduct time-course experiments in which the 
N2a cells expressing BBS-CaV2.2 are fixed at various time points after the start 
of endocytosis / forward trafficking experiment to quantify the average cell 
surface CaV2.2 at different time points.  This method also allows post-staining of 
intracellular CaV2.2 with a specific antibody to ensure that the total protein 
expression levels were comparable in all time-points.  
The only disadvantage of the BBS-tagged construct is that the cell 
surface staining with BTX-488 is relatively weak compared to HA, despite the 
insertion of BBSs in tandem.  Using different fluorescent BTX such as BTX-555 
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did not improve the staining (result not shown).  As a result, BBS-CaV2.2 could 
not be successfully visualised in DRGs and hippocampal neurons.  To express 
this construct in these neurons will require a new strategy, such as using much 
stronger expression method and/or subcloning BBS-CaV2.2 into an expression 
vector with a stronger promoter than pcDNA3.  The pCAGGS vector containing 
the CMV early enhancer/chicken β actin (CAG) promoter drives high protein 
expression in mammalian cells for proteins that are difficult to express in a large 
scale, and has been used in a number of expression systems (Aricescu et al., 
2006; Alexopoulou et al., 2008).  Subcloning BBS-CaV2.2 into pCAGGS may be 
a powerful tool for neuronal expression and investigating CaV2.2 trafficking in 
neurons. 
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Chapter 4 Trafficking of CaV2.2 splice 
variants 
4.1 Introduction 
Post-transcriptional modification such as alternative splicing provides 
CaV2.2 with further functional variation, which fine-tunes neuronal excitability.  
To elucidate how CaV2.2 channels are trafficked to the plasma membrane in 
neurons, I investigated whether there are differences in trafficking between two 
CaV2.2 alternative splice variants of exon 37 in the proximal C-terminus of 
CaV2.2, which is alternatively spliced in a mutually exclusive manner to give rise 
to CaV2.2 channels that contain either e37a or e37b (Figure 1.8); (Lipscombe et 
al., 2002; Bell et al., 2004).  This introduces a relatively restricted change in the 
amino acid sequence.  Despite this small change in the amino acid sequence, 
CaV2.2e37a has a larger whole-cell current compared to CaV2.2e37b (Bell et 
al., 2004; Castiglioni et al., 2006; Raingo et al., 2007; Marangoudakis et al., 
2012).  I noted that the exon 37a sequence introduces two canonical adaptor 
protein complex binding motifs, YxxΦ and [DE]xxxL[LI], that are absent from 
exon 37b.  Together with several lines of evidence that the C-terminus of CaV 
channels is important in channel targeting (Bourinet et al., 1999; Gao et al., 
2000; Kepplinger et al., 2000; Krovetz et al., 2000; Hall et al., 2013), I 
hypothesised that CaV2.2 channels containing e37a may be more readily 
trafficked to the plasma membrane compared to CaV2.2e37b channels by virtue 
of these motifs.   
To examine whether alternative splicing regulates trafficking of CaV2.2, 
functional exofacially-tagged CaV2.2 channels, HA- and BBS-tagged CaV2.2 
(Cassidy et al., 2014), as well as the newly-developed GFP-tagged HA-CaV2.2 
(3.6), were used to visualise their cellular localisation in both N2a cells and 
DRG neurons.  Electrophysiological, immunocytochemical and live-cell labelling 
approaches were used to demonstrate the trafficking of CaV2.2 channels 
containing e37a and e37b from the subcellular compartments to the plasma 
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membrane and to the processes of DRG neurons.  Furthermore, it was also 
revealed that this trafficking pathway is indeed dependent on specific motifs in 
e37a that mediate interaction with AP-1, involved in clathrin-mediated protein 
sorting (Bonifacino and Traub, 2003).   
 
 
4.2 Cell surface expression of CaV2.2 splice variants in N2a 
cells  
To investigate whether the increased current exhibited by CaV2.2e37a 
results from an effect on trafficking, mediating altered cellular localisation of the 
CaV2.2e37 isoforms, GFP-HA-tagged channels were transiently expressed in 
the presence of α2δ-1 and β1b (Figure 4.1a).  This revealed a larger plasma 
membrane expression level of CaV2.2e37a compared to CaV2.2e37b, without 
altering the whole-cell expression level of the channels (Figure 4.1b).  GFP at 
the N-terminus did not alter this cellular localisation pattern, as the same 
observation was validated from cells expressing the HA-tagged CaV2.2 
isoforms, in which the intracellular channels were immunolabelled with anti-
CaV2.2 II-III loop antibody, post-permeabilisation (Figure 4.1c).  This confirmed 
that CaV2.2 channels containing e37a are preferentially localised in the plasma 
membrane, and that the increase in the cell surface expression is not due to the 
overall increase in the protein expression level.   
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Figure 4.1 Localisation of GFP-HA-tagged CaV2.2 in N2a cells 
and comparison of GFP-HA-CaV2.2 splice variants cell surface 
expression. 
(a) Confocal images of N2a cells expressing GFP-HA-CaV2.2e37 
isoforms.  CaV2.2 channels were expressed throughout the cells 
including at the cell surface.  Some degree of accumulation in the 
organelles around the nucleus is also observed.  Scale bar, 20 
μm.   (b) Normalised cell surface (left) and total (right) CaV2.2 of 
GFP-HA-CaV2.2e37 isoforms.  Cell surface HA and total GFP 
fluorescence intensities of both CaV2.2e37a and e37b were 
quantified and normalised to the average intensity value of 
CaV2.2e37b from each experiment.  Cell surface: CaV2.2e37b 
(blue, n=148); CaV2.2e37a (red, n=134).  Total: CaV2.2e37b (blue, 
n=148); CaV2.2e37a (red, n=134); P=0.49.  (c) Normalised cell 
surface (left) and total (right) CaV2.2 levels for HA-CaV2.2 
isoforms.  Cell surface: CaV2.2e37b (blue, n=83); CaV2.2e37a 
(red, n=87).  Total: CaV2.2e37b (blue, n=83); CaV2.2e37a (red, 
n=87); P=0.22.  Mean ± SEM, *P<0.05, **P<0.01, ***P<0.001 
(Student’s unpaired t-test).    
 
 
4.3 Cell surface expression of CaV2.2 splice variants in DRG 
neurons 
In order to determine whether preferential expression of CaV2.2e37a at 
the cell membrane was also exhibited in neurons such as DRG neurons, the 
localisation of CaV2.2e37 isoforms was investigated.  Immunolabelling in the 
cell bodies of isolated cultured DRG neurons expressing the HA-tagged GFP-
CaV2.2 isoforms with α2δ-1 and β1b that CaV2.2e37a surface expression level 
was significantly greater than CaV2.2e37b, without altering the whole-cell 
expression level of the channels (Figure 4.2), similarly to the expression pattern 
in N2a.   
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Figure 4.2 Cell surface expression of CaV2.2 splice variants in 
DRG cell bodies. 
(a) Confocal images of DRG cell bodies expressing GFP-HA-
CaV2.2 isoforms with α2δ-1 and β1b (scale bar, 20 μm).  (b) 
Normalised cell surface and total CaV2.2 in DRG cell bodies.  The 
cell surface HA and total GFP fluorescence densities were 
quantified and normalised to the average intensity value of 
CaV2.2e37b from each experiment.  Cell surface: CaV2.2e37b 
(blue, n=49); CaV2.2e37a (red, n=49).  Total: CaV2.2e37b (blue, 
n=49); CaV2.2e37a (red, n=49); P=0.31. 
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4.4 Expression of CaV2.2 splice variants in DRG neurites 
To examine whether CaV2.2e37a was also more highly expressed in 
the neurites of DRG neurons compared to CaV2.2e37b, GFP fluorescence in 
the neurites as a CaV2.2 expression level was quantified from the same 
transfected DRG neuron.  The amount of tagged CaV2.2e37a channels in the 
neurites of these DRG neurons was also significantly higher than CaV2.2e37b, 
without altering the level of an expression marker mCherry that was co-
transfected to visualise the entire field of neurites (Figure 4.3).  CaV2.2e37a 
channels in the DRG neurons were trafficked further along the neurites to a 
significantly greater degree than CaV2.2e37b channels.   
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Figure 4.3 Expression of CaV2.2 splice variants in DRG 
neurites. 
(a) Confocal images of DRG neurites expressing GFP-HA-CaV2.2 
isoforms with free mCherry (scale bar, 20 μm).  (b) (Top) Total 
fluorescence of CaV2.2 isoforms and free mCherry in the DRG 
neurites (in x107 a.u.).  Total GFP-CaV2.2: CaV2.2e37b (blue, 
n=40); CaV2.2e37a (red, n=40).  (Middle) Total mCherry: 
CaV2.2e37b (blue, n=40); CaV2.2e37a (red, n=40); P=0.18.  
(Bottom) Total length of neurites with GFP-CaV2.2: CaV2.2e37b 
(blue, n=40); CaV2.2e37a (red, n=40).  Mean ± SEM, *P<0.05, 
**P<0.01 (Student’s unpaired t-test).   
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4.5 Effect of auxiliary subunits on cell surface expression of 
CaV2.2 splice variants  
It is well-established that auxiliary subunits play an important role in 
CaV2.2 trafficking (Waithe et al., 2011; Dolphin, 2012; Cassidy et al., 2014).  To 
determine whether α2δ-1 and β1b are required for the differential cell surface 
expression of CaV2.2e37a and e37b channels, HA-tagged CaV2.2e37 isoforms 
were expressed, with or without α2δ-1 and β1b, in the N2a cells to compare the 
cell localisation of the CaV2.2 isoforms with both α2δ-1 and β1b.  
In the presence of both α2δ-1 and β1b subunits, the CaV2.2 splice 
variants were efficiently trafficked to the plasma membrane (Figure 4.4).  In the 
absence of α2δ-1, both CaV2.2 splice variants are inefficiently trafficked to the 
cell surface, although a larger amount of CaV2.2e37b was observed at the 
plasma membrane compared to CaV2.2e37a.  Without β1b, the whole-cell 
expression of CaV2.2 was almost completely diminished for both splice variants, 
similarly to the previous report of CaV2.2e37b cell surface expression in the 
absence of β1b (Cassidy et al., 2014).  In addition, the lower expression level of 
CaV2.2 and a smaller number of N2a cells expressing CaV2.2 were also 
observed in the absence of β1b, which indicates that the pore-forming subunits 
are degraded in the absence of β1b, which is in agreement with the previous 
reports (Altier et al., 2011; Waithe et al., 2011). 
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Figure 4.4 Effect of Auxiliary Subunits on Cell Surface 
Expression of HA-tagged CaV2.2 Splice Variants. 
Exemplary confocal images of HA-CaV2.2e37 isoforms expressed 
in N2a cells with or without α2δ-1 or β1b show extracellular HA 
(green), intracellular HA (red) and nuclei (blue).  Both CaV2.2 
isoforms show reduction in cell surface CaV2.2 in the absence of 
α2δ-1 or β1b.  There was a smaller population of cells expressing 
whole-cell CaV2.2 in the absence of β1b, compared to conditions 
with both α2δ-1 and β1b, or α2δ-1 only.   
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4.5.1 Effect of α2δ-1 on cell surface expression of CaV2.2 splice variants  
The effects of α2δ-1 on the cell surface expression of CaV2.2e37 
isoforms were evaluated.  The quantification of immunostaining of the cell 
surface HA-CaV2.2 in N2a cells revealed that the increased plasma membrane 
expression of CaV2.2e37a relative to CaV2.2e37b was lost in the absence of 
α2δ-1 (Figure 4.5), suggesting that α2δ-1 is required for underlying mechanisms 
involved in the differential trafficking of CaV2.2 isoforms.  Although it is highly 
unlikely that α2δ-1 directly interacts with the C-terminus of CaV2.2 where the 
exon 37 alternative splicing occurs, α2δ-1 may be involved in CaV2.2 trafficking 
possibly via interaction through intermediate protein(s) and utilisation of the 
same pathway(s) involved in transporting the channels to the plasma 
membrane.   
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Figure 4.5 Effect of α2δ-1 on cell surface expression of HA-
CaV2.2e37 isoforms.  
(Left) Merged confocal images of N2a cells expressing HA-
CaV2.2e37 isoforms with or without α2δ-1.  HA (green), CaV2.2 
(red), nucleus (blue), scale bar, 20 μm.  (Right) HA fluorescence 
intensities were normalized to the average intensity of CaV2.2e37b 
with α2δ-1 in each experiment.  Cell surface: CaV2.2e37b+α2δ-1 
(blue, n=125); CaV2.2e37b (cyan, n=39); CaV2.2e37a+α2δ-1 (red, 
n=135); CaV2.2e37a (pink, n=37).  The difference between 
CaV2.2e37a and e37b without α2δ-1 was not statistically 
significant.  Mean ± SEM, *P<0.05, **P<0.01, ***P<0.001 (one-
way ANOVA). 
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4.5.2 Effect of α2δ-1 on biophysical properties of CaV2.2 splice variants  
4.5.2.1 Whole-cell current, conductance and V50 activation 
The effects of α2δ-1 on the cell surface expression of CaV2.2 splice variants 
were validated in the whole-cell current recording.  In the absence of α2δ 
subunits, the whole-cell current densities from both CaV2.2e37 isoforms were 
significantly smaller than that with α2δ-1 (Figure 4.6a), confirming the 
immunocytochemistry experiment 4.5.1.  Interestingly, the average IV curves of 
CaV2.2e37a and CaV2.2e37b were very similar in the absence of α2δ, unlike 
those with α2δ-1.  The average whole-cell Gmax for both isoforms in the absence 
of α2δ-1 was significantly reduced, and the difference in conductance between 
e37a and e37b was lost (Figure 4.6b).  Both CaV2.2 isoforms were activated at 
slightly more depolarised potential without α2δ-1, although the differences were 
not statistically significant in one-way ANOVA Bonferroni post-hoc test (Figure 
4.6c). 
 
4.5.2.2 Steady-state inactivation 
In general, the inactivation voltages of both CaV2.2 isoforms were more 
depolarised in the absence of α2δ, compared to those in the presence of α2δ-1 
(Figure 4.7), in consensus with the previous reports (Dolphin, 2012). The effect 
on CaV2.2e37a was more prominent, where the voltage-dependence of steady-
state inactivation was significantly more depolarised in the absence of α2δ-1. 
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Figure 4.6 Whole-cell current of HA-CaV2.2e37 splice variants 
with and without α2δ-1. 
(a) Average whole-cell current densities of CaV2.2 isoforms with 
and without α2δ-1 in tsA-201 cells.  Peak current density (pA/pF): 
e37b+α2δ-1 (blue), -204.5 ± 22.9 (+10mV, n=12); e37b (cyan), -
41.7 ± 19.1 (+15mV, n=6); e37a+α2δ-1 (red), -323.0± 46.8 (+5mV, 
n=10); e37a (pink), -35.2 ± 10.0 (+15mV, n=6).  (b) Conductance 
(Gmax) and (c) Activation voltage (V50,act). e37b+α2δ-1 (blue, 
n=12); e37b (cyan, n=6); e37a+α2δ-1 (red, n=10); e37a (pink, 
n=6).  Mean ± SEM, *P<0.05, **P<0.01, ***P<0.001 (one-way 
ANOVA). 
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Figure 4.7 Inactivation of HA-CaV2.2e37 isoforms with and 
without α2δ-1. 
(a) The average relative currents of CaV2.2e37 isoforms with and 
without α2δ-1 in tsA-201 cells, which were subjected to various 
conditioning voltages.  In general, in the absence of α2δ-1 the 
steady-state inactivation potentials of CaV2.2e37 isoforms were 
more depolarised.  (b) Mean inactivation voltages (V50,inact) of 
CaV2.2e37 isoforms with and without α2δ-1 from (a).  In the 
presence of α2δ-1, the V50,inact is significantly more hyperpolarised.  
The difference in the average V50,inact between CaV2.2e37a and 
e37b was not statistically significant.  CaV2.2e37a (pink, n=6), 
CaV2.2e37b (cyan, n=4), CaV2.2e37a+α2δ-1 (red, n=8), 
CaV2.2e37b+α2δ-1 (blue, n=8)   **P<0.01 (one-way ANOVA).  
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4.6 Forward trafficking of CaV2.2 splice variants 
To investigate the mechanism of differential CaV2.2 splice variant 
trafficking, BBS-tagged CaV2.2 constructs were expressed in N2a cells, to 
monitor the net appearance of the channels in the plasma membrane over time 
(Figure 4.8a).  This protocol determines the net forward trafficking of CaV2.2, 
since the endocytosis of the labelled CaV2.2 channels at the cell surface occurs 
in this condition, as their endocytosis was not blocked.   
The experiments showed that the average initial rate of appearance of 
CaV2.2e37a on the cell surface was significantly greater than for CaV2.2e37b, 
leading to a greater steady-state maximum cell surface expression level (Figure 
4.8b, c).  The appearance of the channel at the cell surface did not occur at 4 
°C.  The overall time constants determined from the fit of the single association 
exponential equation were not significantly different between these isoforms, 
however, it was difficult to interpret these values since the appearance of the 
channels at the cell surface is a product of multiple intracellular trafficking 
events.  In any cases, these results imply that the increased presence of 
CaV2.2e37a on the cell surface is due to an increased trafficking from 
subcellular organelles to the plasma membrane. 
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Figure 4.8 Net forward trafficking of BBS-tagged CaV2.2e37 
splice variants. 
(a) Representative confocal images of N2a expressing BBS-
CaV2.2e37 isoforms at different time points after the start of the 
net forward trafficking assay, showing appearance of CaV2.2 at the 
cell surface by BTX-488 live labelling. Scale bar, 20 μm.  (b) 
Kinetics of CaV2.2e37 isoform net forward trafficking.  As a 
negative control (closed green triangle), CaV2.2e37b was kept at 4 
°C after the start of the experiment.  The kinetic curves were fitted 
to a single exponential to derive time constant  (min). The rates of 
net forward trafficking (1/, min-1) were; CaV2.2e37a (closed red 
circle), 0.212 ± 0.027 (n=3); CaV2.2e37b (closed blue circle), 
0.132 ± 0.036 (n=3).  The data points in the graph contain all the 
cells analysed from the three separate experiments.  (c) The initial 
rates of net forward trafficking. The gradient of linear regression 
was obtained as an initial average forward trafficking rate from 
each of 3 experiments, and summarised (in a.u./min). CaV2.2e37b 
(blue, n=3); CaV2.2e37a (red, n=3). *P< 0.05, **P<0.01, 
***P<0.001 (Student’s unpaired t-test). 
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4.7 Effect of Brefeldin A (BFA) on forward trafficking of CaV2.2 
splice variants 
4.7.1 Determining effective concentration of BFA 
Transmembrane proteins at the cell surface originate from various cell 
organelles.  The two main sources of transmembrane proteins inserted into the 
plasma membrane are; 1) newly synthesised proteins from the ER and the 
Golgi apparatus (for review see Guo et al., 2014), and 2) recycled proteins via 
recycling endosomes (Grant and Donaldson, 2009).  Brefeldin A (BFA), which 
disrupts the structure of the Golgi apparatus and inhibits the translocation of 
proteins from the ER to the plasma membrane (Fujiwara et al., 1988; Lippincott-
Schwartz et al., 1989), was then used to further elucidate the mechanism of 
differential CaV2.2e37a net forward trafficking.   
Firstly, in order to determine the effective concentration of BFA, the cell surface 
expression of BBS-CaV2.2 isoforms was determined in the presence of 50, 200 
and 500 ng/ ml BFA, applied 4 h prior to the start of the experiment and during 
the assay, and compared with the control condition with 0.4% DMSO (Figure 
4.9).  Both CaV2.2 isoforms were significantly reduced at the plasma membrane 
in 200 ng/ml BFA, therefore this concentration was used for the subsequent net 
forward trafficking experiments.   
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Figure 4.9 Effective concentration of BFA on reduction in HA-
CaV2.2 on the cell surface. 
Cell surface CaV2.2 was determined in the N2a cells expressing 
HA-CaV2.2, β1b and α2δ-1 in the presence of 0, 50, 200 and 500 
ng/ml BFA.  The cells were pre-incubated with BFA 4 hours at 37 
°C before the fixation with 4 % PFA.  Cell surface HA fluorescence 
intensity was normalised to the control (0 ng/ml BFA) in each 
condition.  200 ng/ml of BFA was effective in reducing cell surface 
expression of both CaV2.2e37a and e37b.  37a control (n=68), 37a 
+ 50 ng/ml BFA (n=52), 37a + 200 ng/ml BFA (n=33), 37a + 500 
ng/ml BFA (n=14), 37a control (n=68), 37b + 50 ng/ml BFA (n=23), 
37a + 200 ng/ml BFA (n=41), 37a + 500 ng/ml BFA (n=13). 
**P<0.01, ***P<0.001 (one-way ANOVA).    
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4.7.2 Effect of BFA on the net forward trafficking rate of CaV2.2 splice 
variants 
In order to determine the rate of trafficking of CaV2.2e37 isoforms from 
the TGN to plasma membrane, the net forward trafficking experiments were 
performed as described previously in the presence of BFA, which blocks the 
trafficking from the TGN.  In the presence of BFA, the maximum level of CaV2.2 
splice variants appearing on the plasma membrane was markedly reduced 
compared to the control condition as expected (Figure 4.10a).  This shows that 
approximately half of the channel population at the plasma membrane 
originated from the recycling endosomes within the duration of these 
experiments.  Furthermore, in the presence of BFA the difference between 
CaV2.2e37a and CaV2.2e37b in the maximum cell surface level achieved was 
abolished.  In addition, the kinetics of CaV2.2e37a net trafficking to the plasma 
membrane were markedly slowed compared to the absence of BFA (Figure 
4.10b).   
BFA inhibits Arf1, which is essential for the recruitment of AP-1, which 
mediates clathrin-dependent cargo sorting (Zhu et al., 1998; Ren et al., 2013).  
These observations raised the possibility that the greater forward trafficking and 
increased cell surface expression of CaV2.2e37a, relative to CaV2.2e37b, are 
due to differences in sequence of the proximal C-terminus of CaV2.2 as a result 
of alternative splicing, and that the underlying mechanism may involve AP-
mediated sorting.   
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Figure 4.10 Effect of BFA on net forward trafficking of BBS-
CaV2.2e37 isoforms. 
(a) Kinetics of CaV2.2e37 isoform net forward trafficking in the 
presence of BFA. CaV2.2e37a+BFA (open red circle), 1/ = 0.060 
± 0.021 min-1, n=3; CaV2.2e37b+BFA (open blue circle), 0.148 ± 
0.049 min-1, n=3. The cell surface level of CaV2.2 in the absence 
of BFA as a control is shown at t = 60 min (CaV2.2e37a, closed 
red circle and CaV2.2e37b, closed blue circle).  The data points in 
the graph contain all the cells analysed from the three separate 
experiments.  (b) Summary of the net forward trafficking rate of 
CaV2.2e37a isoforms with and without BFA.  The rates of net 
forward trafficking from Figure 4.8b and Figure 4.10a are 
compared. CaV2.2e37a (red closed bar) n=3, CaV2.2e37a+BFA 
(red open bar) n=3, CaV2.2e37b (blue closed bar) n=3, 
CaV2.2e37b+BFA (blue open bar) n=3 (P<0.05, one-way ANOVA). 
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4.8 Endocytosis of CaV2.2 splice variants 
The stability of CaV2.2 at the cell surface is another factor for 
determining the cell surface level of the channels.  To determine if endocytosis 
rates of CaV2.2 isoforms are different, the disappearance of BBS-tagged CaV2.2 
isoforms was determined. The endocytosis of the channels did not occur at 4 
°C.  CaV2.2e37a and CaV2.2e37b showed similar kinetics of internalisation, both 
reaching the same minimum cell surface level after 30 min (Figure 4.11).  This 
result indicates that endocytosis did not contribute significantly to the observed 
differences in net forward trafficking.  In addition, this implies that CaV2.2e37 
isoforms were targeted equally by endocytic machineries for their basal 
endocytosis.   
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Figure 4.11 Endocytosis of CaV2.2e37 isoforms. 
(a) Representative confocal images of N2a cells expressing BBS-
tagged CaV2.2e37 isoforms at different time points after the start 
of an endocytosis assay shows the disappearance of BTX-488-
labelled CaV2.2 from the cell surface (scale bar, 20 μm).  (b) The 
endocytosis kinetics of CaV2.2e37 isoforms. The time constants () 
from fitting a single exponential (min); CaV2.2e37a (red), 7.00 ± 
1.23 (n=3); CaV2.2e37b (blue), 11.6 ± 3.53 (n=3).  CaV2.2e37b 
(open blue circle) was kept at 4 °C as a negative control after the 
start of endocytosis experiment.  The cell surface fluorescence 
was normalised to the average value at t=0 min for each isoform in 
the same experiment.  The data points in the graph contain all the 
cells analysed from the three separate experiments.   
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4.9 Effect of AP-2 on the cell surface expression of CaV2.2 
splice variants 
The primary role of AP-2 is to mediate internalisation of transmembrane 
proteins by clathrin-dependent endocytosis.  In order to determine whether AP-
2 mediates internalisation of CaV2.2 splice variants and regulates the channel 
cell surface expression, CaV2.2e37 isoforms were co-expressed with the wild-
type or mutant μ subunits of AP-2.  The double mutation at F174 and D176 in 
the dominant-negative mutant, AP-2μ2 F174A/D176S has been shown to slow 
down the endocytosis from the plasma membrane by abolishing the interaction 
with YxxΦ motifs in the transmembrane cargo proteins (Motley et al., 2006).   
 
4.9.1 Effect of AP-2 mutant on CaV2.2 cell surface expression  
To investigate the role of AP-2 in trafficking of CaV2.2e37 splice 
variants, either the wild-type AP-2μ2 (WT) or dominant-negative mutant AP-2μ2 
F174A/D176S were co-expressed with HA-tagged CaV2.2e37 isoforms, in the 
presence of α2δ-1 and β1b in N2a cells.  The cell surface expression of HA-
CaV2.2 was examined as previously described against the control condition. 
The previous reports on the effect of the AP-2μ2 F174A/D176S in 
reducing the rate of cargo endocytosis suggested that the cell surface 
expression of Cav2.2 isoforms was expected to increase in this condition.  
However, AP-2μ2 F174A/D176S and WT AP-2μ2 had no significant effect on 
the cell surface expression of CaV2.2e37b (Figure 4.12).  On the contrary, the 
cell surface expression of CaV2.2e37a was significantly reduced in the presence 
of μ2 mutant.  AP-2μ2 WT also reduced the cell surface expression of 
CaV2.2e37a, although this observation could be explained by the 
overexpression of AP-2μ2 causing increased recruitment of clathrin molecules 
and accelerating the rate of CaV2.2 endocytosis, which led to a reduction in 
channel cell surface expression.   
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Figure 4.12 Effect of AP-2μ2 WT and F174A/D176S on cell 
surface expression of CaV2.2e37 isoforms. 
HA-CaV2.2e37 isoforms were coexpressed with AP-2μ2 WT, 
dominant negative mutant AP-2μ2 F174A/D176S or blank 
pcDNA3 in the presence of β1b and α2δ-1 in N2a.  Both AP-2μ2 
WT and F174A/D176S significantly reduced the cell surface 
expression of HA-CaV2.2e37a, but they had no effect on HA-
CaV2.2e37b. 37b (n=95), 37b+AP-2μ2 WT (n=97), 37b+AP-2μ2 
F174A/D176S (n=63), 37a (n=85), 37a+AP-2μ2 WT (n=49), 
37a+AP-2μ2 F174A/D176S (n=74).  **P<0.01, ***P<0.001 (one-
way ANOVA). 
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4.9.2 Effect of AP-2 mutant on CaV2.2 whole-cell current 
 To confirm the effect of AP-2 on CaV2.2e37 splice variant trafficking, 
the effect of AP-2 on whole-cell current of the CaV2.2 isoforms was investigated.  
Similarly to the immunocytochemistry experiments, HA-CaV2.2e37 isoforms 
were co-expressed with either AP-2μ2 WT or F174A/D176S in tsA-201 cells.  
The whole-cell current densities were determined as previously described. 
AP-2μ2 F174A/D176S reduced the whole-cell current density of 
CaV2.2e37a by almost 50% (Figure 4.13a), which validated the observation 
from the cell surface labelling experiments in N2a cells (Figure 4.12).  AP-2μ2 
WT caused non-significant reduction in the CaV2.2e37a whole-cell current 
density, unlike in the previous cell surface labelling assays.  In CaV2.2e37b on 
the other hand, AP-2μ2 F174A/D176S increased the whole-cell current density, 
whereas AP-2μ2 WT decreased the CaV2.2e37b current (Figure 4.13b).  
The opposing effects of AP-2μ2 F174A/D176S on the whole-cell current 
of CaV2.2e37 isoforms were striking, and similar effects were also observed in 
their cell surface expression.  The much smaller stabilising effect of AP-2μ2 
F174A/D176S on CaV2.2e37b cell surface expression compared the whole-cell 
current was probably due to the difference in endogenous protein expression in 
the two different cell lines.  This could be determined by a western blot against 
the endogenous AP-2μ2 with a specific antibody. 
The marked effect of AP-2μ2 F174A/D176S on CaV2.2e37a cell surface 
expression and whole-cell current suggested that the amino acid sequence in 
the exon 37 contains AP interaction motifs and mediates trafficking.  
Nonetheless, the role of AP-2 is predominantly reported to be on endocytosis, 
and not on trafficking to the plasma membrane.  Therefore, I decided to further 
examine the effect of AP-1 instead of AP-2 on the channel trafficking, since AP-
1 plays a key role in trafficking from the TGN in various cell types and also 
interacts with its cargos through the same motifs (YxxΦ and [DE]xxxL[LI]) 
(Bonifacino and Traub, 2003).    
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Figure 4.13 Effect of AP-2μ2 WT and F174A/D176S on whole-
cell current density of CaV2.2e37 splice variants. 
HA-CaV2.2e37 isoforms were coexpressed with AP-2μ2 WT, 
dominant negative mutant AP-2μ2F174A/D176S or blank pcDNA3 
in the presence of β1b and α2δ-1 in tsA-201.  (a) Whole-cell 
current densities of CaV2.2e37a. Peak current density (at 5mV): 
+pcDNA3, -209.9 ± 25.4 pA/pF (n=26); +AP2μ2 WT, -183.0 ± 39.4 
pA/pF (n=7); +AP2μ2 F174A/D176S, -154.8 ± 23.1 pA/pF (n=18).  
(b) Whole-cell current densities of CaV2.2e37b. Peak current 
density (at 10mV): +pcDNA3, -104.5 ± 11.7 pA/pF (n=39); +AP2μ2 
WT, -75.5 ± 16.4 pA/pF (n=8); +AP2μ2 F174A/D176S, -149.4 ± 
20.3 pA/pF (n=26).  The differences in the peak current densities 
were not significantly different in one-way ANOVA. 
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4.9.3 Effect of AP-2 mutant on CaV2.2 endocytosis 
Since AP-2μ2 F174A/D176A dominant negative mutant increased both 
the cell surface expression and the whole-cell current of CaV2.2e37b, the effect 
of this mutant AP-2 on the endocytosis of BBS-CaV2.2e37b was also assessed.  
The cell surface expression of BBS-CaV2.2e37b with the AP-2 mutant was 
greater than that with the control condition (pcDNA3) throughout the course of 
the experiment (Figure 4.14), as predicted from the previous 
immunocytochemistry experiment (Figure 4.12).  However, the rate of 
endocytosis was not significantly different from the control condition (Figure 
4.14).  This may imply that clathrin-independent endocytic proteins such as 
caveolin can also mediate the internalisation of CaV2.2 channels in N2a cells .  
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Figure 4.14 Effect of AP-2μ2 F174A/D176S on CaV2.2 
endocytosis.  
BBS-CaV2.2e37b was coexpressed with dominant negative mutant 
AP-2μ2F174A/D176S or blank pcDNA3 in the presence of β1b 
and α2δ-1 in N2a.  The cell surface BBS-CaV2.2e37b was 
normalised to the cell surface fluorescence density of the control 
condition with pcDNA3 at t=0 in each experiment.  The rate of 
endocytosis (τ, min) was: e37b + pcDNA3 (blue, n=2) 4.61 ± 4.12, 
37b + AP2μ2 F174A/D176A (blue open circle, n=2) 6.28 ± 3.81.  
The cell surface fluorescence was normalised to the average 
value of 37b + pcDNA3 at t=0 min in the same experiment.  The 
data points in the graph contain all the cells analysed from the two 
separate experiments.   
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4.10 Effect of AP-1γ knockdown on trafficking of CaV2.2 splice 
variants 
AP-1 mediates cargo sorting in the Golgi apparatus, via interaction with 
YxxΦ and [DE]xxxL[LI] motifs in the cargo.  I noted that both these canonical 
motifs are present in the e37a sequence DMYSLL (Figure 1.8), supporting the 
possibility of interaction with AP-1.  Interestingly, CaV2.2e37a contains both 
motifs in an overlapping manner, whereas CaV2.2e37b contains only a non-
canonical [DE]xxxL[LI] motif where LL is substituted by ML (Hofmann et al., 
1999; Motta et al., 1995).  BFA disrupts AP-1-mediated sorting in the Golgi, and 
the reduction in the maximum level of CaV2.2 detected at the plasma membrane 
in the presence of BFA (Figure 4.10) implicated a role for AP-1 in CaV2.2 
trafficking from the TGN to the plasma membrane.   
To examine the involvement of AP-1 in CaV2.2 trafficking, AP-1γ shRNA 
was co-expressed with HA-tagged CaV2.2e37 isoforms to knockdown the 
expression of the key AP-1 subunit for interaction with [DE]xxxL[LI] (Cheung 
and Cousin, 2012).  AP-1 1a shRNA is specific to AP-1γ sequence that is 
conserved in human, mouse and rat, while AP-1 1b shRNA is specific to the rat 
sequence only.  These shRNAs inhibited reserve pool replenishment from bulk 
endosomes.  Both AP-1γ shRNAs reduced intracellular AP-1γ (or γ-adaptin) 
expression level significantly by approximately 40-50% of the control scrambled 
AP-1γ shRNA in N2a cells (Figure 4.15).  Subsequently, the effect of AP-1 1a 
shRNA on CaV2.2 cell surface expression was examined.  Knockdown of AP-1 
caused a modest, but significant reduction in the cell surface expression of both 
CaV2.2e37 isoforms (Figure 4.16), despite the partial reduction in the 
endogenous AP-1γ.  These experiments demonstrate that AP-1 mediates 
trafficking of both CaV2.2e37 splice variants, and modulates cell surface 
expression.  
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Figure 4.15 Effect of AP-1 knockdown by AP-1 shRNA on γ 
adaptin levels   
Scrambled shRNA control, AP-1γ 1a shRNA or AP-1γ 1b shRNA 
were expressed in N2a.  (Left) The γ adaptin expression was 
determined by immunostaining, and the expression levels were 
normalised to the cells expressing the scrambled control.  Both 
AP-1γ shRNA 1a and 1b against AP-1γ subunit significantly 
reduces the expression of γ adaptin. (Right) The expression level 
of AP-1γ shRNAs were determined from mCerulean fluorescence, 
the shRNA expression levels were normalised to the cells 
expressing the scrambled control.  AP-1γ 1b was not expressed 
as well as other shRNAs.  Scrambled shRNA control (black), 
n=75; AP-1 1a (grey), n=44; AP-1 1b (white), n=83.  **P<0.01, 
***P<0.001 (one-way ANOVA).  
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Figure 4.16 Effect of AP-1 knockdown on cell surface 
expression level of CaV2.2e37 isoforms. 
HA-CaV2.2e37 isoforms were coexpressed with scrambled shRNA 
control or AP-1γ 1a shRNA in the presence of β1b and α2δ-1 in 
N2a.  The cell surface HA-CaV2.2 was normalised to the cells 
expressing scrambled control.  AP-1γ shRNA significantly reduced 
cell surface expression of both CaV2.2e37 isoforms. Cell surface 
CaV2.2 was normalized to the scrambled AP-1 shRNA control 
condition in each experiment.  The expression of shRNA detected 
by mCerulean was comparable in all conditions.  
CaV2.2e37a+control shRNA (closed bar, n=62); CaV2.2e37a+AP-1 
shRNA (red, n=72).  CaV2.2e37b+control shRNA (closed bar, 
n=92); CaV2.2e37b+AP-1 shRNA (blue, n=76).   *P<0.05, 
**P<0.01 (Student’s unpaired t-test).  
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4.11 Effect of dominant-negative AP-1σ mutant overexpression 
on trafficking of CaV2.2 splice variants 
To confirm the importance of the interaction between AP-1 and CaV2.2 
for the channel trafficking, the dominant-negative mutant of the σ subunit of AP-
1 (AP-1σ V98S) was co-expressed with the CaV2.2e37 isoforms in N2a cells, in 
order to impair the interaction with [DE]xxxL[LI].  This construct has been shown 
to disrupt the somatodendritic trafficking of the copper transporter ATP7B in 
hippocampal neurons (Jain et al., 2015).  AP-1σ V98S significantly reduced the 
cell surface expression of both CaV2.2e37 isoforms by approximately 50%, 
elative to those that were co-expressed with the wild type AP-1σ (Figure 4.17), 
validating the effect of AP-1γ knockdown.  The disrupted trafficking of both 
CaV2.2 isoforms, as a result of the impairment of AP-1 function suggests that 
trafficking of both isoforms was mediated by AP-1 and that the non-canonical 
DxxxML motif in CaV2.2e37b may also function as an AP-1 binding motif and 
mediate trafficking to the plasma membrane.   
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Figure 4.17 Effect of AP-1σ V98S on cell surface expression 
of CaV2.2e37 isoforms.  
(a) Confocal images of BBS-tagged CaV2.2e37b, showing reduced 
cell surface expression (second panel) in the presence of AP-1σ 
V98S, compared to WT (scale bar, 20 μm).  (b) Dominant-
negative AP-1σ V98S mutant significantly reduced cell surface 
expression of both CaV2.2e37 isoforms.  Cell surface CaV2.2 was 
normalized to the wild-type AP-1σ control condition in each 
experiment.  The expression level of myc-tagged AP-1σ detected 
by anti-myc antibody was comparable in all conditions. (Left) 
CaV2.2e37a+AP-1σ WT (closed bar, n=44); CaV2.2e37a+AP-1σ 
V98S (red, n=41).  (Right) CaV2.2e37b+AP-1σ WT (closed bar, 
n=47), CaV2.2e37b+AP-1σ V98S (blue, n=46).  ***P< 0.001 
(Student’s unpaired t-test). 
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4.12 Adaptor protein interaction motifs in CaV2.2 splice variants 
Since the CaV2.2e37a sequence contains both YxxΦ and [DE]xxxL[LI] 
motifs, key residues in wild-type (WT) DMYSLL were mutated to identify which 
motif is important in AP-1 interaction, and to elucidate the mechanism of CaV2.2 
channel trafficking.  In total 4 CaV2.2e37a mutants were created, mutating 
DMYSLL to DMASLL (Y/A), DMYSAL (L/A), DMYSAA (LL/AA) and DMASAA 
(YSLL/ASAA) (Table 4.1).  The L/A mutant is only able to interact with AP-1μ, 
and the Y/A mutant can only interact with AP-1γσ, whereas the LL/AA and 
YSLL/ASAA mutants completely abolish the interaction with AP-1 via these 
motifs.  
 
Table 4.1 AP binding motif mutants of CaV2.2e37a.  
  Interaction with: 
Name Motif µ1 γ-σ1 
WT DMYSLL √ √ 
L / A DMYSAL √  
LL / AA DMYSAA   
Y / A DMASLL  √ 
YSLL/YSAA DMASAA   
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4.12.1 Whole-cell expression of CaV2.2e37a AP binding motif mutants 
In order to confirm that CaV2.2e37a AP binding motif mutants are 
expressed to the same extent as the WT CaV2.2, they were co-expressed with 
α2δ-1 and β1b in tsA-201 cells to determine their whole-cell expression levels 
against the WT.  All mutants were expressed at full length, and no truncated 
proteins were detected (Figure 4.18).  The whole-cell expression levels of the 
mutants were similar with each other but slightly reduced compared to the WT, 
particularly for the YSLL/ASAA mutant.   
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Figure 4.18 Western blot analysis of CaV2.2e37a AP binding 
motif mutants.   
(a) The exemplary western blot showing full length CaV2.2 
channels detected in the whole cell lysates (20 μg per lane) of tsA-
201 expressing AP-binding motif mutants with α2δ-1 and β1b.  In 
the untransfected negative control (U/T), cells were transfected 
with GFP.  GAPDH staining shows equal protein loading in all 
lanes.  (b) The whole-cell expression levels of CaV2.2 channels 
were not significantly different (n=4, one-way ANOVA).   
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4.12.2 Cell surface expression of CaV2.2e37a AP binding motif mutants 
The cell surface and whole-cell expression levels of these 4 mutants 
and the WT CaV2.2e37a were determined by immunocytochemistry (Figure 
4.19a).  The plasma membrane expression levels of the L/A and Y/A mutants 
were approximately 50 % of the WT, and the LL/AA and YSLL/ASAA mutants 
were almost undetectable at the cell surface (Figure 4.19b), despite the 
intracellular expression levels of all mutants showing no significant difference 
relative to the WT CaV2.2e37a (Figure 4.19b). This may reflect the smaller 
number of cells in which intracellular CaV2.2 expression was detected, 
particularly for the YSLL/ASAA mutant, as mutations in these motifs can lead to 
mis-sorting of the proteins, which are then degraded (Braulke and Bonifacino, 
2009).  I therefore took the L/A, Y/A and LL/AA mutants forward to further 
investigate the function and trafficking of these mutants.    
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Figure 4.19 Cell surface expression of CaV2.2e37a AP binding 
motif mutants.  
(a) Confocal images showing N2a expressing HA-tagged AP 
binding motif mutants (scale bar, 20 μm).  (b) Cell surface 
expression of AP binding motif mutants.  The values were 
normalised to the average HA fluorescence intensity of wild-type 
CaV2.2e37a from each experiment.  (Left) cell surface: WT (red, 
n=64); L/A (purple, n=82); LL/AA (pink, n=43); Y/A (green, n=94); 
YSLL/ASAA (yellow, n=7).  (Right) total CaV2.2 levels were not 
significantly different all conditions. Only few cells that were 
expressing CaV2.2 from YSLL/ASAA mutation were detected, due 
to a very low expression of CaV2.2.  Mean ± SEM, ***P< 0.001 
(one-way ANOVA).   
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4.12.3 Biophysical properties of CaV2.2e37a AP binding motif mutants 
To investigate whether the reduced plasma membrane expression of 
these CaV2.2 mutants leads to a parallel reduction in function, the whole-cell 
current of the L/A, Y/A and LL/AA mutants expressed in tsA-201 cells were 
recorded in the presence of α2δ-1 and β1b.  No current was detected from the 
LL/AA mutant (Figure 4.20a), as predicted from the imaging experiments 
(Figure 4.19b).  The L/A and Y/A mutations caused the CaV2.2 peak currents 
and Gmax to be significantly reduced, compared to the WT CaV2.2e37a (Figure 
4.20b).  The V50 activation voltages were not altered for these mutants (Figure 
4.20c).   
Furthermore, inactivation properties of the AP binding motif mutant 
channels were also investigated. Inactivation kinetics (τ) were determined from 
the decay phase of the current traces at various activation voltages (Figure 
4.21a).  The inactivation profiles of the WT and L/A mutant were not significantly 
different, while the inactivation of the Y/L mutant at 0 mV was significantly faster 
than WT (Figure 4.21b).  In addition, steady-state inactivation of the AP binding 
mutants was not significantly different (Figure 4.21c). 
These results demonstrate that AP interaction is involved in the 
trafficking of CaV2.2e37a to the cell surface in the presence of the auxiliary 
subunits, and the reduced cell current density is due to the lower density of 
channels in the plasma membrane.   
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Figure 4.20 Whole-cell current density of CaV2.2e37a AP 
binding motif mutants. 
(a) Whole-cell current density of HA-CaV2.2e37a AP-binding motif 
mutants.  The current density of HA-CaV2.2e37b is shown in 
Figure 3.17.  The peak current densities at +0 mV (pA/pF); WT 
(red), -185.7 ± 28.7 (n=24); L/A (purple), -103.2 ± 12.8 (n=27); Y/A 
(green), -101.9 ± 18.3 (n=30); LL/AA (pink), 2.44 ± 0.34 (n=4).  (b) 
Conductance (Gmax) values.  WT (red, n=24); L/A (purple, n=27); 
Y/A (green, n=30). (c) Activation voltages (V50,act) are not 
significantly different. WT (red, n=22); L/A (purple, n=27); Y/A 
(green, n=30).  P= 0.27.  Mean ± SEM, *P< 0.05 (one-way 
ANOVA). 
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Figure 4.21 Inactivation of CaV2.2e37a AP binding motif 
mutants. 
(a) Inactivation kinetics (τ) of WT and AP binding motif mutant 
CaV2.2e37a at 0, 10, 20 and 30 mV. Current decay of Y/A at 0 mV 
were significantly smaller than WT and L/A (P<0.05, one-way 
ANOVA).  All other values were not significantly different from 
each other. (b) Representative current traces of WT and Y/A with 
a 0 mV long pulse. The holding potential was -90 mV.  (c) Steady-
state inactivation of the AP binding mutants were not significantly 
different from WT. 
 
 
 
 
- 158 - 
4.13  Expression and cellular localisation of CaV2.2e37a AP 
binding mutants in DRG neurons 
4.13.1  Cell surface expression of CaV2.2e37a AP interaction mutants in 
the cell bodies of DRG neurons 
In order to validate that the mutations in the AP-1 binding motifs at the 
proximal C-terminus of CaV2.2 have an effect on channel trafficking in neurons, 
these mutant CaV2.2 channels were also tagged with GFP at the N-terminus 
and expressed in DRG neurons, in the presence of α2δ-1 and β1b (Figure 
4.22a).  Immunostaining for HA revealed that in the cell body of DRG neurons, 
expression of all mutants at the plasma membrane was reduced, particularly for 
the LL/AA mutant, without significantly affecting the total expression levels of 
the channels (Figure 4.22b), similarly to the findings in N2a cells.  
 
 
4.13.2 Expression of CaV2.2e37a AP interaction mutants in the neurites of 
DRG neurons 
To determine whether the AP binding motifs mediate CaV2.2 trafficking 
to neuronal processes, expression levels of CaV2.2e37 mutants in the neurites 
were determined by measuring fluorescence intensities of the GFP-tag.  A 
significantly lower level of these mutants was observed in the neurite 
compartment (Figure 4.23a), without affecting the expression level of free 
mCherry as an expression marker (Figure 4.23b).  This suggests that these 
motifs are also crucial for CaV2.2 trafficking along the neurites.   
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Figure 4.22 CaV2.2 AP binding motif mutants exhibit reduced 
trafficking to the cell surface of DRG soma.   
(a) Confocal images of DRG somata expressing GFP-HA-tagged 
CaV2.2e37a AP-binding mutants (scale bar, 20 μm).  (b) Cell 
surface expression of AP binding mutants.  The values were 
normalised to the average HA fluorescence intensity of wild-type 
CaV2.2e37a from each experiment.  Cell surface: WT (red, n=58); 
L/A (purple, n=34); LL/AA (pink, n=17); Y/A (green, n=43).  *P< 
0.05, **P< 0.01, ***P< 0.001 (one-way ANOVA). 
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Figure 4.23 CaV2.2 AP binding motif mutants reduce 
trafficking to DRG neurites.   
(a) Confocal images of DRG neurons expressing GFP-HA-tagged 
CaV2.2e37a AP-binding mutants (green) with free mCherry (red) in 
the neuronal processes (scale bar, 20 μm). GFP is also expressed 
in some non-neuronal cells.  (b) Total fluorescence of CaV2.2 AP-
binding mutants and free mCherry in the DRG neurites (in x107 
a.u.).  Total: WT (red, n=19); L/A (purple, n=18); LL/AA (pink, 
n=23); Y/A (green, n=16).  The total mCherry fluorescence values 
in the neurites were not significantly different.  *P< 0.05, **P< 0.01, 
***P< 0.001 (one-way ANOVA). 
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4.14 Effect of AP binding mutation on CaV2.2 intracellular 
trafficking 
4.14.1 Net forward trafficking of CaV2.2e37a AP binding motif mutants 
The L/A and Y/A mutants were also tagged with the exofacial BBS-tag 
to investigate how these mutations affect intracellular trafficking of CaV2.2e37a.  
The appearance of the AP binding motif mutant channels on the plasma 
membrane was significantly slower than for WT CaV2.2e37a, leading to a 
reduction in the maximum fluorescence density of cell surface channels (Figure 
4.24a).  There was no significant difference between L/A and Y/A in terms of the 
rate of trafficking nor the maximum cell surface level.  The slower overall rates 
of forward trafficking kinetics for these mutants, compared to WT CaV2.2e37a 
(Figure 4.24b), were similar to that for WT CaV2.2e37a in the presence of BFA 
(Figure 4.10). 
 
4.14.2 Endocytosis of CaV2.2e37a AP binding mutants 
Since the AP-binding motifs in the CaV2.2e37 isoforms are also 
recognised by AP-2 involved in endocytosis, the basal rate of endocytosis of the 
two isoforms and the CaV2.2e37a mutants were compared (Figure 4.25a).  The 
average time constant for endocytosis was approximately doubled for the 
CaV2.2e37a L/A mutant, and more than tripled for the Y/A mutant, compared to 
WT CaV2.2e37a (Figure 4.25b).  This observation could be explained by the 
action of AP-2 interacting with either YxxΦ or [DE]xxxL[LI], which mediates 
clathrin-dependent endocytosis (Nesterov et al., 1999; Motley et al., 2003).  
Slower internalisation of the Y/A mutant channels suggests that the YxxΦ motif 
plays a more dominant role than the [DE]xxxL[LI] motif in AP-2-mediated 
endocytosis of CaV2.2e37a.    
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Figure 4.24 The net forward trafficking kinetics of CaV2.2e37a 
AP binding motif mutants.   
(a) Net forward trafficking kinetics of AP binding motif mutants. L/A 
(purple), Y/A (green). Cell surface Cav2.2 of WT (red) was 
determined at t=60min as a control.  The data points in the graph 
contain all the cells analysed from the 3-5 separate experiments.  
(b) Net forward trafficking rates 1/ (min-1): WT (red), 0.212 ± 
0.027 (n=3, from Figure 4.10); L/A (purple), 0.048 ± 0.009 (n=5); 
Y/A (green) 0.045 ± 0.008 (n=4). Mean ± SEM, ***P< 0.001 (one-
way ANOVA). 
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Figure 4.25 Endocytosis of CaV2.2e37a AP binding motif 
mutants.   
(a) Endocytosis kinetics of CaV2.2e37a AP binding motif mutants. 
L/A (purple) and Y/A (green).  WT as a control at t=0min (red). All 
plasma membrane fluorescence densities were normalised to 
average value of the WT at t=0 min. The data points in the graph 
contain all the cells analysed from the 3-4 separate experiments.  
(b) Rate of endocytosis expressed as time constants τ (min); WT 
(red), 7.00 ± 1.23 (n=3, from Figure 4.11); L/A (purple), 13.8 ± 
1.85 (n=4); Y/A (green), 21.1 ± 3.53 (n=3).  Mean ± SEM, *P< 
0.05 (one-way ANOVA). 
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4.15 Summary and Discussion 
Using the tagged CaV2.2 constructs, I demonstrate enhanced trafficking 
of CaV2.2e37a compared to the e37b splice variant, both to the plasma 
membrane and to neuronal processes of DRG neurons where these channels 
are physiologically important.  The cell surface expression of CaV2.2e37 splice 
variants and mutants in transfected tsA-201, N2a and DRG neurons showed 
good correlations, demonstrating that these cells lines are suitable models to 
study CaV2.2 trafficking.  The only exception is when these splice variants were 
expressed in the absence of α2δ-1 (Figure 4.4, Figure 4.5), where N2a showed 
that the cell surface expression of CaV2.2e37b was greater than e37a without 
α2δ-1 (although this difference was not statistically significant in one-way 
ANOVA), whereas the average whole-cell currents of the two splice variants 
without α2δ-1 in tsA-201 were identical.  Neither cell lines express endogenous 
α2δ subunits (Cassidy et al., 2014), and the source of this difference is 
unknown.   
The 37a exon contains interaction motifs for both the μ1 subunit and γ-
σ1 hemicomplex of AP-1, which are overlapping (DMYSLL).  The complete 
abolition of both motifs by mutating the motif to DMYSAA or DMASAA severely 
disrupted the trafficking of CaV2.2e37a to the cell membrane and to DRG 
neurites, demonstrating the importance of these AP-1 interaction sites in the 
proximal C-terminus of CaV2.2.  Furthermore, [DE]xxxL[LI] is also present in 
other voltage-gated calcium channels such as CaV1.3, 1.4 and CaV2.1(e37a) in 
the proximal C-terminus (Table 4.2), which may indicate an importance of this 
motif in trafficking of VGCCs.  On the other hand, the CaV2.2e37b splice variant 
has a non-canonical [DE]xxxL[LI] motif, where L[LI] is substituted by ML 
(DMEFML), which is indicated to be a less efficient signal compared with the 
canonical motif (Motta et al., 1995; Hofmann et al., 1999).  In addition, the e37b 
sequence lacks YxxΦ.  This may explain why CaV2.2e37b channels are less 
efficiently trafficked to the plasma membrane and to the DRG neurites, 
compared to CaV2.2e37a, which contains two strong signals for binding to AP-1 
in this exon. 
The proximity of these motifs in the C-terminus of CaV2.2 to the 
membrane may also create a favourable site for AP-1 interaction.  This has 
been demonstrated for AP-2 which is recruited to the plasma membrane via 
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PtdIns4,5P2 interaction.  This causes AP-2 to undergo a “locked” to “open” 
conformational change which exposes its motif-binding sites (Jackson et al., 
2010).  Although phosphoinositides such as PtdIns4P, that are prevalent in the 
Golgi, are alone insufficient for the recruitment of AP-1, the close proximity of 
these motifs to the membrane is probably important, as membrane-associated 
Arf1 brings AP-1 close to the Golgi membrane, where it unlocks the AP-1 
conformation to allow for cooperative binding of the cargo and PtdIns4P (Ren et 
al., 2013; Stamnes and Rothman, 1993; Crottet et al., 2002). 
The overlapping nature of the AP-1 binding motifs in CaV2.2e37a is 
unprecedented, but the AP-1 complex would be unable to bind both 
simultaneously due to conformational constraints (Heldwein et al., 2004; Ren et 
al., 2013).  However, abolishing either one of the binding sites for AP-1μ1 and 
γ-σ1 in CaV2.2e37a, by mutating the key amino acids, led to a partial loss of cell 
surface expression and trafficking to the DRG neurites in this study.  This 
indicates that both of the AP-1 subunits separately have the ability to interact 
with the overlapping motif in e37a, and are able to partially compensate for the 
trafficking defect in the e37a single mutants, when only one of the potential 
binding sites is available.  However, when both motifs are available for 
interaction, one of the AP-1 subunits may have a higher affinity than the other 
towards its corresponding motif, to mediate more efficient trafficking in a native 
state.  The binding affinity of AP-1 to these motifs has not been reported so far, 
but AP-2 has shown approximately 10-times greater affinity for YxxΦ than 
[DE]xxxL[LI] in recombinant proteins (Höning et al., 2005). 
Other intracellular regions of CaV2.2 also contain possible interaction 
sites for APs.  For example, there is one YxxΦ motif in the N-terminus (Y59), 
and two in the II-III loop (Y811 and Y1154), whereas there is only one other 
[DE]xxxL[LI] site in the distal C-terminus (E2256) in CaV2.2 (Figure 1.11), and 
all of these sites are conserved in human, mouse, rat, rabbit and chicken 
CaV2.2 sequences (available from database of National Center for 
Biotechnology Information (NCBI), U.S. National Library of Medicine).  In the 
case of AP-2, binding to [DE]xxxL[LI], YxxΦ and PtdIns4,5P2 is essential for 
ensuring its high affinity for the cargo in the membrane (Jackson et al., 2010).  
CaV2.2e37a may be able to present both motifs in the e37a sequence to the 
AP-1 complex studied here, and as a result the AP-1 complex is able to interact 
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with the conformationally most favourable counterpart motif for mediating 
effective trafficking.  No mutational or interaction studies have been conducted 
on the other sites in Cav2.2 so far, and it will now be important to investigate the 
involvement of these sites in AP-mediated trafficking. 
Although it is not clear which AP-1 subunit mediates trafficking more 
effectively in the native state, it has been shown for AP-2 that it interacts with 
YxxΦ with a higher affinity than [DE]xxxL[LI] (Jackson et al., 2010).  This was 
also found in our experiments where CaV2.2e37a Y/A mutant showed a 
markedly slower endocytosis rate, indicating that the YxxΦ motif may also 
interact with AP-2μ2 subunits which are involved predominantly in clathrin-
mediated endocytosis (Nesterov et al., 1999).  Our findings suggest that in the 
case of endocytosis, YxxΦ may play a more important role than [DE]xxxL[LI] in 
mediating CaV2.2 internalisation.  
Both shRNA knockdown of AP-1γ and expression of the dominant-
negative AP-1σ mutant V98S reduced trafficking of both isoforms to the plasma 
membrane.  This provides direct evidence for AP-1 mediating trafficking for both 
isoforms of CaV2.2, e37a and e37b.  Nevertheless, incomplete inhibition 
suggests that CaV2.2 trafficking may also involve non-clathrin-mediated 
mechanisms, such as lipid raft and caveolae-mediated trafficking (Le Roy and 
Wrana, 2005; Parton and Simons, 2007).  Indeed, CaV2 channels co-localise 
with caveolin and flotillin-1 in the presence of β and α2δ subunits, and are 
present in lipid rafts (Davies et al., 2006; Robinson et al., 2010).  
Overexpression studies of AP-1 dominant-negative mutants have previously 
indicated that AP-1 mediates somatodendritic trafficking of transmembrane 
receptors in the central neurons such as hippocampal neurons (Farías et al., 
2012; Jain et al., 2015).  CaV2.2e37a AP-1 binding site mutants demonstrate 
that AP-1 may also play an important role in axonal trafficking in DRG neurons, 
since these are pseudo-unipolar neurons that do not form dendrites, therefore 
binding of AP-1 to these sites may modulate the presence of these channels at 
the presynaptic membrane (Figure 4.26).   
Throughout this study, cell surface expression levels of CaV2.2e37 
splice variants and AP-binding mutants were carefully quantified and compared, 
by ensuring that the whole-cell expression levels of these α subunits were not 
significantly different between different conditions, thus the differences 
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observed at the cell surface were due to trafficking, and not due to the 
increased protein expression.  Since the auxiliary subunits α2δ-1 and β1b co-
transfected in these experiments did not contain expression markers indicating 
their expression in the same cells, immunostaining for α subunits was crucial as 
smaller subunits such as α2δ-1 and β1b are likely to be present if a very large 
subunit such as CaV2.2 α subunits is present.  In the case of quadruple 
expression with AP-1 shRNAs and AP-1σ subunits, the cells for analysis were 
selected based on CaV2.2 α expression as well as the expression markers on 
these RNAs and proteins to ensure their presence.  
In summary, this study provides an important insight into a novel CaV2.2 
trafficking mechanism, which is modulated by alternative splicing, and mediated 
by AP-1.  In the future studies, how the disruption of AP-1-mediated CaV2.2 
trafficking affects Ca2+ influx at the presynaptic terminals should be measured 
by genetically-encoded Ca2+ indicator GCaMP (Tian et al., 2009; Akerboom et 
al., 2012) in functional synapses.  Furthermore, how trafficking of CaV2.2 
influences exocytosis from presynaptic terminals upon depolarisation, which 
likely to represent neurotransmitter release, could also be determined by 
electrophysiological methods examining evoked postsynaptic current, or 
presynaptically expressing VGlut1 tagged with pH-sensitive indicators such as 
mOrange or pHluorin (Hoppa et al., 2012; Ferron et al., 2014; Kavalali and 
Jorgensen, 2014).  
- 168 - 
 
Table 4.2 [DE]xxxL[LI] and YxxΦ motifs in the C-terminus of 
VGCCs. 
Ca
V
1.2 GRIKHLDVVTLLRRIQ 
Ca
V
1.3 GRIKHLDVVTLLRRIQ 
Ca
V
2.1 (e37a) GRIHYKDMYSLLRVIS 
Ca
V
2.1 (e37b) GRMPYLDMYQMLRHMS 
Ca
V
2.2 (e37a) CRIHYKDMYSLLRCIA 
Ca
V
2.2 (e37b) GRISYNDMFEMLKHMS 
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Figure 4.26 Trafficking of CaV2.2 splice variants in DRG 
neurons. 
Schematic diagram of CaV2.2e37a (red) and e37b (blue) trafficking 
mediated by AP-1 (orange) to the plasma membrane of DRG 
soma and along the axon, as a result of alternative splicing.   
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Chapter 5 Effect of G protein-coupled 
receptors on calcium channel trafficking  
5.1 Introduction 
Previous studies have demonstrated that both D1 and D2 dopamine 
receptors directly interact with CaV2.2 via intracellular regions to modulate the 
channel properties, cell surface expression and internalisation (Kisilevsky et al., 
2008; Kisilevsky and Zamponi, 2008).  Nevertheless, the effect of GPCRs on 
trafficking of CaV2.2 splice variants has not been examined to this date.  As 
described previously, CaV2.2e37 isoforms exhibit differential voltage-
dependence of their G protein-mediated inhibition (Raingo et al., 2007; Andrade 
et al., 2010).  The key amino acid residue involved in the voltage-independent 
inhibition of CaV2.2e37a was found to be the tyrosine residue in the YxxΦ motif 
(Raingo et al., 2007), which is involved in the AP-mediated channel trafficking 
as described in Chapter 4.  This suggested a possible link between the G 
protein-mediated voltage-independent inhibition and trafficking of CaV2.2 
isoforms.  Here, the effect of D2R activation on CaV2.2e37 splice variant 
trafficking was extensively examined, using cell surface immunocytochemistry, 
electrophysiology and live cell labelling. 
 
 
5.2 Effect of D2R on CaV2.2 trafficking 
First, CaV2.2e37 isoforms (with α2δ-1 and β1b) were co-expressed with 
D2R in N2a cells to determine the effect of D2R on cell surface expression the 
isoform channels without receptor activation.  D2R had no effect on the cell 
surface expression of CaV2.2e37a, and modestly enhanced the cell surface 
expression of CaV2.2e37b (Figure 5.1).  The effect on CaV2.2e37a was  
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Figure 5.1 Effect of D2R expression on cell surface CaV2.2e37 
isoforms.   
(a) Confocal images of N2a cells expressing HA-tagged CaV2.2 
with or without D2R (scale bar, 20 μm), in the presence of β1b and 
α2δ-1.  (b) Cell surface CaV2.2 with D2R is normalised to the 
control condition expressing empty vector in each experiment: 
CaV2.2e37a (closed bar, n=117); CaV2.2e37a+D2R (red, n=136); 
CaV2.2e37b (closed bar, n=133); CaV2.2e37b+D2R (blue, n=153).  
**P<0.01 (Student’s unpaired t-test).  
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unexpected, as it has previously been reported that both D1R and D2R greatly 
enhance CaV2.2e37b expression at the plasma membrane (Kisilevsky and 
Zamponi, 2008; Kisilevsky et al., 2008).  This observation suggests that 
CaV2.2e37 isoforms are differentially modulated by D2R.   
 
5.3 Co-localisation between CaV2.2 splice variants and D2R at 
the cell surface 
It has previously been reported that CaV2.2 and D2R directly interact 
and co-localise in both neurons and in expression system (Kisilevsky and 
Zamponi, 2008), but it is not clear whether these two species interact at the cell 
surface.  To demonstrate the cell surface localisation of D2R, 3xFLAG tag was 
inserted at the end of the N-terminus of D2R, which is the extracellular domain 
in the native receptor.  FLAG-tagged D2R and HA-CaV2.2 splice variants were 
co-expressed in N2a cells and extracellularly immunostained simultaneously 
post-fixation (Figure 5.2a).  Confocal images revealed that D2R and CaV2.2 co-
localise to some extent (Figure 5.2b).  In order to analyse the co-localisation 
further, the images were analysed using a co-localisation analysis plugin in 
ImageJ.  Pearson’s correlation coefficient (rP) indicated a low level of pairing in 
the distributions of the signals from D2R and CaV2.2, particularly for 
CaV2.2e37b (Figure 5.3a).  The overlapping coefficient (r), which is an improved 
representation of the co-localisation between the two signals, indicated that 
approximately half of the total signals co-localise with the counterpart (Figure 
5.3b).  Both splice variants co-localised with D2R to a similar extent.  Manders’ 
coefficients (M1 and M2) are useful when the two images to be compared 
contain unequal numbers of objects, which is the likely case in most biological 
systems (Manders et al., 1993).  M1 indicates the proportion of FLAG-D2R co-
localising with HA-CaV2.2 (Figure 5.3c left), and M2 indicates the proportion of 
HA-CaV2.2 co-localising with FLAG-D2R (Figure 5.3c, right).  For all of these 
co-localisation coefficients, the value would be 0 if the distribution was 
completely random and there were no overlaps of the two objects.  If the two 
objects had the identical distribution, then these co-localisation coefficients 
would be 1 (Manders et al., 1993).  In the M1 analysis, CaV2.2e37b showed a 
significantly lower co-localisation compared to e37a, however, the M2 analysis 
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demonstrated an opposite trend for M1.  This could be due to the fact that many 
of the images for CaV2.2e37b in these experiments contained a higher 
background FLAG signal relative to e37a, which may have confounded the 
results.  The source of the high FLAG noise is unknown, however, the three 
different type of analysis implied that partial co-localisation between D2R and 
CaV2.2 occurs at the cell surface in this expression system. 
 
a 
DAPI FLAG-D2R CaV2.2 HA-CaV2.2 Merge
37a
37b
 
b 
37a 37b
 
 
Figure 5.2 Co-localisation of D2R and CaV2.2 splice variants. 
(a) Confocal images of N2a cells expressing 3xFLAG-D2R with 
HA-CaV2.2e37 (top) and HA-CaV2.2e37b (bottom).  (b) Some co-
localisation between D2R and CaV2.2 was observed at the plasma 
membrane.  DAPI (blue), FLAG-D2R (green), CaV2.2 (red), HA-
CaV2.2 (purple).  White indicates the co-localisation between D1R 
and CaV2.2.  Scale bar, 20 μm.  
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Figure 5.3 Co-localisation coefficients for D2R and CaV2.2 
splice variants. 
These co-localisation coefficients were determined using ImageJ 
plugin, JACoP. The value would be 0 if the distribution of HA-
CaV2.2 and 3xFLAG-D2R in N2a cell surface is completely 
random and there are no overlaps of the two objects.  If the two 
objects have the identical distribution, then these co-localisation 
coefficients would be 1.  (a) Pearson’s correlation coefficients (rP), 
P=0.0201. (b) Overlapping coefficients (r), P=0.34. (c) Manders’ 
co-localisation coefficient. M1, P=0.0093.  M2, P=0.0832.  
CaV2.2e37a (red, n=10), CaV2.2e37b (blue, n=10).   
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5.4 Effect of D2R activation on cell surface CaV2.2 splice 
variants  
5.4.1 Determining effective concentrations of quinpirole for CaV2.2 splice 
variant internalisation  
Next, I examined whether CaV2.2 internalisation initiated by activation of 
GPCRs would be different for CaV2.2e37 isoforms. Upon D2R activation by the 
specific agonist Quin, the amount of both Cav2.2e37 isoforms on the cell 
surface was significantly reduced relative to the 0 nM Quin control after 30 min 
at 37 °C (Figure 5.4), which is likely to represent internalisation.  The cell 
surface expression of CaV2.2 isoforms was dependent on the concentration of 
Quin, and was significantly reduced compared to the control at 100 nM, 300 nM 
and 1 μM.  CaV2.2e37a was more sensitive to a lower concentration of Quin, as 
the relative cell surface expression was significantly less at 30 nM Quin for 
CaV2.2e37a, but not for CaV2.2e37b.  The relative reduction in amount of 
CaV2.2 at the cell surface in the presence of 100nM Quin was similar for both 
isoforms (Figure 5.5).  
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Figure 5.4 Dose-dependent effect of Quin on cell surface 
expression of CaV2.2e37 splice variants.  
N2a cells co-expressing CaV2.2e37 isoforms and D2R were 
incubated with Quin at a range of concentrations for D2R 
activation.  Relative cell surface CaV2.2e37a and e37b after 0, 30, 
100, 300 and 1000 nM Quin application at 30 min at 37 °C.  The 
cell surface florescence intensities of HA-CaV2.2 were normalised 
to the average value at t=0 min in each experiments. (a) 
CaV2.2e37a +0nM Quin (n=90), 30nM Quin (n=71), 100nM Quin 
(n=77), 300nM Quin (n=74), 1000nM Quin (n=51).  (b) 
CaV2.2e37b +0nM Quin (n=80), 30nM Quin (n=76), 100nM Quin 
(n=76), 300nM Quin (n=89), 1000nM Quin (n=74)  *P<0.05, 
**P<0.01, ***P<0.001 (one-way ANOVA).  
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Figure 5.5 Effect of D2R activation on cell surface CaV2.2e37 
splice variants.  
Cell surface CaV2.2 in the presence of D2R, with or without 100nM 
Quin in N2a.  (Left) CaV2.2e37a (closed bar, n=98); 
CaV2.2e37a+Quin (red, n=99). (Right) CaV2.2e37b (closed bar, 
n=104); CaV2.2e37b+Quin (blue, n=91). **P<0.01, ***P<0.001 
(Student’s unpaired t-test).    
 
 
5.4.2 Pertussis toxin is ineffective in blocking activated D2R-mediated 
CaV2.2 internalisation 
In order to investigate further the mechanisms of D2R activity-mediated 
internalisation of CaV2.2, the cells expressing CaV2.2 splice variants and D2R 
were pre-treated with 500 ng/ml pertussis toxin (PTX) 16 h prior to the 
experiment to block any G protein-mediated action on CaV2.2.  The activity of 
PTX was confirmed in the electrophysiological experiment, in which PTX blocks 
the Gβγ-mediated voltage-dependent inhibition of CaV2.2 by Quin at this 
concentration (Figure 5.6).  However, the D2R activation-mediated 
internalisation of CaV2.2 splice variants was not blocked by pre-treatment with 
PTX under the same condition (Figure 5.7), indicating that D2R activity-
mediated internalisation is independent of the direct action of Gβγ on CaV2.2.   
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Figure 5.6  PTX blocks inhibition of CaV2.2 isoforms by D2R 
activation. 
Whole-cell currents of CaV2.2e37 isoforms expressed in tsA-201 
were normalised to the basal current at the beginning of the 
recording, prior to the addition of 300nM Quin. In the control 
condition, Quin application inhibits CaV2.2 current when the 
channels were activated at +5 mV. PTX pre-treated cells block this 
effect.  (a) CaV2.2e37a control (red closed squares), n=22; 
CaV2.2e37a control (red open triangles), n=3.  (b) CaV2.2e37b 
control (blue closed squares), n=23; CaV2.2e37b with PTX (blue 
open triangles), n=10. 
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5.4.3 AP-2 is involved in CaV2.2 internalisation triggered by D2R 
activation 
Receptor sequestration has been reported for a number of GPCRs 
following activation, which is mediated by the recruitment of β-arrestin to the 
activated receptor (Krupnick and Benovic, 1998).  β-arrestin targets GPCRs for 
clathrin-dependent internalisation by directly interacting with AP-2 (Goodman et 
al., 1996; Laporte et al., 1999; Zhang et al., 1996; Laporte et al., 2000).  To test 
if blocking clathrin-mediated internalisation also inhibits D2R activation-induced 
CaV2.2 internalisation, the dominant-negative mutant of the AP-2 μ2 subunit 
F174A/D176S was co-expressed; this construct has been shown to impair 
transferrin endocytosis (Motley et al., 2006).  In the presence of the AP-2μ2 
mutant, CaV2.2 internalisation was not observed after Quin treatment (Figure 
5.8).  This suggests that functional AP-2 is essential for the internalisation of 
CaV2.2, triggered by D2R activation.  All together, these data suggest that 
activation of the D2R cause both CaV2.2e37 isoforms to internalise via β-
arrestin-mediated recruitment of clathrin, which requires functional AP-2.  
 
 
 
 
 
 
 
- 179 - 
 
37a + D2R
+ AP22 F174A/D176S
0nM 100nM
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
[Quin]
C
e
ll
 S
u
rf
a
c
e
 C
a
v
2
.2
 e
3
7
a
(N
o
rm
a
li
z
e
d
)
NS
   
37b + D2R
+ AP22 F174A/D176S
0nM 100nM
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
[Quin]
C
e
ll
 S
u
rf
a
c
e
 C
a
v
2
.2
 e
3
7
b
(N
o
rm
a
li
z
e
d
)
NS
 
Figure 5.8 AP-2μ2 F174A/D176S blocks D2R activation-
mediated internalisation of CaV2.2 splice variants. 
Cell surface CaV2.2 in the presence of D2R and dominant-
negative AP-2μ2 mutant F174A/D176S, with or without 100nM 
Quin.  (Left) CaV2.2e37a (closed bar, n=70); CaV2.2e37a+Quin, 
AP-2μ2 F174A/D176S (red, n=57).  (Right) CaV2.2e37b (closed 
bar, n=73); CaV2.2e37b+Quin (blue, n=71).   
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Figure 5.7 PTX does not block D2R activation-mediated 
internalisation of CaV2.2 splice variants.  
Cell surface CaV2.2 in the presence of D2R in N2a, with or without 
100nM Quin after PTX treatment.  (Left) CaV2.2e37a (closed bar, 
n=72); CaV2.2e37a+Quin (red, n=76).  (Right) CaV2.2e37b (closed 
bar, n=65); CaV2.2e37b+Quin (blue, n=55). *P<0.05, **P<0.01 
(Student’s unpaired t-test).    
- 180 - 
5.5 Effect of AP-2 and dynamin on voltage-dependent 
inhibition of CaV2.2 splice variants 
As observed in 5.4.3, disruption of AP-2 interaction with CaV2.2 splice 
variants blocks internalisation of the channels, which is induced by D2R 
activation.  I hypothesised that voltage-independent inhibition of CaV2.2 caused 
by G protein activation may be a result of, or partly mediated, by internalisation 
of the channels, based on the difference observed between CaV2.2e37a and 
e37b, both in the voltage-dependence of G protein mediated inhibition and the 
D2R-mediated internalisation of the channels.  Thus, blocking internalisation 
may alter the voltage-dependency of G protein-mediated CaV2.2 inhibition.   
In order to test this hypothesis, G protein-mediated voltage dependent 
inhibition of CaV2.2e37 isoforms was examined by activating the D2R with 300 
nM Quin in a double-pulse protocol, as described in 3.5.3, with or without the 
endocytosis blockade.  Dominant negative mutants of AP-2 μ2, F174A/D176S 
(Motley et al., 2006) and dynamin-1 K44R (Ruffieux-Daidié et al., 2008) were 
co-expressed with CaV2.2 splice variants and D2R, and the P2/P1 (relative 
current before and after the prepulse) was determined.  If these proteins cause 
the inhibition to become more voltage-independent, the P2/P1 values are 
expected to decrease.  AP-2 μ2 and dynamin wild-type proteins were also 
expressed as controls.   
The P2/P1 values are summarised in Figure 5.9.  In general, 
CaV2.2e37a showed smaller P2/P1 compared to CaV2.2e37b in any conditions 
tested, indicating the mode of G protein inhibition is more voltage-independent 
for CaV2.2e37a, which is in agreement with my previous observation (Figure 
3.19), and the reports of others (Raingo et al., 2007; Andrade et al., 2010).  
However, AP-2 nor dynamin-1 did not have a significant effect on modulating 
the P2/P1, except for AP-2 WT which enhanced the difference in P2/P1 
between CaV2.2e37a and 37b.  Nevertheless, the lack of differences in P2/P1 
between the control condition and the AP-2 or dynamin-1 (WT or dominant-
negative mutant) conditions suggests it is unlikely that the clathrin-mediated 
endocytosis contributes to the voltage-independent component of CaV2.2 
inhibition. 
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Figure 5.9 Effect of AP-2 and dynamin on G protein-mediated 
voltage-dependent inhibition.  
Differences in the relative currents before and after a prepulse 
(P2/P1) in the presence of 300 nM Quin in tsA-201.  In general, 
CaV2.2e37b showed a greater P2/P1 in all conditions, compared 
to CaV2.2e37a.  There were no significant differences in P2/P1 
among any conditions with AP-2 and dynamin proteins.  Control: 
e37a (red, n=21), e37b (blue, n=24). +AP-2μ2 F174A/D176S: 
e37a (red border, n=15), e37b (blue border, n=28). +AP-2μ2 WT: 
e37a (red stripe, n=11), e37b (blue stripe, n=22). +dynamin-1 
K44R: e37a (shaded red, n=4), e37b (shaded blue, n=4). 
+dynamin-1 WT: e37a (crossed red, n=6), e37b (crossed blue, 
n=8).  **P<0.01 (one-way ANOVA).   
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5.6 Effect of D2R activation on CaV2.2 endocytosis  
 
Since it was evident that D2R co-expression and activation affected the 
cell surface CaV2.2 levels, the effect of these events on CaV2.2 endocytosis was 
examined next.  Using the endocytosis assay with BTX-labelling, the effect of 
100nM Quin was determined on the endocytosis rate of BBS-tagged CaV2.2e37 
isoforms, which were co-expressed with or without D2R.  The endocytosis rate 
of CaV2.2e37b was significantly slowed by the presence of D2R (Figure 5.10a).  
Cav2.2e37b then internalised more rapidly in the presence of Quin, with a  
value similar to that determined for CaV2.2e37b alone (Figure 4.11, Figure 
5.10).  On the other hand, the basal endocytosis rate of CaV2.2e37a was not 
significantly affected by co-expression of D2R, compared to CaV2.2e37a alone 
(Figure 5.10b), as predicted from the previous comparison of cell surface 
expression levels.  In contrast to the effect of Quin to reduce the overall cell 
surface expression of CaV2.2e37a channels (Figure 5.4), Quin treatment did not 
significantly accelerate CaV2.2e37a internalisation, possibly reflecting a 
minimum limit in the determination of endocytosis rate by this protocol.  
 
5.6.1 Involvement of CaV2.2 AP binding motifs in D2R activation-mediated 
endocytosis of CaV2.2 
To determine whether the AP interaction motifs in CaV2.2e37a were 
involved in the differential effect of the D2R to slow CaV2.2e37b internalisation, 
the effect of the CaV2.2e37a L/A and Y/A mutants were also examined (Figure 
5.11a).  Co-expression of D2R slowed the endocytosis of the L/A mutant, 
compared to the WT CaV2.2e37a with D2R (Figure 5.10b), with a time constant 
approaching that for CaV2.2e37b plus D2R (Figure 5.10a).  In contrast, co-
expression of D2R accelerated the endocytosis rate of the Y/A mutant, 
compared to its basal endocytosis rate, to a value similar to WT CaV2.2e37a 
plus D2R (Figure 5.11b).  These results indicate that CaV2.2e37a internalisation 
can be both up- and down-regulated in association with the D2R, by the 
differential availability of the AP-binding motifs in its C-terminus.  Quin treatment  
- 183 - 
a 
0 10 20 30 40
0.0
0.2
0.4
0.6
0.8
1.0
Data: Data5_37b D2R,Data5_37bD2RQ
Model: ExpDec1
Equation: y = A1*exp(-x/t1) + y0
Weighting: 
y(1) No weighting
y(2) No weighting
  
Chi^2/DoF = 0.00112
R^2 =  0.99659
  
y0 0.06549 ±0.12874
A1 0.938 ±0.12236
t1 25.46418 ±6.85572
y0_2 0.22185 ±0.04182
A1_2 0.78248 ±0.05082
t1_2 11.05205 ±1.81265
C
e
ll
 S
u
rf
a
c
e
 C
a
v
2
.2
 
(N
o
rm
a
li
z
e
d
)
 Time (min)
 37b+D2R, Control
 37b+D2R, Quin * *
- + +
0
10
20
30
40
Quin    -      -      +
D2R
37b

 (
m
in
)
 
b 
0 10 20 30 40
0.0
0.2
0.4
0.6
0.8
1.0
Data: Data2_37aD2R,Data2_37aD2RQ
Model: ExpDec1
Equation: y = A1*exp(-x/t1) + y0
Weighting: 
y(1) No weighting
y(2) No weighting
  
Chi^2/DoF = 0.00067
R^2 =  0.99629
  
y0 0.25 ±0
A1 0.74775 ±0.02582
t1 9.07342 ±0.74983
y0_2 0.25 ±0
A1_2 0.75134 ±0.02593
t1_2 5.76658 ±0.62259
C
e
ll
 S
u
rf
a
c
e
 C
a
v
2
.2
 
(N
o
rm
a
li
z
e
d
)
Time (min)
 37a+D2R, Control
 37a+D2R, Quin
- + +
0
10
20
30
40
Quin    -      -      +
D2R
37a

 (
m
in
)
NS
 
Figure 5.10 Effect of D2R activation on CaV2.2 endocytosis.  
(a) (Left) CaV2.2e37b endocytosis rate was slowed by the 
presence of D2R, and accelerated by D2R activation.  e37b+D2R 
(closed blue circle, n=4); e37b+D2R+Quin (open blue circle, n=3).  
(Right) The time constants for the endocytosis kinetics were (min); 
e37b (closed bar), 11.6 ± 3.53 (n=3, from Fig. 7B; e37b+D2R 
(closed blue bar), 29.0 ± 4.89 (n=4); e37b+D2R+Quin (open blue 
bar), 6.90 ± 0.36 (n=3).  (b) (Left) e37a endocytosis was not 
significantly changed by the presence of D2R nor by D2R 
activation; e37a+D2R (closed red circle, n=5), e37a+D2R+Quin 
(open red circle, n=3).  (Right) The time constants for the 
endocytosis kinetics were (min); e37a (closed bar), 7.00 ± 1.23 
(n=3, from Fig. 7B); e37a+D2R (closed red bar), 11.1 ± 1.43 (n=5), 
e37a+D2R+Quin (open red bar) = 6.60 ± 0.22 (n=3).  The cell 
surface fluorescence was normalised to the average value at t=0 
min in each condition in the same experiment.  The data points in 
the graph contain all the cells analysed from the 3-5 separate 
experiments.  Mean ± SEM, *P< 0.05 (one-way ANOVA). 
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Figure 5.11 Mutation in AP binding motifs blocks D2R 
activation-mediated CaV2.2 endocytosis. 
(a) (Left) Endocytosis of e37a L/A mutant was slowed by the 
presence of D2R, similarly to e37b, but was not accelerated by 
D2R activation.  The time constants for the endocytosis kinetics 
were (min); L/A+D2R (closed purple circle), 27.3 ± 4.43 (n=3); 
L/A+D2R+Quin (open purple circle), 18.6 ± 1.62 (n=3).  (Right) 
e37a+D2R (red, from Figure 5.10a), L/A+D2R (purple).  (b) (Left) 
Endocytosis of CaV2.2e37a Y/A mutant was not changed by the 
presence of D2R, similarly to CaV2.2e37a, and was not 
accelerated by D2R activation.  The time constants for the 
endocytosis kinetics were (min); Y/A+D2R (closed green circle), 
12.6 ± 2.20 (n=3); Y/A+D2R+Quin (open green circle), 7.28 ± 0.90 
(n=3).  (Right) CaV2.2e37a+D2R (red, from Figure 5.10b), 
Y/A+D2R (green).  The cell surface fluorescence was normalised 
to the average value at t=0 min in each condition in the same 
experiment.  The data points in the graph contain all the cells 
analysed from the 3 separate experiments.  Mean ± SEM, *P< 
0.05 (one-way ANOVA). 
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did not alter the endocytosis of either mutant.  These results indicate that 
disrupting the AP interaction motifs in CaV2.2e37 alters its interaction with the 
D2R and agonist-induced internalisation.    
 
 
 
5.6.2 Interaction between CaV2.2 AP-binding motifs and D2R on whole-
cell current 
The endocytosis rates of CaV2.2 AP-binding mutants with and without 
the co-expression of D2R showed that L/A and Y/A mutants behave differently 
with D2R co-expression.  While the endocytosis rate of the Y/A mutant was not 
affected by the presence of the D2R, the L/A mutant showed much slower 
endocytosis rate with D2R (Figure 5.11).  To determine whether this difference 
in endocytosis rate leads to altered cell surface expression and the whole-cell 
current of the mutant channels, they were co-expressed with D2R in tsA-201 
cells, in order to compare the whole-cell current densities, which is likely to 
represent the cell surface expression, according to the previous experiments 
(Figure 4.19, Figure 4.20).   
To address whether the co-expression of D2R also affects the whole-
cell current of these AP-binding mutants, the current densities were determined 
with co-expression of D2R in tsA-201 cells (Figure 5.12), and compared with 
those in the absence of D2R (Figure 4.20).  Interestingly, the peak current 
density of the Y/A mutant with D2R was similar to that in the absence of D2R.  
Meanwhile, the peak current density of L/A with D2R increased, which was not 
significantly different from that of the WT CaV2.2e37a with D2R (Figure 5.13).    
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Figure 5.12 Whole-cell current densities of CaV2.2 AP-binding 
mutants in the presence of D2R. 
CaV2.2e37a WT and AP-binding mutants were coexpressed with 
D2R, α2δ-1 and β1b in tsA-201.  In the presence of D2R, the peak 
current density of the Y/A mutant (purple) was significantly smaller 
than that of the WT (red) or the L/A mutant (green).  Peak current 
density (pA/pF): CaV2.2e37a WT -164.1 ± 23.9 (n=19), L/A -175.7 
± 42.0 (n=6) at 5mV, Y/A -85.7 ± 16.6 (n=7) at 10 mV. 
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Figure 5.13 Summary graph of peak current densities of 
CaV2.2e37a AP-binding mutants with and without D2R. 
The peak current densities of CaV2.2e37a WT and AP-binding 
mutants from Figure 4.20 (without D2R) and Figure 5.12 (with 
D2R) are summarised.  The whole-cell current density of HA-
CaV2.2e37b without D2R is shown in Figure 3.17.  In the absence 
of D2R; CaV2.2e37a WT (red, n=24), L/A (green, n=27), Y/A 
(purple, n=30).  In the presence of D2R; WT (shaded red, n=19), 
L/A (shaded green,n=6), Y/A (shaded purple, n=7).  *P<0.05, 
**P<0.01 (one-way ANOVA). 
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5.7 Summary and Discussion 
Direct interaction between CaV2.2 and dopamine receptors has been 
reported as an important event in regulating the surface expression of CaV2.2 
(Kisilevsky et al., 2008; Kisilevsky and Zamponi, 2008), but the precise 
mechanisms for this trafficking have been poorly understood.  In this study, 
differential effect of D2R co-expression on CaV2.2 splice variants was observed 
on their cell surface expression and endocytosis rates.  In my experiments, co-
expression of D2R does not increase the cell surface expression of 
CaV2.2e37a, and produces only a modest increase for CaV2.2e37b, whereas 
Kisilevsky and Zamponi (2008) reported a 2 to 3-fold increase in the cell surface 
expression of untagged and HA-tagged CaV2.2e37b in the presence of D2R in 
tsA-201 cells (Kisilevsky and Zamponi, 2008).  Nonetheless, this difference 
between the CaV2.2 isoforms may be due to the further observations in which 
the rate of endocytosis of CaV2.2e37b is considerably slowed by the D2R, thus 
the channels are more stable and they accumulate at the cell surface.  
CaV2.2e37a, on the other hand, did not have this effect.  This could be due to 
the lack of a canonical [DE]xxxL[LI] motif in CaV2.2e37b, since mutating this 
motif in CaV2.2e37a (i.e. the L/A mutant) results in a larger whole-cell current in 
the presence of D2R, compared to the current in the absence of D2R, indicating 
an increase in the cell surface expression.    
Interestingly, this stabilising effect at the plasma membrane diminishes 
upon D2R activation, and CaV2.2e37b internalises at an increased rate similar 
to that for the channel expressed in the absence of the receptor.  Upon D2R 
activation β-arrestin may be recruited to the activated D2R where it acts as an 
adaptor for AP-2-mediated internalisation (Goodman et al., 1996; Laporte et al., 
2000, 2002; Lan et al., 2009).  This recruitment of AP-2 to activated D2R via β-
arrestin could occur without affecting the receptor coupling to G-proteins 
(Hausdorff et al., 1991).  My study shows a new possible role of AP-2, mediated 
by β-arrestin recruitment to the receptor, which may also be important for the 
D2R activity-dependent CaV2.2 internalisation.  This is supported by the results 
showing that disrupting the recruitment of functional AP-2 by overexpressing the 
dominant-negative mutant AP-2μ2 and mutations in [DE]xxxL[LI] and YxxΦ 
motifs inhibit CaV2.2 internalisation upon D2R activation, demonstrating that 
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functional AP-2 interaction is required for CaV2.2 internalisation mediated by 
D2R activation (Figure 5.14).  It appears that CaV2.2e37a and 37b co-localise 
with D2R at the cell surface to a similar extent in the basal state.  However, it is 
unclear whether CaV2.2 and D2R co-internalise together or they separate from 
each other and undergo internalisation pathway separately upon receptor 
activation. 
Internalisation of CaV2.2 by activation of endogenous D2R has not 
previously been reported.  Altier et al. (2006) showed ORL1 receptor-mediated 
internalisation of CaV2.2 upon chronic application of an ORL1 agonist, 
nociceptin in isolated DRG neurons by immunocytochemistry (Altier et al., 
2006).  However, this observation was not confirmed by the functional studies of 
Murali et al. (2012), where the prolonged (30 min) application of nociceptin did 
not decrease the CaV2.2 current in cell bodies of isolated small-diameter 
peptidergic DRG neurons, nor the post-synaptic current (Murali et al., 2012).  
The discrepancy between these studies could be explained by the difference in 
the subpopulation of the DRG neurons observed in the two studies.  The 
difference in the expression patterns of CaV2.2 isoforms in peptidergic and non-
peptidergic neurons has not been described, but this information may further 
elucidate the difference in the channel internalisation.  Furthermore, the lack of 
decrease in CaV2.2 current upon prolonged ORL1 receptor activation could be 
explained by the balancing effect of increased de novo insertion of CaV2.2 into 
the plasma membrane.  Further studies on the forward trafficking of BBS-
CaV2.2 upon GPCR activation are required to validate this hypothesis.  
In summary, this study provides a further insight into how D2R activities 
regulate CaV2.2 trafficking.  The AP-binding motifs in the proximal C-terminus of 
CaV2.2 may be involved in the co-trafficking of CaV2.2 and D2R.  Further 
investigations are required to determine two key mechanisms; how D2R 
enhance CaV2.2 cell surface expression, and how its activation causes CaV2.2 
endocytosis.  In addition, a future work on the D2R-mediated internalisation of 
CaV2.2 in neurons from regions of the brain rich in D2R expression such as the 
dorsal striatum and nucleus accumbens is also required to demonstrate the 
physiological significance of this phenomenon.  
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Figure 5.14 Possible mechanisms for AP-mediated trafficking 
of CaV2.2 and D2R. 
Schematic diagram of CaV2.2 trafficking mediated by APs and 
D2R.  Cell surface level of CaV2.2 (blue) is tightly regulated by AP-
1 (orange) and AP-2 (purple). Additionally, D2R (green) activation 
controls the CaV2.2 at the cell surface, where the channel 
endocytosis is mediated by AP-2.   
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Chapter 6 General discussion and 
Conclusion 
6.1 Co-trafficking of CaV2.2 and D2R 
In Chapter 5, the stabilising effect of D2R co-expression on CaV2.2e37b 
at the plasma membrane was demonstrated, which diminished upon D2R 
activation, and the channel internalised at an increased rate similar to that for 
the channel expressed in the absence of the receptor.  There are two possible 
explanations for this observation; 1) the activated D2R-CaV2.2 complex 
internalises together at an accelerated rate, 2) the activated D2R undergoes a 
conformational change and dissociates from CaV2.2 at the cell surface, and 
they internalise separately at their own native rates.  How D2 receptors 
decrease the endocytosis rate of CaV2.2e37b channels is still not clear, 
however, the co-localisation of CaV2.2 and D2R via direct interaction of their 
intracellular regions suggested previously (Kisilevsky and Zamponi, 2008) 
implies that APs may be able to bind to the cargo motifs in CaV2.2 and D2R 
simultaneously to regulate their co-trafficking.  Indeed, the D2R contains YxxΦ 
motifs in its intracellular loop 2 and 3 near the plasma membrane, but does not 
contain [DE]xxxL[LI] (Namkung and Sibley, 2004).  This implies that an adaptor 
protein may potentially interact with CaV2.2 via [DE]xxxL[LI], and D2R via YxxΦ 
simultaneously if co-trafficking of CaV2.2 and D2R were to be mediated 
efficiently, similarly to the higher affinity of AP-2 shown in the presence of both 
motifs, compared to each single one separately (Jackson et al., 2010).  The 
stabilising effect of CaV2.2e37b at the cell surface in the presence of D2R could 
be explained by this novel concept where the μ-subunit of AP-2 interacts with 
either of these YxxΦ motifs in D2R, while the α-σ2 hemicomplex interacts with 
the DxxxML motif in the e37b sequence, which may be inefficient for AP-2 
mediated endocytosis in their co-internalisation from the cell surface, compared 
to CaV2.2e37a which contains a canonical motif, DxxxLL mediating efficient 
endocytosis.  My data supports this mode of interaction, since mutating the 
DxxxLL motif in CaV2.2e37a to DxxxAL slows its endocytosis, only in the 
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additional presence of the D2R, but mutating YxxΦ motif in the C-terminus of 
CaV2.2e37a does not.  All the rates of endocytosis of CaV2.2e37 isoforms and 
AP-binding mutants with or without D2R are summarised in Table 6.1.   
It is still unclear where the interaction between CaV2.2 and D2R 
predominantly occurs.  Co-localisation experiments here have shown that some 
interaction occurs at the plasma membrane.  The previous report indicated an 
intracellular co-localisation (Kisilevsky and Zamponi, 2008), but this could mean 
either that they are co-trafficked to the plasma membrane together, or they 
internalise together from the cell surface.  To address this question, it would be 
interesting to determine how co-expression of D2R affects the forward 
trafficking of CaV2.2, by monitoring the appearance of BBS-tagged channels.  
However, it is unlikely that the AP-binding motifs in CaV2.2 play a major role in 
forward trafficking of D2R-CaV2.2 complexes, since the whole-cell current of the 
AP-binding motif mutants remained the same, or rather increased in the 
presence of D2R, therefore these motifs may play more dominant role in 
endocytosis in the presence of D2R.  
Since the use of BTX to track the internalised CaV2.2 was not 
sufficiently effective, improved fluorescent tags, for example using quantum dot 
(Qdot) technology, which has a greater tracking efficiency of transmembrane 
proteins (Groc et al., 2007) could prove useful.  Qdot is brighter and more 
photostable than single dyes such as AF-488, and particularly useful in live-
imaging experiments.  This molecular tool may improve the monitoring of co-
trafficking of CaV2.2 and D2R to and from the cell surface in future experiments.  
In addition, how the activities of D2R and other GPCRs affect trafficking of 
endogenous CaV2.2 has not been studied so far.  Inserting the sequence for the 
exofacial tag such as HA and BBS or pHlourin into the same location as in the 
constructs used in this study within the CaV2.2-encoding gene of transgenic 
mice in order to generate the exofacial tag knock-in mice would create a 
powerful tool to further investigate the regulatory mechanisms of CaV2.2 
trafficking in the native neurons.  The exofacial tag knock-in mice may enable 
investigation into the developmental effect on CaV2.2 trafficking by comparing 
the CaV2.2 traffikcing in neurons of embryonic and adult mice.  In addition, 
these transgenic mice may also allow one to investigate the effect of 
endogenous GPCR activation (such as D2, μ-opioid and GABAB receptors) on 
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CaV2.2 trafficking.  If the approach for the exofocial tag knock-in into the 
CaV2.2-encoding sequence was proven successful, this technique could also be 
applied to the transgenic mice expressing only e37a (aa*) and 37b (b*b) 
(Andrade et al., 2010) to tag only the CaV2.2e37a or e37b isoforms to determine 
the endogenous trafficking and the effect of endogenous GPCR activation on 
the isoform trafficking in the neurons of these animals.  Finally, these transgenic 
mice could potentially be useful tools to study the effect of various 
pharmacological drugs targeted to CaV2.2 on the channel trafficking.   
 
 
 
Table 6.1 Effect of D2R activation on rate of endocytosis of 
CaV2.2e37 splice variants and mutants. 
 τ (min) 
[Quin] 0 nM 100 nM 
37a 7.00 ± 1.23 n/a 
37a + D2R 11.1 ± 1.43 6.60 ± 0.22 
37b 11.6 ± 3.53 n/a 
37b + D2R 29.0 ± 4.89 6.90 ± 0.36 
37a L/A 13.8 ± 1.85 n/a 
37a L/A + D2R 27.3 ± 4.43 18.6 ± 1.62 
37a Y/A 21.1 ± 3.53 n/a 
37a Y/A + D2R 12.6 ± 2.20 7.28 ± 0.90 
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6.2 Alternative CaV2.2 trafficking mechanisms 
In Chapter 4, the role of APs in the differential trafficking of 
isoforms to the plasma membrane and neurites was explored 
led to a conclusion that APs interact with the proximal C-
mediate channel trafficking.  Nevertheless, as summarised in  
Figure 1.11, CaV2.2 contains a number of other potential AP-interaction 
sites which were not investigated in this study.  These potential sites may be 
able to compensate for the interaction with APs when the motifs in exon 37 are 
mutated.  Furthermore, these motifs that have not yet been studied could be 
used preferentially or have higher affinity for APs than the motifs in exon 37 
explored in this study.  Although the binding affinity of adaptor APs to these 
motifs has been reported to be relatively weak (Höning et al., 2005; Jackson et 
al., 2010),  direct interaction of APs with these motifs in CaV2.2 could be 
assessed by surface plasmon resonance, as the dissociation constants (KD) 
between AP-2 and the cargos were demonstrated to be approximated 1 μM 
(Jackson et al., 2010).  The involvement of these potential AP-interaction sites 
(particularly those that are close to the plasma membrane), as well as the non-
canonical DxxxML motif in exon 37b, in CaV2.2 trafficking also requires further 
investigation using site-directed mutagenesis to address this issue in the future.  
This could be assessed by the series of trafficking experiments demonstrated in 
this study, and in conjunction with the surface plasmon resonance experiments.   
Some of the results in this study suggest that APs may not be the only 
determinants in CaV2.2 trafficking.  Ubiquitination leading to proteasomal 
degradation has been reported to be greater in CaV2.2e37b than e37a 
(Marangoudakis et al., 2012), however, whole-cell expression levels of 
CaV2.2e37 isoforms in my study did not support this observation.  Other 
possible trafficking mechanisms for CaV2.2 include protein sorting in caveolae, 
which is one of the most studied clathrin-independent sorting domains (Parton 
and Simons, 2007), although some reports suggest that clathrin-independent 
pathways have a minor role in endocytosis (Bitsikas et al., 2014).  Both 
exocytosis and endocytosis take place in caveolae to control plasma membrane 
protein distribution (Parton and del Pozo, 2013).  Moreover, a number of 
VGCCs, such as CaV1.2 (Balijepalli et al., 2006; Xia et al., 2007), CaV2.1 
(Davies et al., 2006) and CaV2.2 (Xia et al., 2007; Robinson et al., 2010), are 
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present in lipid raft domains.  Furthermore, α2δ subunits are also present in lipid 
rafts / caveolae (Davies et al., 2006; Robinson et al., 2011).  The mechanism by 
which α2δ subunits regulate VGCC trafficking is still unclear; however, the 
CaV2.2e37a isoform requires the presence of α2δ-1 for its greater cell surface 
expression compared to e37b, indicating that α2δ-1 may promote CaV2.2e37a 
trafficking in caveolae.  This could be confirmed by determining the protein 
levels of these splice variants in the lipid rafts with or without coexpression of 
α2δ-1 with the methods previously used in this group, namely the detergent-
resistance membrane (DRM) or Triton X-100 insoluble membrane fractions 
(Kadurin et al., 2012).   
 
 
6.3 Possible consequences of CaV2.2 trafficking in diseases / 
treatments 
The involvement of CaV2.2e37a in modulating neuropathic pain through 
morphine analgesia has already been implicated by other studies (Bell et al., 
2004; Altier et al., 2007; Raingo et al., 2007; Andrade et al., 2010).  The 
differential modulation of CaV2.2 isoform trafficking by α2δ-1 described in this 
study could be a further link for CaV2.2e37a in neuropathic pain modulation.  
Firstly, α2δ-1 is mainly expressed in the small-diameter nociceptive DRG 
neurons (Newton et al., 2001).  In addition, at least 20 % of DRG neurons 
express CaV2.2e37a, and of these ~75 % are small-diameter nociceptive 
neurons, exhibiting a preferential expression (Bell et al., 2004).  In sciatic nerve 
ligated rats, as an animal model of neuropathic pain, α2δ-1 expression is 
increased in all DRG neurons in terms of the mRNA and protein level, 
regardless of their modalities and diameter (Bauer et al., 2009; Newton et al., 
2001).  Although a further investigation is required to understand how the α2δ-1 
level expressed in the heterologous system is correlated to the endogenous 
level in these DRG neurons, more CaV2.2e37a may be trafficked to the cell 
surface and to presynaptic terminals compared to e37b to increase the 
presynaptic Ca2+ currents upon up-regulation of α2δ-1 in neuropathic pain 
states.  Although CaV2.2e37a mRNA was downregulated in a neuropathic pain 
model, this reduction was in the total DRG RNA and there are no reports on 
- 195 - 
changes in CaV2.2e37a level specifically in the small-diameter neurons (Altier et 
al., 2007).  In addition, even if there are less CaV2.2e37a channels present in 
nociceptive neurons during neuropathic pain, the up-regulated α2δ-1 may 
potentially enhance the trafficking of these channels to the plasma membrane 
where they are active.  Secondly, the voltage-dependence of CaV2.2e37a/b 
splice variants is also differentially modulated by α2δ-1.  In neuropathic pain 
conditions, the increased level of α2δ-1 may cause CaV2.2e37a to be activated 
at a more hyperpolarised potentials upon the arrival of action potentials, to 
release more neurotransmitter into the synaptic cleft.  Finally, although there are 
some contradicting reports (Eroglu et al., 2009), neuropathic pain is thought to 
be alleviated by gabapentinoid drugs such as gabapentin and pregabalin which 
act by disrupting the trafficking of α2δ-1 to the plasma membrane, and as a 
result reduce the CaV2 cell surface expression (Hendrich et al., 2008; Bauer et 
al., 2009).  Since CaV2.2e37a may be more sensitive to α2δ-1 level, the effect of 
the gabapentinoid drugs in trafficking of e37a may be greater, affecting the 
trafficking from Rab11-dependent recycling endosomes in particular, as shown 
previously for α2δ-2 (Tran-Van-Minh and Dolphin, 2010).  
Mutations in AP1S2 which encodes for the brain isoform of AP-1σ1, 
σ1B, have been found in families with X-linked mental retardation (Tarpey et al., 
2006).  To elucidate the molecular basis for X-linked mental retardation, σ1B-
knockout transgenic mice have been studied which causes ~ 50 % reduction in 
the synaptic vesicle (SV) density in the hippocampal synaptic boutons, 
demonstrating the crucial role of AP-1 in SV recycling (Glyvuk et al., 2010).  
However, as demonstrated in my study, disrupting interaction between AP-1 
and CaV2.2 also leads to reduction in CaV2.2 trafficking to the synaptic 
terminals, which may also disturb the SV recycling by reducing Ca2+ flux upon 
depolarisation (Marks and McMahon, 1998).  Furthermore, MEDNIK (mental 
retardation, enteropathy, deafness, neuropathy, ichthyosis and keratodermia) 
syndrome is caused by disruption in subcellular localisation of the Cu2+ 
transporters, ATP7A and ATP7B due to mutations in AP1S1 that encode for 
another isoform AP-1 σ1A, leading to perturbation in Cu2+ metabolism 
(Montpetit et al., 2008; Martinelli et al., 2013; Jain et al., 2015).  Although there 
are no reports on other proteins affected by this mutation in vivo, it 
demonstrates how mis-localisation of a protein due to malfunctioning of clathrin-
mediated protein sorting can be the cause of pathological conditions.  
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Assessing the effect of these mutations on the subcellular localisation of CaV2.2 
would give a further insight to the physiological relevance of my study in the role 
of AP-1 in CaV2.2 trafficking.  Moreover, the protein expression and the role of 
AP-1 in the peripheral nervous system is still unknown, which should be 
investigated in the future using the σ1B-knockout in transgenic mice described 
by Glyvuk et al. (2010).  Finally, development of specific pharmacological tools 
to disrupt the interaction between CaV2.2 and AP-1 would be of a great interest 
for a further investigation in modulating CaV2.2 activity at the presynaptic 
terminals.   
 
 
6.4 Conclusion 
This study presents novel evidence that CaV2.2 trafficking in cell lines 
and in cell bodies and neurites of DRG neurons is mediated by AP-1, and is 
fine-tuned by alternative splicing of exon 37.  The difference in the trafficking of 
these splice variants originates in protein sorting in the Golgi network.  
Furthermore, alternative splicing of exon 37 also modulates the trafficking 
pattern of CaV2.2 resulting from D2R interaction and activation.  Blocking the 
interaction of APs with the binding motif in the proximal C-terminus of CaV2.2 
may modulate calcium entry into neuronal cells and its response to dopamine 
receptor activation.  This study has provided a further insight, not only into how 
alternative splicing modulates ion channel trafficking, but also to the key 
mechanisms for CaV2.2 trafficking in neurons.  My findings here potentially lead 
to new studies of AP-mediated trafficking of other VGCCs, as well as other ion 
channels and receptors that are essential for neurotransmission.      
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Appendix 
Supplementary experiments 
Appendix 1: Whole-cell current recordings from N2a cells 
In this study, all the immunocytochemistry experiments and trafficking 
assays were carried out in N2a cells.  However, the electrophysiological 
recordings were performed typically in transfected tsA-201 cells due to their 
robustness in whole-cell patch clamp.  To validate the observations on the cell 
surface expression of CaV2.2 in these experiments, whole-cell current recording 
in N2a cells was performed in order to validate the results and circumvent 
possible differences in the endogenous protein expression in these two different 
cells lines, that might differentially affect the trafficking of CaV2.2.  
N2a cells were transfected with mEos-CaV2.2e37a/b, α2δ-1 and β1b, 
and whole-cell current recording was attempted under the same protocol for 
tsA-201 cells.  The N2a cells expressing CaV2.2 were much more difficult to 
obtain current recordings in whole-cell patch clamp due to the poor seals 
obtained.  Therefore, perforated whole-cell patch clamp was utilised using 200 
μg/ml amphotericin B in 0.4 % DMSO in the internal electrode solution.  The cell 
was held in the cell-attached mode for approximately 5 min until the whole-cell 
access was established by amphotericin B, and the cell capacitance and series 
resistance were compensated prior to the voltage clamp protocol.  
The whole-cell current recordings were obtained, but less successfully 
compared to tsA-201 cells due to the higher series resistance that was not 
compensated sufficiently.  Nevertheless, CaV2.2e37a appeared to exhibit a 
greater whole-cell current density and hyperpolarised shift in its activation, 
compared to CaV2.2e37b in N2a cells (Appendix Figure 1), however, it requires 
more experiments to confirm the electrophysiological properties in N2a cells. 
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Appendix Figure 1: Perforated whole-cell patch clamp of N2a 
cells. 
N2a cells expressing mEos-CaV2.2e37 isoforms show whole-cell 
current densities that are similar to those obtained from tsA-201.  
Peak current density (at -10 mV): mEos-CaV2.2e37a (red), -101.3 
± 13.9 pA/PF (n=10), mEos-CaV2.2e37b (blue), -83.2 ± 16.7 
pA/PF (n=6).  Mean ± SEM. 
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